BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy10445
(425 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 167 bits (424), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 99/248 (39%), Positives = 139/248 (56%), Gaps = 17/248 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK---QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGGQ A +++WPW V++ G FCGGSLI Q VLTAAHCV D+A L V
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVK-DLAALRVQ 59
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + ++ ++++ V R++ H F + D+A+L L++PVK S + + LP
Sbjct: 60 LREQHLYYQDQL----LPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPA 115
Query: 306 RASYE-GKIATVIGWGSLR--ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG-----I 357
++ G V GWG + E P P L++V +P+ N C A+Y A G +
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIV 175
Query: 358 VDHFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
D LCAG +DSC GDSGGPL+ +G W Q G+VSWG GC + PG+YTRVTY++
Sbjct: 176 RDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLD 235
Query: 417 WITKNLKK 424
WI + K
Sbjct: 236 WIHHYVPK 243
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 167 bits (424), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 99/249 (39%), Positives = 139/249 (55%), Gaps = 17/249 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK---QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGGQ A +++WPW V++ G FCGGSLI Q VLTAAHCV D+A L V
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVK-DLAALRVQ 59
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + ++ ++++ V R++ H F + D+A+L L++PVK S + + LP
Sbjct: 60 LREQHLYYQDQL----LPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPA 115
Query: 306 RASYE-GKIATVIGWGSLR--ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG-----I 357
++ G V GWG + E P P L++V +P+ N C A+Y A G +
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIV 175
Query: 358 VDHFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
D LCAG +DSC GDSGGPL+ +G W Q G+VSWG GC + PG+YTRVTY++
Sbjct: 176 RDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLD 235
Query: 417 WITKNLKKN 425
WI + K
Sbjct: 236 WIHHYVPKK 244
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 167 bits (423), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 99/249 (39%), Positives = 139/249 (55%), Gaps = 17/249 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGGQ A +++WPW V++ G FCGGSLI Q VLTAAHCV D+A L V
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVK-DLAALRVQ 59
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + ++ ++++ V R++ H F + D+A+L L++PVK S + + LP
Sbjct: 60 LREQHLYYQDQL----LPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPA 115
Query: 306 RASYE-GKIATVIGWGSLR--ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG-----I 357
++ G V GWG + E P P L++V +P+ N C A+Y A G +
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIV 175
Query: 358 VDHFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
D LCAG +DSC GDSGGPL+ +G W Q G+VSWG GC + PG+YTRVTY++
Sbjct: 176 RDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLD 235
Query: 417 WITKNLKKN 425
WI + K
Sbjct: 236 WIHHYVPKK 244
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 165 bits (417), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 98/249 (39%), Positives = 139/249 (55%), Gaps = 17/249 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK---QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGGQ A +++WPW V++ + FCGGSLI Q VLTAAHCV D+A L V
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVK-DLATLRVQ 59
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + ++ ++++ V R++ H F + D+A+L L++PV S + + LP
Sbjct: 60 LREQHLYYQDQL----LPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPA 115
Query: 306 RASYE-GKIATVIGWGSLR--ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG-----I 357
++ G V GWG + E P P L++V +P+ N C A+Y A G I
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRII 175
Query: 358 VDHFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
D LCAG + +DSC GDSGGPL+ +G W Q G+VSWG GC + PG+YTRVTY++
Sbjct: 176 RDDMLCAGNSQRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLD 235
Query: 417 WITKNLKKN 425
WI + K
Sbjct: 236 WIHHYVPKK 244
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 165 bits (417), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 98/249 (39%), Positives = 139/249 (55%), Gaps = 17/249 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK---QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGGQ A +++WPW V++ + FCGGSLI Q VLTAAHCV D+A L V
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVK-DLATLRVQ 59
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + ++ ++++ V R++ H F + D+A+L L++PV S + + LP
Sbjct: 60 LREQHLYYQDQL----LPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPA 115
Query: 306 RASYE-GKIATVIGWGSLR--ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG-----I 357
++ G V GWG + E P P L++V +P+ N C A+Y A G I
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRII 175
Query: 358 VDHFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
D LCAG + +DSC GDSGGPL+ +G W Q G+VSWG GC + PG+YTRVTY++
Sbjct: 176 RDDMLCAGNSQRDSCKGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLD 235
Query: 417 WITKNLKKN 425
WI + K
Sbjct: 236 WIHHYVPKK 244
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 161 bits (408), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 96/249 (38%), Positives = 138/249 (55%), Gaps = 17/249 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK---QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGGQ A +++WPW V++ + FCGGSLI Q VLTAAHC+ D+A L V
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVK-DLATLRVQ 59
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + ++ ++++ V R++ H F + D+A+L L++PV S + + LP
Sbjct: 60 LREQHLYYQDQL----LPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPA 115
Query: 306 RASYE-GKIATVIGWGSLR--ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG-----I 357
++ G V GWG + E P P L++V +P+ N C A+Y A G I
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRII 175
Query: 358 VDHFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
D LCAG + +DSC GDSGGPL+ +G W Q G+VSW GC + PG+YTRVTY++
Sbjct: 176 RDDMLCAGNSQRDSCKGDSGGPLVCKVNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLD 235
Query: 417 WITKNLKKN 425
WI + K
Sbjct: 236 WIHHYVPKK 244
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 160 bits (406), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 97/246 (39%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V
Sbjct: 19 DDDKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQV 70
Query: 245 NLGDHNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + L
Sbjct: 71 RLGEHNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVAL 127
Query: 303 PRGRASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+
Sbjct: 128 PSSCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNM 182
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
+C G KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI
Sbjct: 183 VCVGFLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQ 239
Query: 420 KNLKKN 425
+ N
Sbjct: 240 DTIAAN 245
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 160 bits (404), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 97/246 (39%), Positives = 142/246 (57%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D + IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V
Sbjct: 7 DDDAIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQV 58
Query: 245 NLGDHNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + L
Sbjct: 59 RLGEHNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL 115
Query: 303 PRGRASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+
Sbjct: 116 PSSCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNM 170
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
+C G KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI
Sbjct: 171 VCVGFLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQ 227
Query: 420 KNLKKN 425
+ N
Sbjct: 228 DTIAAN 233
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 160 bits (404), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 96/246 (39%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V
Sbjct: 7 DDDKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQV 58
Query: 245 NLGDHNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + L
Sbjct: 59 RLGEHNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL 115
Query: 303 PRGRASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+
Sbjct: 116 PSSCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNM 170
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
+C G KDSC GD+GGP++ N G+ GIVSWG GC + PGVYT+V ++ WI
Sbjct: 171 VCVGFLEGGKDSCQGDAGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQ 227
Query: 420 KNLKKN 425
+ N
Sbjct: 228 DTIAAN 233
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 157 bits (396), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 96/242 (39%), Positives = 140/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 157 bits (396), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 96/242 (39%), Positives = 140/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 157 bits (396), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 129/240 (53%), Gaps = 12/240 (5%)
Query: 189 IVGGQNAEQNEWPWVVAI----FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
IVGG +A E+P+ ++ FCG S+ + + +TA HCV + + L +
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
G+ ++ NE V +++ H+ FD L ND+++L L + ++D + I LP
Sbjct: 61 VAGELDMS-VNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALPE 119
Query: 305 GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ G + V GWG+ E G P VLQKV +P+ ++ DC+A YG I+D +CA
Sbjct: 120 QGHTATGDV-IVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADE---ILDSMICA 175
Query: 365 G--RATKDSCTGDSGGPLMVND-GKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G KDSC GDSGGPL +D G GIVSWG GC + YPGVYT V+Y + WI N
Sbjct: 176 GVPEGGKDSCQGDSGGPLAASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDWIKAN 235
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 156 bits (394), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 96/242 (39%), Positives = 136/242 (56%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + I LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG SG P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCNG---ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 155 bits (393), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 140/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GD+GGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDAGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 155 bits (392), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 91/244 (37%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V
Sbjct: 5 DDDKIVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQV 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG+HNI E +++ H F+ TL ND+ ++ L P + + + LPR
Sbjct: 57 RLGEHNIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 115
Query: 305 GRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
A+ G + GWG+ + SG P++LQ + PV +++ CK+ Y PG I + +C
Sbjct: 116 SCAA-AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY----PGQITGNMIC 170
Query: 364 AG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 171 VGFLEGGKDSCQGDSGGPVVCN-GQLQ--GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQT 227
Query: 422 LKKN 425
+ N
Sbjct: 228 IAAN 231
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 155 bits (392), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 96/242 (39%), Positives = 138/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG SG P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 155 bits (392), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 139/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIV WG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVEWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 155 bits (391), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 94/240 (39%), Positives = 133/240 (55%), Gaps = 19/240 (7%)
Query: 189 IVGGQNAEQNEWPWVVAI---FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS-- 243
IVGG N+ EWPW V++ + + CGGSLI Q VLTAAHC + DV ++
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 244 -VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
+NL D I + ++K ++ H+ + + +D+A++ L P+ Y++ + I L
Sbjct: 61 ILNLSD--ITKDTPFS----QIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISL 114
Query: 303 P-RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P +G S V GWG +E G +LQKVNIP+ TN +C+ RY I
Sbjct: 115 PSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYK---ITQRM 171
Query: 362 LCAG--RATKDSCTGDSGGPLMV-NDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
+CAG KD+C GDSGGPL+ ++G W VGI SWG GC + E PGVYT+V +M WI
Sbjct: 172 VCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 155 bits (391), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 139/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIV WG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVKWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 155 bits (391), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 139/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GD GGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDCGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 155 bits (391), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 140/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL N++ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 155 bits (391), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 140/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL N++ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 154 bits (389), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 139/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
K SC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKSSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 154 bits (389), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 130/242 (53%), Gaps = 13/242 (5%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-QFCGGSLIDTQHVLTAAHCVAHMSSW---DVAKLSV 244
+VGG +A++ EWPW V++ G+ CG SLI +++AAHC + D + +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG H+ Q++ ER++KR++ H F+ T D+A+L L+KP +YS +R ICLP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 305 GRASY-EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+ GK V GWG + G +LQK I V C+ + P I +C
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCEN----LLPQQITPRMMC 176
Query: 364 AGRATK--DSCTGDSGGPL--MVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
G + DSC GDSGGPL + DG+ Q G+VSWG GC + PGVYTR+ F WI
Sbjct: 177 VGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIK 236
Query: 420 KN 421
+N
Sbjct: 237 EN 238
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 154 bits (389), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 130/242 (53%), Gaps = 13/242 (5%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-QFCGGSLIDTQHVLTAAHCVAHMSSW---DVAKLSV 244
+VGG +A++ EWPW V++ G+ CG SLI +++AAHC + D + +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG H+ Q++ ER++KR++ H F+ T D+A+L L+KP +YS +R ICLP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 305 GRASY-EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+ GK V GWG + G +LQK I V C+ + P I +C
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCEN----LLPQQITPRMMC 176
Query: 364 AGRATK--DSCTGDSGGPL--MVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
G + DSC GDSGGPL + DG+ Q G+VSWG GC + PGVYTR+ F WI
Sbjct: 177 VGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIK 236
Query: 420 KN 421
+N
Sbjct: 237 EN 238
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 154 bits (389), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 138/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD T ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 154 bits (388), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 94/240 (39%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 191 GGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHN 250
GG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+HN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGEHN 62
Query: 251 IKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
I N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP A
Sbjct: 63 I---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 119
Query: 309 YEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 120 -AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVGFL 174
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI + N
Sbjct: 175 EGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 231
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 153 bits (387), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 132/240 (55%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI E +++ H F+ TL ND+ ++ L P + + + LPR A+
Sbjct: 53 HNIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ + SG P++LQ + PV +N+ CK+ Y PG I + +C G
Sbjct: 112 -AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSY----PGQITGNMICVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
+ KDSC GDSGGP++ N GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 167 QGGKDSCQGDSGGPVVCNG---QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 223
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 152 bits (385), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 90/244 (36%), Positives = 135/244 (55%), Gaps = 13/244 (5%)
Query: 189 IVGGQNAEQNEWPWVVAI---FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGG + EWPW V++ + + CGGSLI Q VLTAAHC + DV ++
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-R 304
+ + + K+ ++K ++ H+ + + +D+A++ L P++Y++ + I LP +
Sbjct: 61 ILELSDITKDTPF---SQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSK 117
Query: 305 GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
G S V GWG +E G +LQKVNIP+ TN +C+ RY I +CA
Sbjct: 118 GDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYK---ITQRMVCA 174
Query: 365 G--RATKDSCTGDSGGPLMV-NDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G KD+C GDSGGPL+ ++G W VGI SWG GC + E PGVYT+V +M WI +
Sbjct: 175 GYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEK 234
Query: 422 LKKN 425
+ +
Sbjct: 235 TQSS 238
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 152 bits (384), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 93/240 (38%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 191 GGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHN 250
GG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+HN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGEHN 62
Query: 251 IKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
I N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP A
Sbjct: 63 I---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 119
Query: 309 YEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 120 -AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVGFL 174
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC G+SGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI + N
Sbjct: 175 EGGKDSCQGNSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 231
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 152 bits (384), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 93/240 (38%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 191 GGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHN 250
GG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+HN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGEHN 62
Query: 251 IKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
I N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP A
Sbjct: 63 I---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 119
Query: 309 YEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ SG +P +L+ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 120 -AGTQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASY----PGKITDNMVCVGFL 174
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI + N
Sbjct: 175 EGGKDSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 231
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 151 bits (382), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 99/270 (36%), Positives = 150/270 (55%), Gaps = 25/270 (9%)
Query: 175 CGQKNGYQDLDQERIVGGQN-AEQNEWPWVVAIFN------SGKQ--FCGGSLIDTQHVL 225
CG +N + LD +I G N AE E+PW+VA+ SG++ CGGSLI VL
Sbjct: 118 CGIRN-ERGLDF-KITGQTNEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVL 175
Query: 226 TAAHCV-AHMSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAI 284
T AHCV ++ S+ D K+ D + +K + + ERK+++++ H F+ +T+ NDVA+
Sbjct: 176 TGAHCVNSYQSNLDAIKIRAGEWD-TLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVAL 234
Query: 285 LTLDKPVKYSDTIRAICLPRGRASYEGKIATVIGWGSLRESGPQ---PAVLQKVNIPVWT 341
L LD+P+ +D I ICLP+ ++ GWG +E G + +L+K+ +P
Sbjct: 235 LLLDRPLVQADNIGTICLPQQSQIFDSTECFASGWGK-KEFGSRHRYSNILKKIQLPTVD 293
Query: 342 NADCKA--RYGPVAPGGIVDH-FLCA-GRATKDSCTGDSGGPLMV----NDGKWTQVGIV 393
C+A R + ++D F+CA G KD+CTGD G PL N ++ Q+GIV
Sbjct: 294 RDKCQADLRNTRLGLKFVLDQTFVCAGGEQGKDTCTGDGGSPLFCPDPRNPSRYMQMGIV 353
Query: 394 SWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
+WGIGCG PGVY V +F WI + ++
Sbjct: 354 AWGIGCGDENVPGVYANVAHFRNWIDQEMQ 383
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 151 bits (381), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 94/242 (38%), Positives = 138/242 (57%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD +TL ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A Y PG I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY----PGKITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
K SC GDSGGP++ N G+ GIVSWG GC + P VYT+V ++ WI +
Sbjct: 165 FLEGGKGSCQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPDVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 151 bits (381), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 131/240 (54%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI E +++ H F+ TL ND+ ++ L P + + + LPR A+
Sbjct: 53 HNIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ + SG P++LQ + PV +++ CK+ Y PG I + +C G
Sbjct: 112 -AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY----PGQITGNMICVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 167 EGGKDSCQGDSGGPVVCNG---QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 223
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 150 bits (380), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 130/240 (54%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI E +++ H F+ TL ND+ ++ L P + + LPR A+
Sbjct: 53 HNIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPRSCAA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ + SG P++LQ + PV +++ CK+ Y PG I + +C G
Sbjct: 112 -AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY----PGQITGNMICVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 167 EGGKDSCQGDSGGPVVCNG---QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 223
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 150 bits (380), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 131/240 (54%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCAANSVPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI E +++ H F+ TL ND+ ++ L P + + + LPR A+
Sbjct: 53 HNIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ + SG P++LQ + PV +++ CK+ Y PG I + +C G
Sbjct: 112 -AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAY----PGQITGNMICVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 167 EGGKDSCQGDSGGPVVCNG---QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 223
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 150 bits (380), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 129/242 (53%), Gaps = 13/242 (5%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-QFCGGSLIDTQHVLTAAHCVAHMSSW---DVAKLSV 244
+VGG +A++ EWPW V++ G+ CG SLI +++AAHC + D + +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG H+ Q++ ER++KR++ H F+ T D+A+L L+KP +YS +R I LP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPD 120
Query: 305 GRASY-EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+ GK V GWG + G +LQK I V C+ + P I +C
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCEN----LLPQQITPRMMC 176
Query: 364 AGRATK--DSCTGDSGGPL--MVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
G + DSC GDSGGPL + DG+ Q G+VSWG GC + PGVYTR+ F WI
Sbjct: 177 VGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIK 236
Query: 420 KN 421
+N
Sbjct: 237 EN 238
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 150 bits (378), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 88/239 (36%), Positives = 130/239 (54%), Gaps = 20/239 (8%)
Query: 190 VGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDH 249
VGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V LG+H
Sbjct: 2 VGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQVRLGEH 53
Query: 250 NIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRASY 309
NI E +++ H F+ TL ND+ ++ L P + + + LPR A+
Sbjct: 54 NIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA- 111
Query: 310 EGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + GWG+ + SG P++LQ + PV +++ CK+ Y PG I + +C G
Sbjct: 112 AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY----PGQITGNMICVGFLE 167
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 168 GGKDSCQGDSGGPVVCNG---QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 223
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 149 bits (377), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 88/243 (36%), Positives = 128/243 (52%), Gaps = 15/243 (6%)
Query: 187 ERIVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
RIV G+ A WPW V++ + +G FCGGSLI+ V+TAAHC S VA
Sbjct: 14 SRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA----- 68
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G+ + +E K + K+ ++ ++ ++ T+ ND+ +L L +S T+ A+CLP
Sbjct: 69 -GEFDQGSSSE-KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSA 126
Query: 306 RASYE-GKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+ G GWG R + P LQ+ ++P+ +N +CK +G I D +C
Sbjct: 127 SDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGT----KIKDAMIC 182
Query: 364 AGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
AG + SC GDSGGPL+ +G WT VGIVSWG PGVY RVT + W+ + L
Sbjct: 183 AGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 242
Query: 423 KKN 425
N
Sbjct: 243 AAN 245
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 149 bits (375), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 82/238 (34%), Positives = 129/238 (54%), Gaps = 8/238 (3%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++ + WPWVVA++ +Q CG SL+ +++AAHCV + + + +K LG
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCV-YGRNMEPSKWKAVLGL 59
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H + R + ++V + ++ R ND+A++ L+ V Y+D I+ ICLP
Sbjct: 60 HMASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQV 119
Query: 309 Y-EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
+ G+I ++ GWG+L G VLQ+ ++P+ +N C+ + + I ++ +CAG
Sbjct: 120 FPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQ---MPEYNITENMVCAGYE 176
Query: 368 TK--DSCTGDSGGPLMVND-GKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
DSC GDSGGPLM + +W G+ S+G C PGVY RV F WI L
Sbjct: 177 AGGVDSCQGDSGGPLMCQENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQSFL 234
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 147 bits (371), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 95/285 (33%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 161 VPVTTTEAGKVDMSCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLID 220
+ V G+ + Q G + L +RIVGG++ WPW V++ G CGGSL+
Sbjct: 90 ISVCDCPRGRFLAAICQDCGRRKLPVDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLS 149
Query: 221 TQHVLTAAHCVAH----MSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAF--- 273
VLTAAHC +S W V +V + ++ V+ +V H +
Sbjct: 150 GDWVLTAAHCFPERNRVLSRWRVFAGAV--------AQASPHGLQLGVQAVVYHGGYLPF 201
Query: 274 ---DMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRASYEGKIATVIGWGSLRESGPQP 329
+ ND+A++ L P+ ++ I+ +CLP G+A +GKI TV GWG+ + G Q
Sbjct: 202 RDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQA 261
Query: 330 AVLQKVNIPVWTNADCKAR--YGPVAPGGIVDHFLCAG--RATKDSCTGDSGGPLMVNDG 385
VLQ+ +P+ +N C YG I CAG D+C GDSGGP + D
Sbjct: 262 GVLQEARVPIISNDVCNGADFYG----NQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDS 317
Query: 386 -----KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
+W GIVSWG GC + PGVYT+V+ F WI + +K +
Sbjct: 318 ISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTH 362
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 147 bits (371), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 95/285 (33%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 161 VPVTTTEAGKVDMSCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLID 220
+ V G+ + Q G + L +RIVGG++ WPW V++ G CGGSL+
Sbjct: 90 ISVCDCPRGRFLAAICQDCGRRKLPVDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLS 149
Query: 221 TQHVLTAAHCVAH----MSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAF--- 273
VLTAAHC +S W V +V + ++ V+ +V H +
Sbjct: 150 GDWVLTAAHCFPERNRVLSRWRVFAGAV--------AQASPHGLQLGVQAVVYHGGYLPF 201
Query: 274 ---DMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRASYEGKIATVIGWGSLRESGPQP 329
+ ND+A++ L P+ ++ I+ +CLP G+A +GKI TV GWG+ + G Q
Sbjct: 202 RDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQA 261
Query: 330 AVLQKVNIPVWTNADCKAR--YGPVAPGGIVDHFLCAG--RATKDSCTGDSGGPLMVNDG 385
VLQ+ +P+ +N C YG I CAG D+C GDSGGP + D
Sbjct: 262 GVLQEARVPIISNDVCNGADFYG----NQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDS 317
Query: 386 -----KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
+W GIVSWG GC + PGVYT+V+ F WI + +K +
Sbjct: 318 ISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTH 362
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 127/241 (52%), Gaps = 15/241 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IV G+ A WPW V++ + +G FCGGSLI+ V+TAAHC S VA G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA------G 54
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
+ + +E K + K+ ++ ++ ++ T+ ND+ +L L +S T+ A+CLP
Sbjct: 55 EFDQGSSSE-KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD 113
Query: 308 SYE-GKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
+ G GWG R + P LQ+ ++P+ +N +CK +G I D +CAG
Sbjct: 114 DFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGT----KIKDAMICAG 169
Query: 366 RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKK 424
+ SC GDSGGPL+ +G WT VGIVSWG PGVY RVT + W+ + L
Sbjct: 170 ASGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAA 229
Query: 425 N 425
N
Sbjct: 230 N 230
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/245 (35%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG++ + E PW V + +G Q CGG+LI+T V++AAHC + +W L LG+
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNW--RNLIAVLGE 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H++ + + + R+V +++ + T +D+A+L L +PV +D + +CLP S
Sbjct: 59 HDLSEHDGDEQ-SRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFS 117
Query: 309 YEG----KIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPG-GIVDHFLC 363
+ + V GWG L + G VLQ +N+P DC + V I ++ C
Sbjct: 118 ERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFC 177
Query: 364 AGRA--TKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG + +KDSC GDSGGP + G W GIVSWG GC + GVYTRV+ ++ W+ K
Sbjct: 178 AGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQK 237
Query: 421 NLKKN 425
++
Sbjct: 238 LMRSE 242
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 146 bits (369), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 90/248 (36%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I GG +A +WPW V+I G CGGSL+ Q VL+AAHC S V LG
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFP--SEHHKEAYEVKLGA 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H + +E V +K ++ H ++ D+A+L L +P+ +S IR I LP +AS
Sbjct: 59 HQLDSYSEDAKV-STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQAS 117
Query: 309 Y-EGKIATVIGWGSLRES----GPQPAVLQKVNIPVWTNADCKARYG----PVAPGGIVD 359
+ G TV GWG + S P+P LQ++ +P+ + C + Y P P + +
Sbjct: 118 FPNGLHCTVTGWGHVAPSVSLLTPKP--LQQLEVPLISRETCNSLYNIDAKPEEPHFVQE 175
Query: 360 HFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
+CAG KD+C GDSGGPL +G W GIVSWG CG PGVYT + +
Sbjct: 176 DMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYAS 235
Query: 417 WITKNLKK 424
WI + +
Sbjct: 236 WIQSKVTE 243
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 146 bits (369), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 90/248 (36%), Positives = 126/248 (50%), Gaps = 17/248 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I GG +A +WPW V+I G CGGSL+ Q VL+AAHC S V LG
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFP--SEHHKEAYEVKLGA 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H + +E V +K ++ H ++ D+A+L L +P+ +S IR I LP +AS
Sbjct: 59 HQLDSYSEDAKV-STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQAS 117
Query: 309 Y-EGKIATVIGWGSLRES----GPQPAVLQKVNIPVWTNADCKARYG----PVAPGGIVD 359
+ G TV GWG + S P+P LQ++ +P+ + C + Y P P + +
Sbjct: 118 FPNGLHCTVTGWGHVAPSVSLLTPKP--LQQLEVPLISRETCNSLYNIDAKPEEPHFVQE 175
Query: 360 HFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
+CAG KD+C GDSGGPL +G W GIVSWG CG PGVYT + +
Sbjct: 176 DMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYAS 235
Query: 417 WITKNLKK 424
WI + +
Sbjct: 236 WIQSKVTE 243
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 146 bits (368), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 91/248 (36%), Positives = 125/248 (50%), Gaps = 17/248 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I GG +A +WPW V+I G CGGSL+ Q VL+AAHC S V LG
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFP--SEHHKEAYEVKLGA 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H + +E V +K ++ H ++ D+A+L L +P+ +S IR I LP AS
Sbjct: 59 HQLDSYSEDAKV-STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANAS 117
Query: 309 Y-EGKIATVIGWGSLRES----GPQPAVLQKVNIPVWTNADCKARYG----PVAPGGIVD 359
+ G TV GWG + S P+P LQ++ +P+ + C A Y P P + +
Sbjct: 118 FPNGLHCTVTGWGHVAPSVSLLTPKP--LQQLEVPLISRETCNALYNIDAKPEEPHFVQE 175
Query: 360 HFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
+CAG KD+C GDSGGPL +G W GIVSWG CG PGVYT + +
Sbjct: 176 DMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYAS 235
Query: 417 WITKNLKK 424
WI + +
Sbjct: 236 WIQSKVTE 243
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 145 bits (367), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 136/246 (55%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V
Sbjct: 11 DDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQV 62
Query: 245 NLGDHNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+ NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I L
Sbjct: 63 RLGEDNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 119
Query: 303 PRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I +
Sbjct: 120 PTSCAS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNM 174
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI
Sbjct: 175 FCAGYLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIK 231
Query: 420 KNLKKN 425
+ + N
Sbjct: 232 QTIASN 237
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 145 bits (367), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 136/246 (55%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V
Sbjct: 17 DDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQV 68
Query: 245 NLGDHNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+ NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I L
Sbjct: 69 RLGEDNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 125
Query: 303 PRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I +
Sbjct: 126 PTSCAS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNM 180
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI
Sbjct: 181 FCAGYLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Query: 420 KNLKKN 425
+ + N
Sbjct: 238 QTIASN 243
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 145 bits (367), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 93/246 (37%), Positives = 132/246 (53%), Gaps = 17/246 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIF--NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
IVGG A E+PW V++ +S FCGGS+I+ + V+ AAHC M A +S+ +
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHC---MQGEAPALVSLVV 57
Query: 247 GDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
G+H+ + V+ V + ++ +D TL NDV+++ + + + IC P
Sbjct: 58 GEHDSSAASTVRQTH-DVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPA 116
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA- 364
Y + + GWG++ G PAVL+ V + + TNA C A Y I D +CA
Sbjct: 117 NDYVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVY---TSDTIYDDMICAT 173
Query: 365 ---GRATKDSCTGDSGGPLMVNDGK--WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
G +DSC GDSGGPL V DG ++ VGIVSWGIGC G YPGVY+RV + WIT
Sbjct: 174 DNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCASG-YPGVYSRVGFHAGWIT 232
Query: 420 KNLKKN 425
+ N
Sbjct: 233 DTITNN 238
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 145 bits (367), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 135/246 (54%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V
Sbjct: 2 DDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQV 53
Query: 245 NLGDHNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+ NI N V+ E+ + + H +++ TL ND+ ++ L + + +I L
Sbjct: 54 RLGEDNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 110
Query: 303 PRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I +
Sbjct: 111 PTSCAS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNM 165
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI
Sbjct: 166 FCAGYLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIK 222
Query: 420 KNLKKN 425
+ + N
Sbjct: 223 QTIASN 228
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 145 bits (366), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 135/246 (54%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V
Sbjct: 3 DDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQV 54
Query: 245 NLGDHNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+ NI N V+ E+ + + H +++ TL ND+ ++ L + + +I L
Sbjct: 55 RLGEDNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 111
Query: 303 PRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I +
Sbjct: 112 PTSCAS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNM 166
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI
Sbjct: 167 FCAGYLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIK 223
Query: 420 KNLKKN 425
+ + N
Sbjct: 224 QTIASN 229
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 145 bits (366), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 136/242 (56%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++N P+ V++ NSG FCGGSLI+ Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
HNI N ++ E+ V ++++H FD T ND+ ++ L PVK + + + LP
Sbjct: 53 HNI---NVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 307 ASYEGKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
A G + GWG+ SG +P +LQ ++ P+ ADC+A + I D+ +C G
Sbjct: 110 AP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASSSFI----ITDNMVCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP++ N G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 165 FLEGGKDACQGDSGGPVVCN-GELQ--GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
Query: 424 KN 425
N
Sbjct: 222 AN 223
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 145 bits (366), Expect = 5e-35, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 127/240 (52%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N E+N P+ V++ NSG FCGGSLI+ Q V++A HC +++ V LG+
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI+ + K ++RH +D +TL ND+ ++ L + + I LP +
Sbjct: 53 HNIEVLEGNEQFINAAK-IIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ SG P LQ ++ PV + A C+A Y PG I + C G
Sbjct: 112 -TGTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASY----PGKITSNMFCVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N G+VSWG GC + PGVYT+V ++ WI + N
Sbjct: 167 EGGKDSCQGDSGGPVVCNG---QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN 223
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 145 bits (365), Expect = 5e-35, Method: Compositional matrix adjust.
Identities = 89/236 (37%), Positives = 131/236 (55%), Gaps = 14/236 (5%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG++A ++P+ V++ SG CG S++D +VLTAAHCV +S+ + +L V++G
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDGLSNLN--RLKVHVGT 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
+ + + +V VE V +K +D L NDVA++ L P+K++D ++ I L
Sbjct: 59 NYLSESGDVYDVEDAVV----NKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTNDED 114
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRAT 368
E T+ GWGS R G P LQ++ + V C+ V I H +
Sbjct: 115 LESNPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQWRV----IDSHICTLTKRG 170
Query: 369 KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKK 424
+ +C GDSGGPL+ N Q+GIVS+G C GE P VYTRV+ F+ WI NLKK
Sbjct: 171 EGACHGDSGGPLVAN---GAQIGIVSFGSPCALGE-PDVYTRVSSFVSWINANLKK 222
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 144 bits (364), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 91/246 (36%), Positives = 136/246 (55%), Gaps = 24/246 (9%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
D ++IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V
Sbjct: 17 DDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQV 68
Query: 245 NLGDHNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICL 302
LG+ NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I L
Sbjct: 69 RLGEDNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 125
Query: 303 PRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I +
Sbjct: 126 PTSCAS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNM 180
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG KDSC GD+GGP+ V GK GIVSWG GC + PGVYT+V ++ WI
Sbjct: 181 FCAGYLEGGKDSCQGDAGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Query: 420 KNLKKN 425
+ + N
Sbjct: 238 QTIASN 243
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 144 bits (362), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 88/240 (36%), Positives = 127/240 (52%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N E+N P+ V++ NSG FCGGSLI+ Q V++A HC +++ V LG+
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI+ E +++RH +D +TL ND+ ++ L + + I LP +
Sbjct: 53 HNIEVL-EGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPPA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ SG P LQ ++ PV + A C+A Y PG I + C G
Sbjct: 112 -TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASY----PGKITSNMFCVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GD+GGP++ N G+VSWG GC + PGVYT+V ++ WI + N
Sbjct: 167 EGGKDSCQGDAGGPVVCNG---QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAAN 223
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 144 bits (362), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 85/240 (35%), Positives = 125/240 (52%), Gaps = 19/240 (7%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+ ++IVGG + P V++ NSG FCGGSL++ V++AAHC +++ V
Sbjct: 17 EDDKIVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEV 68
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG+HNIK + R++RH + + ND+ ++ L KP + ++ + LP
Sbjct: 69 RLGEHNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 127
Query: 305 GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
A G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CA
Sbjct: 128 SCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY----PGMITNAMFCA 182
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 183 GYLEGGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 239
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 143 bits (361), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 84/240 (35%), Positives = 126/240 (52%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG +N + ++ SG FCGGSLI + V++AAHC +++ V LG+
Sbjct: 1 IVGGYECRKNSASYQASL-QSGYHFCGGSLISSTWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI + VK ++ H +++ R L ND+ ++ L KP + + + LP AS
Sbjct: 53 HNIAVNEGTEQFIDSVK-VIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSCAS 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G V GWG+L S P L+ +++P+ +++ C + Y PG I + CAG
Sbjct: 112 -SGTRCLVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAY----PGQITSNMFCAGFM 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC GDSGGP++ N G+VSWG GC + PGVYT+V + WI+ + N
Sbjct: 167 EGGKDSCQGDSGGPVVCNG---QLQGVVSWGYGCAQRNKPGVYTKVCNYRSWISSTMSSN 223
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 142 bits (359), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 122/239 (51%), Gaps = 15/239 (6%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-S 243
RIVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 387 RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 446
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R ICLP
Sbjct: 447 GILNQSEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLP 502
Query: 304 -RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
+G + V GWG + LQK IP+ TN +C+ RY I +
Sbjct: 503 SKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMI 559
Query: 363 CAG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
CAG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI
Sbjct: 560 CAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 618
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 141 bits (356), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 129/238 (54%), Gaps = 8/238 (3%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG +A++ WPWVV ++ + CG SL+ + +++AAHCV + + + +K + LG
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCV-YGRNLEPSKWTAILGL 59
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H + V R + +V + ++ R ND+A++ L+ V Y+D I+ I LP
Sbjct: 60 HMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQV 119
Query: 309 Y-EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
+ G+ ++ GWG++ G +LQ+ ++P+ +N C+ + + I ++ +CAG
Sbjct: 120 FPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQ---MPEYNITENMICAGYE 176
Query: 366 RATKDSCTGDSGGPLMVND-GKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
DSC GDSGGPLM + +W G+ S+G C PGVY RV+ F WI L
Sbjct: 177 EGGIDSCQGDSGGPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQSFL 234
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 141 bits (356), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 122/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + P V++ NSG FCGGSL++ V++AAHC +++ V LG+
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L KP + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 141 bits (356), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCXK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 XLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 141 bits (356), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 122/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + P V++ NSG FCGGSL++ V++AAHC +++ V LG+
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L KP + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 141 bits (356), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 124/240 (51%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E+N P+ V++ NSG FCGGSLI Q V++AAHC ++ V LG+
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGSHFCGGSLISEQWVVSAAHCYK-------TRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + VK ++RH ++ TL ND+ ++ L P + + I LP +
Sbjct: 53 HNIKVLEGNEQFINAVK-IIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ G P L+ ++ PV T A+CKA Y PG I + C G
Sbjct: 112 -AGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY----PGKITNSMFCVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC DSGGP++ N G+VSWG GC PGVYT+V ++ WI + N
Sbjct: 167 EGGKDSCQRDSGGPVVCNG---QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN 223
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 141 bits (356), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 141 bits (356), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 123/236 (52%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + P V++ NSG FCGGSL++ V++AAHC ++++V LG+
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVAVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L KP + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 141 bits (355), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 91/240 (37%), Positives = 132/240 (55%), Gaps = 23/240 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
DSC GDSGGP+ V GK GIVSWG GC K + PGVYT+V ++ WI + + N
Sbjct: 165 LEGGDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAKNK-PGVYTKVCNYVSWIKQTIASN 220
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 141 bits (355), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 122/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + P V++ NSG FCGGSL++ V++AAHC +++ V LG+
Sbjct: 1 IVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L KP + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 141 bits (355), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 141 bits (355), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ + + CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 141 bits (355), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 84/240 (35%), Positives = 124/240 (51%), Gaps = 19/240 (7%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+ ++IVGG + V++ NSG FCGGSL++ V++AAHC +++ V
Sbjct: 12 EDDKIVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEV 63
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG+HNIK + R++RH + + ND+ ++ L KP + ++ + LP
Sbjct: 64 RLGEHNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 122
Query: 305 GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
A G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CA
Sbjct: 123 SCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY----PGMITNAMFCA 177
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 178 GYLEGGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 234
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 140 bits (354), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 84/245 (34%), Positives = 130/245 (53%), Gaps = 11/245 (4%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ + E PW V + +G Q CGG+LI+T V++AAHC + +W L LG+
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNW--RNLIAVLGE 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H++ + + + R+V +++ + T +D+A+L L +PV +D + +CLP S
Sbjct: 59 HDLSEHDGDEQ-SRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFS 117
Query: 309 YEG----KIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPG-GIVDHFLC 363
+ + V GWG L + G L +N+P DC + V I ++ C
Sbjct: 118 ERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFC 177
Query: 364 AGRA--TKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG + +KDSC GDSGGP + G W GIVSWG GC + GVYTRV+ ++ W+ K
Sbjct: 178 AGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQK 237
Query: 421 NLKKN 425
++
Sbjct: 238 LMRSE 242
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 140 bits (354), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 121/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + P V++ NSG FCGGSL++ V++AAHC ++ V LG+
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------TRVEVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L KP + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTSTM 219
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 140 bits (354), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 91/238 (38%), Positives = 129/238 (54%), Gaps = 24/238 (10%)
Query: 190 VGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDH 249
VGG N P+ V++ NSG FCGGSLID+Q V++AAHC + + V LG+
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLIDSQWVVSAAHCYK-------SGIQVRLGED 53
Query: 250 NIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
NI N V+ E+ + + H ++D TL ND+ ++ L + +I LP A
Sbjct: 54 NI---NVVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSCA 110
Query: 308 SYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG- 365
S G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 111 S-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAGY 165
Query: 366 -RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 166 LEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 140 bits (353), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 89/257 (34%), Positives = 128/257 (49%), Gaps = 32/257 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAH----MSSWDVAKLSV 244
IVGG++ WPW V++ G CGGSL+ VLTAAHC +S W V +V
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAV 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAF------DMRTLYNDVAILTLDKPVKYSDTIR 298
+ ++ V+ +V H + + ND+A++ L P+ ++ I+
Sbjct: 61 --------AQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQ 112
Query: 299 AICLP-RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPG 355
+CLP G+A +GKI TV GWG+ + G Q VLQ+ +P+ +N C YG
Sbjct: 113 PVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYG----N 168
Query: 356 GIVDHFLCAG--RATKDSCTGDSGGPLMVNDG-----KWTQVGIVSWGIGCGKGEYPGVY 408
I CAG D+C GDSGGP + D +W GIVSWG GC + PGVY
Sbjct: 169 QIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVY 228
Query: 409 TRVTYFMPWITKNLKKN 425
T+V+ F WI + +K +
Sbjct: 229 TKVSDFREWIFQAIKTH 245
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 140 bits (352), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + H +++ TL ND+ ++ L + + ++ LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCAGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 140 bits (352), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 92/243 (37%), Positives = 134/243 (55%), Gaps = 25/243 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDT-IRAICLPRG 305
NI N V+ E+ + + + H +++ TL ND+ ++ L D+ + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTS 109
Query: 306 RASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CA
Sbjct: 110 CAS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCA 164
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 GYLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 221
Query: 423 KKN 425
N
Sbjct: 222 ASN 224
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 139 bits (351), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GD GGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDXGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 139 bits (351), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 139 bits (350), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 83/241 (34%), Positives = 123/241 (51%), Gaps = 18/241 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGG N + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ E +V+ +++H F T D+A+L L P+ + + LP
Sbjct: 56 DRNTEQE-EGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPP 114
Query: 308 SYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG- 365
+ G + GWG+ SG P LQ ++ PV + A C+A Y PG I + C G
Sbjct: 115 A-TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASY----PGKITSNMFCVGF 169
Query: 366 -RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKK 424
KDSC GDSGGP++ N G+VSWG GC + PGVYT+V ++ WI +
Sbjct: 170 LEGGKDSCQGDSGGPVVCNG---QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAA 226
Query: 425 N 425
N
Sbjct: 227 N 227
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 139 bits (349), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 88/240 (36%), Positives = 123/240 (51%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E+N P+ V++ NSG FCGGSLI Q V++AAHC ++ V LG+
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGSHFCGGSLISEQWVVSAAHCYK-------TRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + K ++RH ++ TL ND+ ++ L P + + I LP +
Sbjct: 53 HNIKVLEGNEQFINAAK-IIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ G P L+ ++ PV T A+CKA Y PG I + C G
Sbjct: 112 -AGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY----PGKITNSMFCVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC D+GGP++ N G+VSWG GC PGVYT+V ++ WI + N
Sbjct: 167 EGGKDSCQRDAGGPVVCNG---QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN 223
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 139 bits (349), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 84/236 (35%), Positives = 121/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + V++ NSG FCGGSL++ V++AAHC +++ V LG+
Sbjct: 1 IVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L KP + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFSDWLTSTM 219
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 84/236 (35%), Positives = 121/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG + P V++ NSG FCGGSL++ V++AAHC +++ V LG+
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYK-------SRVEVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + R++RH + + ND+ ++ L K + ++ + LP A
Sbjct: 53 HNIKVTEGSEQFISS-SRVIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALPSSCAP 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
G + TV GWG+ S LQ +NIP+ + +DC Y PG I + CAG
Sbjct: 112 -AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY----PGMITNAMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + PGVY +V F W+T +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 90/242 (37%), Positives = 132/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ R ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 138 bits (347), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 88/243 (36%), Positives = 123/243 (50%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R ICLP
Sbjct: 61 ILNQSEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 138 bits (347), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 88/240 (36%), Positives = 123/240 (51%), Gaps = 20/240 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E+N P+ V++ NSG FCGGSLI Q V++AAHC ++ V LG+
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGYHFCGGSLISEQWVVSAAHCYK-------TRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNIK + K ++RH ++ TL ND+ ++ L P + + I LP +
Sbjct: 53 HNIKVLEGNEQFINAAK-IIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPA 111
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + GWG+ G P L+ ++ PV T A+CKA Y PG I + C G
Sbjct: 112 -AGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY----PGKITNSMFCVGFL 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
KDSC D+GGP++ N G+VSWG GC PGVYT+V ++ WI + N
Sbjct: 167 EGGKDSCQRDAGGPVVCNG---QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAAN 223
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 138 bits (347), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 130/238 (54%), Gaps = 24/238 (10%)
Query: 190 VGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDH 249
VGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGED 53
Query: 250 NIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
NI N V+ E+ + + H +++ TL ND+ ++ L + + +I LP A
Sbjct: 54 NI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA 110
Query: 308 SYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG- 365
S G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CAG
Sbjct: 111 S-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAGY 165
Query: 366 -RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 166 LEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 137 bits (346), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 88/243 (36%), Positives = 123/243 (50%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R ICLP
Sbjct: 61 ILNQAEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 137 bits (346), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 96/260 (36%), Positives = 130/260 (50%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE+ PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A+L L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP RA Y+G+ V GWG+LRE+ QP+VLQ VN+P+ CKA
Sbjct: 120 LPDKQTVTSLLRAGYKGR---VTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAS 176
Query: 349 YGPVAPGGIVDHFLCAGRATKDS-----CTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+ C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RKGKYGFYTHVFRLKAWIQK 252
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 137 bits (344), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 137/245 (55%), Gaps = 22/245 (8%)
Query: 189 IVGGQN-AEQNEWPWVVAIFNSGKQFC-GGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
IVGG + N P+ V++ NSG FC GGSLI++Q V++AAHC +++ V L
Sbjct: 1 IVGGYTCSAANSIPYQVSL-NSGSHFCSGGSLINSQWVVSAAHCSYK------SRIQVRL 53
Query: 247 GDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
G+HNI E +++ H F+ TL ND+ ++ L P + + + LPR
Sbjct: 54 GEHNIDVL-EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC 112
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQ-KVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
A+ + + + GWG+ + SG P++LQ + PV +++ CK+ Y PG I + +C
Sbjct: 113 AAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSY----PGQITGNMICV 168
Query: 365 G--RATKDSCT-GDSGGPLMVNDGKWTQVGIVSWGIGC-GKGEYPGVYTRVTYFMPWITK 420
G KDSC+ GDSGGP++ ++G+ GIVSWG GC + PGVYT+V ++ WI +
Sbjct: 169 GFLEGGKDSCSQGDSGGPVVCSNGQLQ--GIVSWGYGCSAQKNKPGVYTKVCNYVNWIQQ 226
Query: 421 NLKKN 425
+ N
Sbjct: 227 TIAAN 231
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 137 bits (344), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 97/279 (34%), Positives = 137/279 (49%), Gaps = 42/279 (15%)
Query: 177 QKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHM 234
+K ++ + RIV GQ+AE PW V +F Q CG SLI + VLTAAHC+ +
Sbjct: 38 EKELFESYIEGRIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY- 96
Query: 235 SSWD----VAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN-------DVA 283
WD V L V +G H+ + ERKV+++ + YN D+A
Sbjct: 97 PPWDKNFTVDDLLVRIGKHSRTR------YERKVEKISMLDKIYIHPRYNWKENLDRDIA 150
Query: 284 ILTLDKPVKYSDTIRAICLPRGRAS----YEGKIATVIGWGSLRESGP------QPAVLQ 333
+L L +P++ SD I +CLP + + + G V GWG+ RE+ QP+VLQ
Sbjct: 151 LLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQ 210
Query: 334 KVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA-----TKDSCTGDSGGPLMVN---DG 385
VN+P+ CKA I D+ CAG D+C GDSGGP ++ +
Sbjct: 211 VVNLPLVERPVCKAS----TRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNN 266
Query: 386 KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKK 424
+W Q+GIVSWG GC + G YT V WI K + +
Sbjct: 267 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR 305
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 88/243 (36%), Positives = 122/243 (50%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R ICLP
Sbjct: 61 ILNQAEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 95/260 (36%), Positives = 130/260 (50%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE+ PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A+L L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP RA Y+G+ V GWG+LRE+ QP+VLQ VN+P+ CKA
Sbjct: 120 LPDKQTVTSLLRAGYKGR---VTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAS 176
Query: 349 YGPVAPGGIVDHFLCAGRATKDS-----CTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+ C GD+GGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RKGKYGFYTHVFRLKRWIQK 252
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 135 bits (341), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 92/254 (36%), Positives = 128/254 (50%), Gaps = 30/254 (11%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWGQPSVLQVVNLPIVERPVCKDS----TR 172
Query: 355 GGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCGKGEYPG 406
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC + G
Sbjct: 173 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 232
Query: 407 VYTRVTYFMPWITK 420
YT V WI K
Sbjct: 233 FYTHVFRLKKWIQK 246
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 135 bits (341), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 87/243 (35%), Positives = 122/243 (50%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L I + V+ ++ H + M D+A+L L+ V Y+D+ R ICLP
Sbjct: 61 ILNQAEIAEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 135 bits (340), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 93/254 (36%), Positives = 129/254 (50%), Gaps = 31/254 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
LP +A Y+G+ V GWG+L+E+G QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETG-QPSVLQVVNLPIVERPVCKDS----TR 171
Query: 355 GGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCGKGEYPG 406
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC + G
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 407 VYTRVTYFMPWITK 420
YT V WI K
Sbjct: 232 FYTHVFRLKKWIQK 245
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 135 bits (339), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 88/233 (37%), Positives = 121/233 (51%), Gaps = 18/233 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG A N WP A+F FCGGSLI + +LTAAHC+ DV LG
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGFVDVV-----LGA 55
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI++ +E V + H+ ++ + ND+A++ L PV + I + LP
Sbjct: 56 HNIRE-DEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPSTDVG 114
Query: 309 YEGKIATVIGWGSLRESGPQPA-VLQKVNIPVWTNADCKARYGPVAPGGI-VDHFLCAGR 366
G + T GWG +S + VL++V++P+ +NADC A YG V G I +D
Sbjct: 115 V-GTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGIVTDGNICIDS-----T 168
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPWI 418
K +C GDSGGPL N + GI S+G G + YP +TRVTYF+ WI
Sbjct: 169 GGKGTCNGDSGGPLNYNGLTY---GITSFGAAAGCEAGYPDAFTRVTYFLDWI 218
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 120/238 (50%), Gaps = 15/238 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R I LP
Sbjct: 61 ILNQSEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGERNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 87/247 (35%), Positives = 136/247 (55%), Gaps = 20/247 (8%)
Query: 188 RIVGGQNAEQNEWPWVVAIF----NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
R+VGG++A + WPW +++ N+ + CGG+LI HVLTAAHC+++ ++ VA
Sbjct: 13 RVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYRVA--- 69
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP 303
LG +N++ ++E + V + H+ ++ + ND+A++ L + V+ DTI+ CLP
Sbjct: 70 --LGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLP 127
Query: 304 -RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGIVDH 360
G + V GWG L +GP A LQ+ PV A C R +G + +
Sbjct: 128 SEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGTT----VKET 183
Query: 361 FLCA-GRATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIG--CGKGEYPGVYTRVTYFMP 416
+CA G +C GDSGGPL DG+W GIVS+G G C + P V+TRV+ ++
Sbjct: 184 MVCAGGDGVISACNGDSGGPLNCQADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYID 243
Query: 417 WITKNLK 423
WI + L+
Sbjct: 244 WINQKLQ 250
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 93/254 (36%), Positives = 128/254 (50%), Gaps = 31/254 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
LP +A Y+G+ V GWG+L+E G QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKEKG-QPSVLQVVNLPIVERPVCKDS----TR 171
Query: 355 GGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCGKGEYPG 406
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC + G
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 407 VYTRVTYFMPWITK 420
YT V WI K
Sbjct: 232 FYTHVFRLKKWIQK 245
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 83/250 (33%), Positives = 126/250 (50%), Gaps = 20/250 (8%)
Query: 183 DLDQERIVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAK 241
D + RIVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + +
Sbjct: 10 DNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKR 64
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAIC 301
V +GD N +Q+ + V +V+ +++H F T D+A+L L P+ + + C
Sbjct: 65 FKVRVGDRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPAC 123
Query: 302 LPRGRASYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG 356
LP R E + T V G+G E G Q L+ + +P CK +
Sbjct: 124 LPE-RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---- 178
Query: 357 IVDHFLCAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTY 413
I + CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT
Sbjct: 179 ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTA 238
Query: 414 FMPWITKNLK 423
F+ WI +++K
Sbjct: 239 FLKWIDRSMK 248
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 134 bits (338), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 93/254 (36%), Positives = 128/254 (50%), Gaps = 31/254 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
LP +A Y+G+ V GWG+L+E+G QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETG-QPSVLQVVNLPIVERPVCKDS----TR 171
Query: 355 GGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCGKGEYPG 406
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC + G
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 407 VYTRVTYFMPWITK 420
YT V WI K
Sbjct: 232 FYTHVFRLKKWIQK 245
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 134 bits (337), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVER--KVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA- 364
AS G + GWG+ + SG P VL+ + P+ +++ CK+ Y PG I + CA
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY----PGQITSNMFCAY 164
Query: 365 GRATK-DSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
G K DSC GDSGGP+ V GK GIVSWG GC PGVYT+V ++ WI + +
Sbjct: 165 GLEGKGDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCQAKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 134 bits (337), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 120/238 (50%), Gaps = 15/238 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R I LP
Sbjct: 61 ILNQSEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 134 bits (337), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 87/243 (35%), Positives = 122/243 (50%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L IK+ V+ ++ H + M D+A+L L+ V Y+D+ R I LP
Sbjct: 61 ILNQAEIKEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 133 bits (335), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 104/316 (32%), Positives = 149/316 (47%), Gaps = 52/316 (16%)
Query: 147 SIVSSTETAHFPTEVPVTTTEAGKVDMSCG-----QKNGYQDLDQE---------RIVGG 192
+I +T T+ + T T +G+ D CG +K +D + RIV G
Sbjct: 112 AIEGATATSEYQTFFNPATFGSGEAD--CGLRPLFEKKSLEDKTERELLESYIDGRIVEG 169
Query: 193 QNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWD----VAKLSVNL 246
+AE PW V +F Q CG SLI + VLTAAHC+ + WD L V +
Sbjct: 170 SDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDLLVRI 228
Query: 247 GDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H+ + ++++ H ++ R L D+A++ L KPV +SD I +CLP
Sbjct: 229 GKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDR 288
Query: 306 -------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKARYGPV 352
+A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 289 ETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS---- 341
Query: 353 APGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCGKGEY 404
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC +
Sbjct: 342 TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGK 401
Query: 405 PGVYTRVTYFMPWITK 420
G YT V WI K
Sbjct: 402 YGFYTHVFRLKKWIQK 417
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 93/260 (35%), Positives = 129/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ PG YT V WI K
Sbjct: 233 RDGKPGFYTHVFRLKKWIQK 252
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 95/260 (36%), Positives = 129/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE+ PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A+L L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP RA Y+G+ V GWG+LRE+ QP+VLQ VN+P+ CKA
Sbjct: 120 LPDKQTVTSLLRAGYKGR---VTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAS 176
Query: 349 YGPVAPGGIVDHFLCAGRATKDS-----CTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+ C GDSGGP ++ + +W Q+GIVS G GC
Sbjct: 177 ----TRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RKGKYGFYTHVFRLKRWIQK 252
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAV-HEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 132 bits (333), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWD----VAK 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 94
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 95 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 154
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 155 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 211
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 212 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 267
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 268 DRDGKYGFYTHVFRLKKWIQK 288
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 132 bits (333), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 93/259 (35%), Positives = 140/259 (54%), Gaps = 28/259 (10%)
Query: 186 QERIVGGQNAEQNEWPWVVAIF-----NSGKQF-CGGSLIDTQHVLTAAHCVAHMSSWDV 239
Q GG + PW AIF +SG++F CGG LI + VLTAAHC S+
Sbjct: 11 QLHSTGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCF--QESYLP 68
Query: 240 AKLSVNLG-DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTL--DKP--VKYS 294
+L V LG + +K E + KVK+ + HK FD T ND+A+L L D P + S
Sbjct: 69 DQLKVVLGRTYRVKPGEEEQTF--KVKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQES 126
Query: 295 DTIRAICLPRGRASY-EGKIATVIGWGSLRESGP-QPAVLQKVNIPVWTNADCKARYGPV 352
D++RAICLP + + G+G + S P L++ ++ ++ ++ C ++ +
Sbjct: 127 DSVRAICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKF--L 184
Query: 353 APGGIVDHFLCAGRA--------TKDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGE 403
+ ++ LCAG D+C GDSGGPL+ +ND T +GI+SWG+GCG+ +
Sbjct: 185 FNKTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMTLLGIISWGVGCGEKD 244
Query: 404 YPGVYTRVTYFMPWITKNL 422
PGVYT+VT ++ WI N+
Sbjct: 245 VPGVYTKVTNYLGWIRDNM 263
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 132 bits (332), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAV-HEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 132 bits (332), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 95/267 (35%), Positives = 131/267 (49%), Gaps = 42/267 (15%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWD----VAKL 242
IV GQ+AE PW V +F Q CG SLI + VLTAAHC+ + WD V L
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTVDDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN-------DVAILTLDKPVKYSD 295
V +G H+ + ERKV+++ + YN D+A+L L +P++ SD
Sbjct: 60 LVRIGKHSRTR------YERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSD 113
Query: 296 TIRAICLPRGRAS----YEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADC 345
I +CLP + + + G V GWG+ RE+ QP+VLQ VN+P+ C
Sbjct: 114 YIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVC 173
Query: 346 KARYGPVAPGGIVDHFLCAGRA-----TKDSCTGDSGGPLMVN---DGKWTQVGIVSWGI 397
KA I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG
Sbjct: 174 KAS----TRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 229
Query: 398 GCGKGEYPGVYTRVTYFMPWITKNLKK 424
GC + G YT V WI K + +
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVIDR 256
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 95/267 (35%), Positives = 131/267 (49%), Gaps = 42/267 (15%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWD----VAKL 242
IV GQ+AE PW V +F Q CG SLI + VLTAAHC+ + WD V L
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTVDDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN-------DVAILTLDKPVKYSD 295
V +G H+ + ERKV+++ + YN D+A+L L +P++ SD
Sbjct: 60 LVRIGKHSRTR------YERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSD 113
Query: 296 TIRAICLPRGRAS----YEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADC 345
I +CLP + + + G V GWG+ RE+ QP+VLQ VN+P+ C
Sbjct: 114 YIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVC 173
Query: 346 KARYGPVAPGGIVDHFLCAGRA-----TKDSCTGDSGGPLMVN---DGKWTQVGIVSWGI 397
KA I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG
Sbjct: 174 KAS----TRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 229
Query: 398 GCGKGEYPGVYTRVTYFMPWITKNLKK 424
GC + G YT V WI K + +
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVIDR 256
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 88
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 89 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 149 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 206 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 261
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 262 DRDGKYGFYTHVFRLKKWIQK 282
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/236 (34%), Positives = 121/236 (51%), Gaps = 19/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG ++ V++ NSG FCGGSL+ V++AAHC + L V LG+
Sbjct: 1 IVGGYECTKHSQAHQVSL-NSGYHFCGGSLVSKDWVVSAAHCYKSV-------LRVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+I+ NE ++RH + + ND+ ++ L KP + + A+ LP A+
Sbjct: 53 HHIR-VNEGTEQYISSSSVIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALPTECAA 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
+ + TV GWG+ S LQ +++P+ ++ADC Y PG I CAG
Sbjct: 112 -DATMCTVSGWGNTMSSVADGDKLQCLSLPILSHADCANSY----PGMITQSMFCAGYLE 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
KDSC GDSGGP++ N G+VSWG GC + ++PGVY +V W+ +
Sbjct: 167 GGKDSCQGDSGGPVVCNG---VLQGVVSWGYGCAERDHPGVYAKVCVLSGWVRDTM 219
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 94
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 95 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 154
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 155 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 211
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 212 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 267
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 268 DRDGKYGFYTHVFRLKKWIQK 288
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 92/250 (36%), Positives = 134/250 (53%), Gaps = 22/250 (8%)
Query: 189 IVGGQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+VGG++A N WPW V++ ++S Q+ CGG+L+D VLTAAHC++ ++ V
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSRTYRVV---- 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLY--NDVAILTLDKPVKYSDTIRAICL 302
LG H++ NE + KV +LV H+ ++ L ND+A+L L PV +D I+ CL
Sbjct: 57 -LGRHSLS-TNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCL 114
Query: 303 P-RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVD-H 360
P G + V GWG L+ +G P +LQ+ + V A C P G V +
Sbjct: 115 PAAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSK---PGWWGSTVKTN 171
Query: 361 FLCA-GRATKDSCTGDSGGPLMVN--DGKWTQVGIVSWG--IGCGKGEYPGVYTRVTYFM 415
+CA G SC GDSGGPL +G+W GIVS+G +GC P V+TRV+ ++
Sbjct: 172 MICAGGDGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYI 231
Query: 416 PWITKNLKKN 425
WI + N
Sbjct: 232 DWINSVIANN 241
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 88
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 89 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 149 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 206 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 261
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 262 DRDGKYGFYTHVFRLKKWIQK 282
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 87
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 88 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 147
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 148 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 204
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 205 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 260
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 261 DRDGKYGFYTHVFRLKKWIQK 281
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 86/243 (35%), Positives = 121/243 (49%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L I + V+ ++ H + M D+A+L L+ V Y+D+ R I LP
Sbjct: 61 ILNQSEIAEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 132 bits (331), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 132 bits (331), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 86/243 (35%), Positives = 121/243 (49%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L I + V+ ++ H + M D+A+L L+ V Y+D+ R I LP
Sbjct: 61 ILNQAEIAEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 132 bits (331), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 88
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 89 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 149 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 206 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 261
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 262 DRDGKYGFYTHVFRLKKWIQK 282
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 90
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 91 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 150
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 151 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 207
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 208 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 263
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 264 DRDGKYGFYTHVFRLKKWIQK 284
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 90
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 91 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 150
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 151 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 207
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 208 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 263
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 264 DRDGKYGFYTHVFRLKKWIQK 284
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 93/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 88
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 89 LLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 149 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 205
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 206 S----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 261
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 262 DRDGKYGFYTHVFRLKKWIQK 282
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 86/243 (35%), Positives = 121/243 (49%), Gaps = 15/243 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSG---KQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL-SV 244
IVGG + + EWPW V + + + CGGS+I Q +LTAAHC + S + ++ S
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
L I + V+ ++ H + M D+A+L L+ V Y+D+ R I LP
Sbjct: 61 ILNQAEIAEDTSF----FGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPS 116
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+G + V GWG + LQK IP+ TN +C+ RY I +C
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY---RGHKITHKMIC 173
Query: 364 AG--RATKDSCTGDSGGPLMVNDGK-WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
AG KD+C GDSGGPL + W VGI SWG GC + E PGVYT V ++ WI +
Sbjct: 174 AGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
Query: 421 NLK 423
+
Sbjct: 234 KTQ 236
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 92/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 107
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 108 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 167
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 168 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 224
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GD+GGP ++ + +W Q+GIVSWG GC
Sbjct: 225 S----TRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGC 280
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 281 DRDGKYGFYTHVFRLKKWIQK 301
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 131 bits (330), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 93/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+LRE+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 131 bits (329), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 92/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 89
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 90 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 149
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 150 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 206
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GD+GGP ++ + +W Q+GIVSWG GC
Sbjct: 207 S----TRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGC 262
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 263 DRDGKYGFYTHVFRLKKWIQK 283
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 131 bits (329), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 123/244 (50%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N +Q+ + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTEQEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GD+GGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 130 bits (327), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 92/261 (35%), Positives = 129/261 (49%), Gaps = 36/261 (13%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----K 241
RIV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTEND 59
Query: 242 LSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAI 300
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +
Sbjct: 60 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 119
Query: 301 CLPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKA 347
CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 CLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 176
Query: 348 RYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGC 399
I D+ CAG D+C GD+GGP ++ + +W Q+GIVSWG GC
Sbjct: 177 S----TRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGC 232
Query: 400 GKGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 DRDGKYGFYTHVFRLKKWIQK 253
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATKD-----SCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D +C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RKGKYGFYTHVFRLKKWIQK 252
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCA 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RKGKYGFYTHVFRLKKWIQK 252
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 129 bits (325), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 129 bits (325), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 129 bits (325), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 129 bits (325), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 129 bits (325), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKIGFYTHVFRLKKWIQK 252
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFIENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKFGFYTHVFRLKKWIQK 252
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 121/244 (49%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGGQ + E PW + N + FCGG+++ ++LTAAHC+ + + V +G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRVG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
D N + + V +V+ +++H F T D+A+L L P+ + + CLP R
Sbjct: 56 DRNTAAEEGGEAVH-EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE-RD 113
Query: 308 SYEGKIAT-----VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
E + T V G+G E G Q L+ + +P CK + I +
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 363 CAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
CAG TK D+C GDSGGP + + GIVSWG GC + G+YT+VT F+ WI
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
Query: 420 KNLK 423
+++K
Sbjct: 230 RSMK 233
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 126/245 (51%), Gaps = 22/245 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IVGG++ + E PW + N + FCGG++++ +VLTAAHC+ + +V +G
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQ-----AKRFTVRVG 55
Query: 248 DHNIKQK--NEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR- 304
D N +Q+ NE+ H +V+ V+H F T D+A+L L P+++ + CLP
Sbjct: 56 DRNTEQEEGNEMAH---EVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEK 112
Query: 305 --GRAS-YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
A+ K V G+G E G + L+ + +P + CK + I +
Sbjct: 113 DWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLS----SSFTITPNM 168
Query: 362 LCAGRATK--DSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
CAG T+ D+C GDSGGP + + GIVSWG GC + GVYT+V+ F+ WI
Sbjct: 169 FCAGYDTQPEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWI 228
Query: 419 TKNLK 423
K +K
Sbjct: 229 DKIMK 233
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 129 bits (323), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 129 bits (323), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 91/254 (35%), Positives = 126/254 (49%), Gaps = 33/254 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
LP +A Y+G+ V GWG+L+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKG---QPSVLQVVNLPIVERPVCKDS----TR 169
Query: 355 GGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCGKGEYPG 406
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC + G
Sbjct: 170 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 229
Query: 407 VYTRVTYFMPWITK 420
YT V WI K
Sbjct: 230 FYTHVFRLKKWIQK 243
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 129 bits (323), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 127/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 128 bits (322), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 91/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GD+GGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 128 bits (321), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 120/238 (50%), Gaps = 20/238 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+V G ++ P+ A++ SG CGG LI VLTAAHC L V LG
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKK-------PNLQVFLGK 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HN++Q+ E + V R V H +D + D+ +L L +P K S+ I+ + L R S
Sbjct: 54 HNLRQR-ESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERD-CS 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
++GWG + G P +Q I + + +C+ Y PG I + LCAG +
Sbjct: 112 ANTTSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAY----PGQITQNMLCAGDEK 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGPL+ D G+VSWG I CG E PGVYT V + WI K ++
Sbjct: 167 YGKDSCQGDSGGPLVCGD---HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 128 bits (321), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 23/265 (8%)
Query: 180 GYQDLDQERIVGGQNAEQNEWPWVVAI-FNSGKQF----CGGSLIDTQHVLTAAHCVAHM 234
GYQ ++ ++I+ G + E+PW I + + F CGGSLI+ ++++TAAHCVA
Sbjct: 15 GYQ-VEADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGR 73
Query: 235 SSWDVAKLS-VNLGDHNIKQKNEV----------KHVERKVKRLVRHKAF--DMRTLYND 281
V L+ V LG+ N + K ++ ++ ++H + + Y+D
Sbjct: 74 VLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHD 133
Query: 282 VAILTLDKPVKYSDTIRAICLPRGRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVW 340
+A++ L++ V++++ IR +CLP+ + G+ TV+GWG E+G + QK+ +PV
Sbjct: 134 IALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGRT-ETGQYSTIKQKLAVPVV 192
Query: 341 TNADCKARYGPVAPGGIVDHFLCAGRATKDSCTGDSGGPLMVN--DGKWTQVGIVSWGIG 398
C +G G KDSC GDSGGPL+ + ++ G+VS+G
Sbjct: 193 HAEQCAKTFGAAGVRVRSSQLCAGGEKAKDSCGGDSGGPLLAERANQQFFLEGLVSFGAT 252
Query: 399 CGKGEYPGVYTRVTYFMPWITKNLK 423
CG +PG+YT+V + WI N++
Sbjct: 253 CGTEGWPGIYTKVGKYRDWIEGNIR 277
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 128 bits (321), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 82/241 (34%), Positives = 122/241 (50%), Gaps = 19/241 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
+VGG A Q E+P++V + N + FCGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVS--GSGNNTSITATGG 58
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
+++ + VK KV ++ F T D A++ L +P+ A +
Sbjct: 59 VVDLQSSSAVKVRSTKV---LQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQG 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
++ TV GWG+ RE G Q L K N+P ++A C++ + + + +CAG
Sbjct: 116 TF-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFIL---VANEMICAGYP 167
Query: 366 -RATKDSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
D+C GDSGGP+ D +W QVGIVSWG GC + YPGVYT V+ F I
Sbjct: 168 DTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAA 227
Query: 423 K 423
+
Sbjct: 228 R 228
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 128 bits (321), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 127/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCR 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
G YT V WI K
Sbjct: 233 DDGKYGFYTHVFRLKKWIQK 252
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 127 bits (320), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 91/260 (35%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L ++A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 127 bits (320), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C DSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 127 bits (320), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 82/239 (34%), Positives = 122/239 (51%), Gaps = 20/239 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E+ EWPW ++ G CG +LI+ +++AAHC + A+ + + G
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYK--NPARWTASFGV 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
IK ++R ++R++ H+ + + D+++ L PV Y++ + +CLP AS
Sbjct: 59 -TIKPSK----MKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLP--DAS 111
Query: 309 YE---GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVA-PGGIVDHFLCA 364
YE G + V G+G+L+ G L++ + + C P A I LCA
Sbjct: 112 YEFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNE---PQAYNDAITPRMLCA 168
Query: 365 G--RATKDSCTGDSGGPLMVNDGK--WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
G D+C GDSGGPL+ +D + W GIVSWG C K PGVYTRVT WIT
Sbjct: 169 GSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWIT 227
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C DSGGP ++ + +W Q+GIVSWG GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 125 bits (315), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 117/234 (50%), Gaps = 18/234 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG +A ++P++V+I +G +CGGSL++ VLTAAHCV S + + + G
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCV---SGYAQSGFQIRAG- 56
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIR-AICLPRGRA 307
+ + + H ++ ND+AIL L + I A G
Sbjct: 57 ---SLSRTSGGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARLAASGSD 111
Query: 308 SYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGR 366
G ATV GWG+ E G P L KV +P+ + A C+A+YG A I + CAG
Sbjct: 112 PVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSA---ITNQMFCAGV 168
Query: 367 AT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
++ KDSC GDSGGP++ D T +G VSWG GC + Y GVY V +I
Sbjct: 169 SSGGKDSCQGDSGGPIV--DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 125 bits (315), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 90/272 (33%), Positives = 143/272 (52%), Gaps = 30/272 (11%)
Query: 174 SCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIF-----NSGKQF-CGGSLIDTQHVLTA 227
+CG + Q Q RI GG A+ PW AIF + G++F CGG LI + +L+A
Sbjct: 1 TCGLRQYSQP--QFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSA 58
Query: 228 AHCVAHMSSWDVAKLSVNLG-DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILT 286
AHC + L+V LG + + E + E V++ + HK FD T ND+A+L
Sbjct: 59 AHCF--QERFPPHHLTVILGRTYRVVPGEEEQKFE--VEKYIVHKEFDDDTYDNDIALLQ 114
Query: 287 L----DKPVKYSDTIRAICLPRGRASY-EGKIATVIGWGSLRESGP-QPAVLQKVNIPVW 340
L + + S +R +CLP + + G+G P L++ ++ ++
Sbjct: 115 LKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLY 174
Query: 341 TNADCKARYGPVAPGGIVDHFLCAGRATK--------DSCTGDSGGPLM-VNDGKWTQVG 391
++ C +++ + + D+ LCAG D+C GDSGGPL+ +NDG+ T VG
Sbjct: 175 PSSRCTSQH--LLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVG 232
Query: 392 IVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
I+SWG+GCG+ + PGVYT+VT ++ WI N++
Sbjct: 233 IISWGLGCGQKDVPGVYTKVTNYLDWIRDNMR 264
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 125 bits (315), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 124/236 (52%), Gaps = 20/236 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
+VGG A Q E+P++V + N + FCGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVS--GSGNNTSITATGG 58
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
+++ + VK KV ++ F T D A++ L +P+ A +
Sbjct: 59 VVDLQSSSAVKVRSTKV---LQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQG 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
++ TV GWG+ RE G Q L K N+P ++A C++ + + + +CAG
Sbjct: 116 TF-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFIL---VANEMICAGYD 167
Query: 368 TK--DSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPWI 418
TK D+C GDSGGP+ D +W QVGIVSWG GC KG+Y GVYT V+ F I
Sbjct: 168 TKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKY-GVYTEVSTFASAI 222
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 125 bits (314), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 81/236 (34%), Positives = 118/236 (50%), Gaps = 11/236 (4%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ AE + P++ ++ +G CGG L+ Q VL+AAHC+ + K+ V LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAAD---GKVQVLLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GRA 307
H++ Q K + V R V H + T+ +D+ +L L + +R + R R
Sbjct: 58 HSLSQPEPSKRLY-DVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRD 116
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G + V GWG + +G +P LQ V +PV A C R G I + +CA
Sbjct: 117 VAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH--HDGAITERLMCAESN 174
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKNL 422
+DSC GDSGGPL+ G+VSWG CG + PG+YTRV + WI L
Sbjct: 175 RRDSCKGDSGGPLVCGG---VLEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDSVL 227
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 125 bits (314), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVS G GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 125 bits (313), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+C GDSGGP ++ + +W Q+GIVS G GC
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 125 bits (313), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSAI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 127/242 (52%), Gaps = 23/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIF--NSGK-QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG A+ + P++ + SGK CGG L+ VLTAAHC+ + ++V
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLG-------SSINVT 53
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
LG HNI ++ + V V+R + H ++ TL ND+ +L L + +D + I LPR
Sbjct: 54 LGAHNIMERERTQQVI-PVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRS 112
Query: 306 RASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
A + G + +V GWG L + P LQ+V++ V + C AR+ P + CA
Sbjct: 113 LAEVKPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKCIARFKNYIPFTQI----CA 168
Query: 365 GRAT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G + K+S +GDSGGPL+ N GIVS+G G P VYTR++ F+ WI +
Sbjct: 169 GDPSKRKNSFSGDSGGPLVCNG---VAQGIVSYGR--NDGTTPDVYTRISSFLSWIHSTM 223
Query: 423 KK 424
++
Sbjct: 224 RR 225
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 87/249 (34%), Positives = 132/249 (53%), Gaps = 24/249 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQF-CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
++ G+ + + PW V + +S K+ CG LI VLTAAHC+ + KL V LG
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMD-----ESKKLLVRLG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGR 306
+++++ + E ++ +K + H + T ND+A+L L +P S TI ICLP G
Sbjct: 56 EYDLR-RWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGL 114
Query: 307 ASYE----GKIATVIGWG--SLRESGPQ---PAVLQKVNIPVWTNADCKARYGPVAPGGI 357
A E G+ V GWG S RE + VL + IPV + +C V +
Sbjct: 115 AERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSE----VMSNMV 170
Query: 358 VDHFLCAGRA--TKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYF 414
++ LCAG +D+C GDSGGP++ + G W VG+VSWG GCG GVYT+V+ +
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRY 230
Query: 415 MPWITKNLK 423
+ WI +++
Sbjct: 231 LDWIHGHIR 239
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 87/249 (34%), Positives = 132/249 (53%), Gaps = 24/249 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQF-CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
++ G+ + + PW V + +S K+ CG LI VLTAAHC+ + KL V LG
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMD-----ESKKLLVRLG 55
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGR 306
+++++ + E ++ +K + H + T ND+A+L L +P S TI ICLP G
Sbjct: 56 EYDLR-RWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGL 114
Query: 307 ASYE----GKIATVIGWG--SLRESGPQ---PAVLQKVNIPVWTNADCKARYGPVAPGGI 357
A E G+ V GWG S RE + VL + IPV + +C V +
Sbjct: 115 AERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECS----EVMSNMV 170
Query: 358 VDHFLCAGRA--TKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYF 414
++ LCAG +D+C GDSGGP++ + G W VG+VSWG GCG GVYT+V+ +
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRY 230
Query: 415 MPWITKNLK 423
+ WI +++
Sbjct: 231 LDWIHGHIR 239
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 90/252 (35%), Positives = 120/252 (47%), Gaps = 31/252 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E+N PW VA++ + CGG L+D VLTAAHC V LG
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDD-------NYKVWLGK 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLY-----------NDVAILTLDKPVKYSDTI 297
+N+ K+E R V + + H F+M + ND+ +L L KP +DT+
Sbjct: 54 NNL-FKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTV 112
Query: 298 RAICLPRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGG 356
+ I LP G GWGS+ + Q L VN+ + N DC +
Sbjct: 113 KPITLPTEEPKL-GSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAHIE----K 167
Query: 357 IVDHFLCAGRAT--KDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTY 413
+ D LCAG KD+C GDSGGPL+ DG GI SWG CG+ + PGVYT++
Sbjct: 168 VTDAMLCAGEMDGGKDTCKGDSGGPLIC-DG--VLQGITSWGHTPCGEPDMPGVYTKLNK 224
Query: 414 FMPWITKNLKKN 425
F WI + KN
Sbjct: 225 FTSWIKDTMAKN 236
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 124 bits (311), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 82/246 (33%), Positives = 131/246 (53%), Gaps = 24/246 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG++A+ ++PW V + FCGGS+++ + ++TAAHCV K++V G+
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVE-----TGVKITVVAGE 55
Query: 249 HNIKQKNEVKHVE--RKVKRLVRHKAFD--MRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
HNI+ E +H E R V R++ H F+ + T +D+A+L LD+P+ + + IC+
Sbjct: 56 HNIE---ETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 305 GRAS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ + V GWG + G VLQ + +P+ A C I ++
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS----TKFTITNNM 168
Query: 362 LCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPW 417
CAG +DSC GDSGGP + +G GI+SWG C KG+Y G+YT+V+ ++ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKY-GIYTKVSRYVNW 227
Query: 418 ITKNLK 423
I + K
Sbjct: 228 IKEKTK 233
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 124 bits (311), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 92/264 (34%), Positives = 131/264 (49%), Gaps = 40/264 (15%)
Query: 189 IVGGQNAEQNEWPWVVAIF-----NSGKQF-CGGSLIDTQHVLTAAHCVAHMSSWDVA-- 240
IV G +AE PW V +F + G++F CG SLI + VLTAAHC+ + WD
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLY-PPWDKNFT 59
Query: 241 --KLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTI 297
L V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I
Sbjct: 60 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 119
Query: 298 RAICLPRG-------RASYEGKIATVIGWGSLRESGP------QPAVLQKVNIPVWTNAD 344
+CLP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+
Sbjct: 120 HPVCLPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 176
Query: 345 CKARYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWG 396
CK I D+ CA D+C GDSGGP ++ + +W Q+GIVSWG
Sbjct: 177 CKDS----TRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWG 232
Query: 397 IGCGKGEYPGVYTRVTYFMPWITK 420
GC + G YT V WI K
Sbjct: 233 EGCDRDGKYGFYTHVFRLKKWIQK 256
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSRI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 82/234 (35%), Positives = 116/234 (49%), Gaps = 18/234 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG +A ++P++V+I +G +CGGSL++ VLTAAHCV S + + + G
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCV---SGYAQSGFQIRAG- 56
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIR-AICLPRGRA 307
+ + + H ++ ND+AIL L + I A G
Sbjct: 57 ---SLSRTSGGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARLAASGSD 111
Query: 308 SYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGR 366
G ATV GWG+ E G P L KV +P+ + A C+A+YG A I + CAG
Sbjct: 112 PVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSA---ITNQMFCAGV 168
Query: 367 AT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
++ KDSC GD GGP++ D T +G VSWG GC + Y GVY V +I
Sbjct: 169 SSGGKDSCQGDXGGPIV--DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 116/233 (49%), Gaps = 18/233 (7%)
Query: 190 VGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDH 249
VGG +A ++P++V+I +G +CGGSL++ VLTAAHCV S + + + G
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCV---SGYAQSGFQIRAG-- 56
Query: 250 NIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIR-AICLPRGRAS 308
+ + + H ++ ND+AIL L + I A G
Sbjct: 57 --SLSRTSGGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARLAASGSDP 112
Query: 309 YEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G ATV GWG+ E G P L KV +P+ + A C+A+YG A I + CAG +
Sbjct: 113 VAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSA---ITNQMFCAGVS 169
Query: 368 T--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
+ KDSC GDSGGP++ D T +G VSWG GC + Y GVY V +I
Sbjct: 170 SGGKDSCQGDSGGPIV--DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSYI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 82/246 (33%), Positives = 131/246 (53%), Gaps = 24/246 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG++A+ ++PW V + FCGGS+++ + ++TAAHCV K++V G+
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVE-----TGVKITVVAGE 55
Query: 249 HNIKQKNEVKHVE--RKVKRLVRHKAFD--MRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
HNI+ E +H E R V R++ H F+ + T +D+A+L LD+P+ + + IC+
Sbjct: 56 HNIE---ETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 305 GRAS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ + V GWG + G VLQ + +P+ A C I ++
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRS----TKFTITNNM 168
Query: 362 LCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPW 417
CAG +DSC GDSGGP + +G GI+SWG C KG+Y G+YT+V+ ++ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKY-GIYTKVSRYVNW 227
Query: 418 ITKNLK 423
I + K
Sbjct: 228 IKEKTK 233
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 123 bits (309), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 81/266 (30%), Positives = 131/266 (49%), Gaps = 34/266 (12%)
Query: 187 ERIVGGQNAEQNEWPWVVAI----FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKL 242
+R+ G + + PW+ + F + CGG++I +++LTAAHCV H D+ +
Sbjct: 117 QRVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCV-HGLQNDLYE- 174
Query: 243 SVNLGDHNIKQKNEVKHVERK-----------VKRLVRHKAFDMRTLYNDVAILTLDKPV 291
+ LG+H I + + + RK +++ + H+ +D R + +D+A+L L++ V
Sbjct: 175 -IRLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRSV 233
Query: 292 KYSDTIRAICLPRGRASYEG--KIAT--VIGWGSLRESGPQPAVLQKVNIPVWTNADCKA 347
+ I+ ICLP E +I+T V GWG+ E+G VL + N+P+ + C
Sbjct: 234 PFQKHIKPICLPITDELKEKAEQISTYFVTGWGTT-ENGSSSDVLLQANVPLQPRSACSQ 292
Query: 348 RYGPVAPGGIVDHFLCAGRATKDSCTGDSGGPLMVNDG-------KWTQVGIVSWG-IGC 399
Y P + G +DSC GDSGGPL K + GIVS G + C
Sbjct: 293 AYRRAVP---LSQLCVGGGDLQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTC 349
Query: 400 GKGEYPGVYTRVTYFMPWITKNLKKN 425
G+ PG+YT V ++ WIT + N
Sbjct: 350 GQISLPGLYTNVGEYVQWITDTMASN 375
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 90/260 (34%), Positives = 126/260 (48%), Gaps = 36/260 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES------GPQPAVLQKVNIPVWTNADCKAR 348
LP +A Y+G+ V GWG+L+E+ QP+VLQ VN+P+ CK
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDS 176
Query: 349 YGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMVN---DGKWTQVGIVSWGIGCG 400
I D+ CAG D+ GDSGGP ++ + +W Q+GIVSWG G
Sbjct: 177 ----TRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGAD 232
Query: 401 KGEYPGVYTRVTYFMPWITK 420
+ G YT V WI K
Sbjct: 233 RDGKYGFYTHVFRLKKWIQK 252
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ TL ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSWI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 81/246 (32%), Positives = 131/246 (53%), Gaps = 24/246 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG++A+ ++PW V + FCGGS+++ + ++TAAHCV K++V G+
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVE-----TGVKITVVAGE 55
Query: 249 HNIKQKNEVKHVE--RKVKRLVRHKAFD--MRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
HNI+ E +H E R V R++ H ++ + T +D+A+L LD+P+ + + IC+
Sbjct: 56 HNIE---ETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 305 GRAS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ + V GWG + G VLQ + +P+ A C I ++
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS----TKFTITNNM 168
Query: 362 LCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPW 417
CAG +DSC GDSGGP + +G GI+SWG C KG+Y G+YT+V+ ++ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKY-GIYTKVSRYVNW 227
Query: 418 ITKNLK 423
I + K
Sbjct: 228 IKEKTK 233
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 122 bits (306), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 86/239 (35%), Positives = 122/239 (51%), Gaps = 20/239 (8%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
++V G ++ P+ A++ SG CGG LI VLTAAHC L V LG
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-------KKPNLQVFLG 53
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
HN++Q+ + + V R V H +D + D+ +L L +P K S+ I+ + L R
Sbjct: 54 KHNLRQQESSQ-EQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLER-DC 111
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
S + ++GWG + G P +Q I + + +C+ Y PG I + LCAG
Sbjct: 112 SAQTTSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAY----PGQITQNMLCAGDE 166
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNLK 423
+ KDSC GDSGGPL+ D G+VSWG I CG E PGVYT V + WI K ++
Sbjct: 167 KYGKDSCQGDSGGPLVCGD---HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 222
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 122 bits (306), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 85/257 (33%), Positives = 136/257 (52%), Gaps = 28/257 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIF-----NSGKQF-CGGSLIDTQHVLTAAHCVAHMSSWDVAKL 242
I GG A+ PW AIF + G++F CGG LI + +L+AAHC + L
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCF--QERFPPHHL 58
Query: 243 SVNLG-DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTL----DKPVKYSDTI 297
+V LG + + E + E V++ + HK FD T ND+A+L L + + S +
Sbjct: 59 TVILGRTYRVVPGEEEQKFE--VEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVV 116
Query: 298 RAICLPRGRASY-EGKIATVIGWGSLRESGP-QPAVLQKVNIPVWTNADCKARYGPVAPG 355
R +CLP + + G+G P L++ ++ ++ ++ C +++ +
Sbjct: 117 RTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQH--LLNR 174
Query: 356 GIVDHFLCAGRA--------TKDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPG 406
+ D+ LCAG D+C GDSGGPL+ +NDG+ T VGI+SWG+GCG+ + PG
Sbjct: 175 TVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPG 234
Query: 407 VYTRVTYFMPWITKNLK 423
VYT+VT ++ WI N++
Sbjct: 235 VYTKVTNYLDWIRDNMR 251
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 121 bits (303), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 83/247 (33%), Positives = 133/247 (53%), Gaps = 21/247 (8%)
Query: 189 IVGGQNAEQNEWPWVVAI----FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+VGG++A + WPW +++ ++ + CGG+LI + VLTAAHC+++ ++ VA
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYRVA---- 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
+G +N++ ++E + V + HK ++ L ND+A++ L + V+ SDTI+ CLP
Sbjct: 57 -VGKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPE 115
Query: 305 GRASYEGKI-ATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKA--RYGPVAPGGIVDHF 361
+ V GWG L +GP LQ+ PV +A C +G +V
Sbjct: 116 KDSLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKKTMV--- 172
Query: 362 LCA-GRATKDSCTGDSGGPL--MVNDGKWTQVGIVSWGI--GCGKGEYPGVYTRVTYFMP 416
CA G +C GDSGGPL + +G W GIVS+G GC + P VYTRV+ ++
Sbjct: 173 -CAGGDGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYID 231
Query: 417 WITKNLK 423
WI + ++
Sbjct: 232 WINEKMQ 238
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 121 bits (303), Expect = 9e-28, Method: Compositional matrix adjust.
Identities = 81/263 (30%), Positives = 135/263 (51%), Gaps = 22/263 (8%)
Query: 174 SCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAH 233
+CG+++ + + RI+GG ++ PW+ AI+ G FC GSL+ T V++AAHC +H
Sbjct: 21 ACGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAIY-IGDSFCAGSLVHTCWVVSAAHCFSH 79
Query: 234 MSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN----DVAILTL-- 287
D +SV LG H + +V + + ++ + + +++N D+ ++ L
Sbjct: 80 SPPRD--SVSVVLGQHFFNRTTDVT----QTFGIEKYIPYTLYSVFNPSDHDLVLIRLKK 133
Query: 288 --DKPVKYSDTIRAICLPRGRASY-EGKIATVIGWGSLRES-GPQPAVLQKVNIPVWTNA 343
D+ S ++ ICLP +++ G + GWG L E+ + L++ +P+ +
Sbjct: 134 KGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADH 193
Query: 344 DCKARYGPVAPGGIVDHFLCAGR--ATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG 400
C + V I + LCAG D+C GDSGGPL +G GI+SWG GCG
Sbjct: 194 KCSSP--EVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCG 251
Query: 401 KGEYPGVYTRVTYFMPWITKNLK 423
+ PGVYTRV ++ WI ++
Sbjct: 252 RLHKPGVYTRVANYVDWINDRIR 274
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 86/242 (35%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 9/236 (3%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
RI+GG+ AE + P++ ++ +G CGG L+ Q VL+AAHC+ + K+ V LG
Sbjct: 7 RILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAAD---GKVQVLLG 63
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GR 306
H++ Q K + V R V H T+ +D+ +L L + +R + R R
Sbjct: 64 AHSLSQPEPSKRLY-DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDR 122
Query: 307 ASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGR 366
G + V GWG + +G +P LQ V +PV A C R G I + +CA
Sbjct: 123 DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH--HDGAITERLMCAES 180
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
+DSC GDSGGPL+ G + + S CG + PG+YTRV + WI L
Sbjct: 181 NRRDSCKGDSGGPLVC--GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVL 234
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 80/246 (32%), Positives = 130/246 (52%), Gaps = 24/246 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG++A+ ++PW V + FCGGS+++ + ++TAAHCV K++V G+
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVE-----TGVKITVVAGE 55
Query: 249 HNIKQKNEVKHVE--RKVKRLVRHKAFD--MRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
HNI+ E +H E R V R++ H ++ + +D+A+L LD+P+ + + IC+
Sbjct: 56 HNIE---ETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 305 GRAS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ + V GWG + G VLQ + +P+ A C I ++
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS----TKFTIYNNM 168
Query: 362 LCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPW 417
CAG +DSC GDSGGP + +G GI+SWG C KG+Y G+YT+V+ ++ W
Sbjct: 169 FCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKY-GIYTKVSRYVNW 227
Query: 418 ITKNLK 423
I + K
Sbjct: 228 IKEKTK 233
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 88/244 (36%), Positives = 121/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G+ FCGG+LI + VLTAAHC+ S + V L
Sbjct: 16 RVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 73
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 74 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 125
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 126 NYMVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 182
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GDSGGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 183 GHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 242
Query: 422 LKKN 425
L+ N
Sbjct: 243 LRNN 246
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 86/242 (35%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 120 bits (301), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 86/242 (35%), Positives = 129/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGP+ V GK GIVSWG GC + PG YT+V ++ WI + +
Sbjct: 165 YLEGGKDSCQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 120 bits (301), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 85/242 (35%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG+YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 85/242 (35%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG+YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGIYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 120/238 (50%), Gaps = 20/238 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+V G ++ P+ A++ SG CGG LI VLTAAHC L V LG
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-------KKPNLQVFLGK 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HN+ Q+ + + V R V H +D + D+ +L L +P K S+ I+ + L R S
Sbjct: 54 HNLGQQESSQ-EQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLER-DCS 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--R 366
+ ++GWG + G P +Q I + + +C+ Y PG I + LCAG +
Sbjct: 112 AQTTSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAY----PGQITQNMLCAGDEK 166
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGPL+ D G+VSWG I CG E PGVYT V + WI K ++
Sbjct: 167 YGKDSCQGDSGGPLVCGD---HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 23/251 (9%)
Query: 188 RIVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAH--------MSSWD 238
+I G+ A++ PW+ + + +G+ FCGGSL+ + ++TAAHC+ + D
Sbjct: 155 QIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPEDPTLRDSD 214
Query: 239 V---AKLSVNLGDH-NIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYS 294
+ + + LG H ++ +H+ VK H +D T NDVA++ L + +
Sbjct: 215 LLSPSDFKIILGKHWRLRSDENEQHL--GVKHTTLHPQYDPNTFENDVALVELLESPVLN 272
Query: 295 DTIRAICLPRGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
+ ICLP G EG + V GWG + P L ++ IP+ ++ C+ Y P+
Sbjct: 273 AFVMPICLPEG-PQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAPLKK 330
Query: 355 GGIVDHFLCAGRAT--KDSCTGDSGGPLMV---NDGKWTQVGIVSWGIGCGKGEYPGVYT 409
+ +CAG KD+C GDSGGP++ G+W VG VSWG CGK + GVY+
Sbjct: 331 K-VTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYS 389
Query: 410 RVTYFMPWITK 420
+ + WI +
Sbjct: 390 YIHHNKDWIQR 400
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 119 bits (299), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 85/242 (35%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GD+GGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDAGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 119 bits (299), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSL+++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLLNSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG+YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 119 bits (299), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 130/246 (52%), Gaps = 24/246 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG++A+ ++PW V + FCGGS+++ + ++TAAHCV K++V G+
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVE-----TGVKITVVAGE 55
Query: 249 HNIKQKNEVKHVE--RKVKRLVRHKAFD--MRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
HNI+ E +H E R V R++ H ++ + +D+A+L LD+P+ + + IC+
Sbjct: 56 HNIE---ETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 305 GRAS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ + V GWG + G VLQ + +P+ A C I ++
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS----TKFTIYNNM 168
Query: 362 LCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPW 417
CAG +DSC GD+GGP + +G GI+SWG C KG+Y G+YT+V+ ++ W
Sbjct: 169 FCAGFHEGGRDSCQGDAGGPHVTEVEGTSFLTGIISWGEECAMKGKY-GIYTKVSRYVNW 227
Query: 418 ITKNLK 423
I + K
Sbjct: 228 IKEKTK 233
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 85/242 (35%), Positives = 130/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GD+GGP+ V GK GIVSWG GC + PGVYT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDAGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 85/242 (35%), Positives = 129/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 87/244 (35%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 74
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 75 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 126
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 127 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 183
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GDSGGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 184 GHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
Query: 422 LKKN 425
++ N
Sbjct: 244 MRNN 247
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 87/244 (35%), Positives = 121/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 618
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 619 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 670
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY + G + LCA
Sbjct: 671 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RYEFLN-GRVQSTELCA 727
Query: 365 GRAT--KDSCTGDSGGPLMV-NDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GDSGGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 728 GHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 787
Query: 422 LKKN 425
++ N
Sbjct: 788 MRNN 791
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 87/244 (35%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 77
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 78 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 129
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 130 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 186
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GDSGGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 187 GHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 246
Query: 422 LKKN 425
++ N
Sbjct: 247 MRNN 250
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 119 bits (297), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 115/235 (48%), Gaps = 9/235 (3%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ AE + P++ ++ +G CGG L+ Q VL+AAHC+ + K+ V LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAAD---GKVQVLLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GRA 307
H++ Q K + V R V H T+ +D+ +L L + +R + R R
Sbjct: 58 HSLSQPEPSKRLY-DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRD 116
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G + V GWG + +G +P LQ V +PV A C R G I + +CA
Sbjct: 117 VAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH--HDGAITERLMCAESN 174
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
+DSC GDSGGPL+ G + + S CG + PG+YTRV + WI L
Sbjct: 175 RRDSCKGDSGGPLVC--GGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSVL 227
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 121/235 (51%), Gaps = 23/235 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG A Q E+P++V + CGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVS--GSGNNTSITATGGV 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
+++ + VK KV ++ F T D A++ L +P+ A + +
Sbjct: 55 VDLQSSSAVKVRSTKV---LQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGT 111
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRAT 368
+ TV GWG+ RE G Q L K N+P ++A C++ + + + +CAG T
Sbjct: 112 F-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFIL---VANEMICAGYDT 163
Query: 369 K--DSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPWI 418
K D+C GDSGGP+ D +W QVGIVSWG GC KG+Y GVYT V+ F I
Sbjct: 164 KQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKY-GVYTEVSTFASAI 217
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 84/244 (34%), Positives = 128/244 (52%), Gaps = 24/244 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
++GG + NE ++VA FN+ FCGG+LI+ + V+TAAHC D + LG
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC-------DSTNFQMQLGV 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+ K NE + ++ + + L D+ ++ LDKP+ S I A
Sbjct: 54 HSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHI-APLSLPSSPP 112
Query: 309 YEGKIATVIGWGSL---RESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDH-FLCA 364
G + ++GWGS+ +E+ P V NI + +A C+A Y P + ++ LCA
Sbjct: 113 SVGSVCRIMGWGSITPVKETFPD--VPYCANINLLDHAVCQAGY----PELLAEYRTLCA 166
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKN 421
G + KD+C GDSGGPL+ N G++ GIVS+G CG+G PG+YT V + WI +N
Sbjct: 167 GIVQGGKDTCGGDSGGPLICN-GQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
Query: 422 LKKN 425
+ N
Sbjct: 224 IAGN 227
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 115/235 (48%), Gaps = 9/235 (3%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ AE + P++ ++ +G CGG L+ Q VL+AAHC+ + K+ V LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAAD---GKVQVLLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GRA 307
H++ Q K + V R V H T+ +D+ +L L + +R + R R
Sbjct: 58 HSLSQPEPSKRLY-DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRD 116
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G + V GWG + +G +P LQ V +PV A C R G I + +CA
Sbjct: 117 VAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH--HDGAITERLMCAESN 174
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
+DSC GDSGGPL+ G + + S CG + PG+YTRV + WI L
Sbjct: 175 RRDSCKGDSGGPLVC--GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVL 227
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 118 bits (296), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 86/244 (35%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 18 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 75
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 76 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 127
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 128 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 184
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GD+GGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 185 GHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 244
Query: 422 LKKN 425
++ N
Sbjct: 245 MRNN 248
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 118 bits (296), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 84/244 (34%), Positives = 128/244 (52%), Gaps = 24/244 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
++GG + NE ++VA FN+ FCGG+LI+ + V+TAAHC D + LG
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC-------DSTDFQMQLGV 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+ K NE + ++ + + L D+ ++ LDKP+ S I A
Sbjct: 54 HSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHI-APLSLPSSPP 112
Query: 309 YEGKIATVIGWGSL---RESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDH-FLCA 364
G + ++GWGS+ +E+ P V NI + +A C+A Y P + ++ LCA
Sbjct: 113 SVGSVCRIMGWGSITPVKETFPD--VPYCANINLLDHAVCQAGY----PELLAEYRTLCA 166
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKN 421
G + KD+C GDSGGPL+ N G++ GIVS+G CG+G PG+YT V + WI +N
Sbjct: 167 GIVQGGKDTCGGDSGGPLICN-GQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
Query: 422 LKKN 425
+ N
Sbjct: 224 IAGN 227
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 118 bits (296), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 86/244 (35%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 19 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 76
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 77 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 128
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 129 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 185
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GD+GGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 186 GHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 245
Query: 422 LKKN 425
++ N
Sbjct: 246 MRNN 249
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 118 bits (295), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 86/244 (35%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 74
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 75 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 126
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 127 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 183
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GD+GGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 184 GHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
Query: 422 LKKN 425
++ N
Sbjct: 244 MRNN 247
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 129/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG YT++ ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGFYTKLCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 129/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GD+GGP+ V GK GIVSWG GC + PG YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDAGGPV-VCSGKLQ--GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 78/250 (31%), Positives = 125/250 (50%), Gaps = 23/250 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAH--------MSSWDV 239
I G+ A++ PW+ + + +G+ FCGGSL+ + ++TAAHC+ + D+
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDL 60
Query: 240 ---AKLSVNLGDH-NIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSD 295
+ + LG H ++ +H+ VK H +D T NDVA++ L + +
Sbjct: 61 LSPSDFKIILGKHWRLRSDENEQHL--GVKHTTLHPQYDPNTFENDVALVELLESPVLNA 118
Query: 296 TIRAICLPRGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPG 355
+ ICLP G EG + V GWG + P L ++ IP+ ++ C+ Y P+
Sbjct: 119 FVMPICLPEG-PQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKK 176
Query: 356 GIVDHFLCAGRAT--KDSCTGDSGGPLMV---NDGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ +CAG KD+C GDSGGP++ G+W VG VSWG CGK + GVY+
Sbjct: 177 -VTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSY 235
Query: 411 VTYFMPWITK 420
+ + WI +
Sbjct: 236 IHHNKDWIQR 245
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 86/244 (35%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
R+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V L
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVIL 77
Query: 247 GDHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
G H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 78 GAH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSP 129
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+ I GWG + + +L++ +PV N C RY G + LCA
Sbjct: 130 NYVVADRTECFITGWGETQGTF-GAGLLKEAQLPVIENKVCN-RY-EFLNGRVQSTELCA 186
Query: 365 GRAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G DSC GD+GGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI
Sbjct: 187 GHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 246
Query: 422 LKKN 425
++ N
Sbjct: 247 MRNN 250
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 126/244 (51%), Gaps = 20/244 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+NA+ ++PW V + FCGGS+I+ + V+TAAHC+ K++V G+
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIE-----PGVKITVVAGE 55
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFD--MRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
+N ++ E R V R + H +++ + +D+A+L LD+P+ + + IC+
Sbjct: 56 YN-TEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKE 114
Query: 307 AS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
+ + V GWG + G +LQ + +P+ A C I + C
Sbjct: 115 YTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRS----TKFTIYSNMFC 170
Query: 364 AG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPWIT 419
AG KDSC GDSGGP + +G GI+SWG C KG+Y G+YT+V+ ++ WI
Sbjct: 171 AGFHEGGKDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAVKGKY-GIYTKVSRYVNWIK 229
Query: 420 KNLK 423
+ K
Sbjct: 230 EKTK 233
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 118 bits (295), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 81/251 (32%), Positives = 129/251 (51%), Gaps = 20/251 (7%)
Query: 189 IVGGQNAEQNEWPWVVAI----FNSGKQF--CGGSLIDTQHVLTAAHCVAHMSSWDVAKL 242
I+GGQ+A WPW+V++ +++ +++ CGGSL+++Q +LTAAHC +L
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 243 SVNLGDHNIKQKNEVKH--VERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAI 300
+ VK ER V++++ H+ + + ND+A++ + PV I
Sbjct: 61 IFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPG 120
Query: 301 CLPRGRASYEGKIAT--VIGWGSLRESGPQPA-VLQKVNIPVWTNADCKA-RYGPVAPGG 356
CLP+ RA T V GWG L+E+ + + +LQ+ + + C + R+ G
Sbjct: 121 CLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRW---YNGR 177
Query: 357 IVDHFLCAG--RATKDSCTGDSGGPLMVNDG---KWTQVGIVSWGIGCGKGEYPGVYTRV 411
I +CAG D+C GDSGGPLM D + VGI SWG+GC + + PGVYT
Sbjct: 178 IRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTST 237
Query: 412 TYFMPWITKNL 422
++ WI +
Sbjct: 238 WSYLNWIASKI 248
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 117 bits (294), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 129/242 (53%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + CAG
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GD+GGP+ V GK GIVSWG GC + PG YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDAGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 117 bits (294), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 82/249 (32%), Positives = 130/249 (52%), Gaps = 33/249 (13%)
Query: 189 IVGGQNAEQNEWPWV--VAIFN--SGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG A+ + P++ + I + SG + CGG LI VLTAAHC +K+ V
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSG-------SKIQV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HNIK++ +++ + VK ++ H A++ +T+ ND+ +L L K S ++ + LPR
Sbjct: 54 TLGAHNIKEQEKMQQIIPVVK-IIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPR 112
Query: 305 GRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF-- 361
+ G + V GWG L G LQ+V + V + C++ + ++F
Sbjct: 113 RNVKVKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESY--------LKNYFDK 164
Query: 362 ---LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
+CAG + + S GDSGGPL+ K GIVS+ G G P +T+V+ F+
Sbjct: 165 ANEICAGDPKIKRASFRGDSGGPLVC---KKVAAGIVSY--GQNDGSTPRAFTKVSTFLS 219
Query: 417 WITKNLKKN 425
WI K +KK+
Sbjct: 220 WIKKTMKKS 228
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 117 bits (294), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 20/254 (7%)
Query: 189 IVGGQNAEQNEWPWVVAI----FNSGKQF--CGGSLIDTQHVLTAAHCVAHMSSWDVAKL 242
+VGG +AE WPW+V++ +++ +++ CGG L+++ VLTAAHC + +L
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 243 SVNLGDHNIKQKNEVKH--VERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAI 300
+ VK ER V+ ++ H+ + ND+A++ + PV I
Sbjct: 61 IFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPG 120
Query: 301 CLPRGRASYEGKIAT--VIGWGSLRESGPQPA-VLQKVNIPVWTNADCKA-RYGPVAPGG 356
CLP+ +A T V GWG L+E GP+ + LQ+ + + C + R+ G
Sbjct: 121 CLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRW---YNGR 177
Query: 357 IVDHFLCAG--RATKDSCTGDSGGPLMVND---GKWTQVGIVSWGIGCGKGEYPGVYTRV 411
I +CAG R D+C GDSGGPLM D + VGI SWG+GC + + PGVYT
Sbjct: 178 IRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTST 237
Query: 412 TYFMPWITKNLKKN 425
++ WI + N
Sbjct: 238 WPYLNWIASKIGSN 251
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 117 bits (294), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 80/240 (33%), Positives = 118/240 (49%), Gaps = 24/240 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG A Q E+P++V + CGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVS--GSGNNTSITATGGV 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
+++ + VK KV + + D A++ L +P+ A + +
Sbjct: 55 VDLQSSSAVKVRSTKVLQAPGYNGTG-----KDWALIKLAQPINQPTLKIATTTAYNQGT 109
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--- 365
+ TV GWG+ RE G Q L K N+P ++A C++ YG + + +CAG
Sbjct: 110 F-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL---VANEEICAGYPD 161
Query: 366 RATKDSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
D+C GDSGGP+ D +W QVGIVSWG GC + YPGVYT V+ F I +
Sbjct: 162 TGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 117 bits (293), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 84/252 (33%), Positives = 120/252 (47%), Gaps = 31/252 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E++ PW V + + G+ CGG L+ Q VLTAAHC+ + S + LG
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKS-------VILLGR 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN-----------DVAILTLDKPVKYSDTI 297
H++ + V +V H +DM L N D+ +L L +P + +D +
Sbjct: 54 HSLFHPEDTGQV-FQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAV 112
Query: 298 RAICLPRGRASYEGKIATVIGWGSLR-ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGG 356
+ + LP + G GWGS+ E P LQ V++ V +N C V P
Sbjct: 113 KVMDLPTQEPAL-GTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQ----VHPQK 167
Query: 357 IVDHFLCAGRAT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTY 413
+ LCAGR T K +C+GDSGGPL+ N GI SWG C E P +YT+V +
Sbjct: 168 VTKFMLCAGRWTGGKSTCSGDSGGPLVCNG---VLQGITSWGSEPCALPERPSLYTKVVH 224
Query: 414 FMPWITKNLKKN 425
+ WI + N
Sbjct: 225 YRKWIKDTIVAN 236
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 117 bits (293), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 9/235 (3%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ AE + P++ ++ +G CGG L+ Q VL+AAHC+ + K+ V LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAAD---GKVQVLLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GRA 307
H++ Q K + V R V H T+ +D+ +L L + +R + R R
Sbjct: 58 HSLSQPEPSKRLY-DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRD 116
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G + V GWG + +G +P LQ V +PV A C R G I + +CA
Sbjct: 117 VAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH--HDGAITERLMCAESN 174
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
+DSC GD+GGPL+ G + + S CG + PG+YTRV + WI L
Sbjct: 175 RRDSCKGDAGGPLVC--GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVL 227
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 117 bits (293), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 115/235 (48%), Gaps = 9/235 (3%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ AE + P++ ++ +G+ CGG L+ Q VL+AAHC+ + K+ V LG
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAAD---GKVQVLLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H++ Q K + V R V H T+ +D+ +L L + +R + R
Sbjct: 58 HSLSQPEPSKRLY-DVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRD 116
Query: 309 YE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
E G + V GWG + +G +P LQ V +PV A C R G I +CA
Sbjct: 117 VEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTH--HDGAITQRMMCAESN 174
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
+DSC GDSGGPL+ G + + S CG + PG+YTRV + WI L
Sbjct: 175 RRDSCKGDSGGPLVC--GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVL 227
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 117 bits (292), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 128/242 (52%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + C G
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 117 bits (292), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 83/238 (34%), Positives = 120/238 (50%), Gaps = 19/238 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+ G++ + PW A+ + FC G L+ Q VL+AAHC + ++ LG
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQN-------SYTIGLGL 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+++ E + VRH ++ L ND+ ++ LD+ V SDTIR+I + +
Sbjct: 54 HSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIAS-QCP 112
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA--GR 366
G V GWG L +G P VLQ VN+ V + C Y P+ CA G+
Sbjct: 113 TAGNSCLVSGWG-LLANGRMPTVLQCVNVSVVSEEVCSKLYDPL----YHPSMFCAGGGQ 167
Query: 367 ATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKNLK 423
KDSC GDSGGPL+ N + Q G+VS+G CG+ PGVYT + F WI K ++
Sbjct: 168 DQKDSCNGDSGGPLICN--GYLQ-GLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQ 222
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 117 bits (292), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 127/242 (52%), Gaps = 24/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC + + V LG+
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYK-------SGIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVK--RLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
NI N V+ E+ + + + H +++ T ND+ ++ L + +I LP
Sbjct: 53 DNI---NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSC 109
Query: 307 ASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
AS G + GWG+ + SG P VL+ + P+ +++ CK+ + I + C G
Sbjct: 110 AS-AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCVG 164
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGP+ V GK GIVSWG GC + PG YT+V ++ WI + +
Sbjct: 165 YLEGGKDACQGDSGGPV-VCSGKLQ--GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIA 221
Query: 424 KN 425
N
Sbjct: 222 SN 223
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 80/240 (33%), Positives = 117/240 (48%), Gaps = 24/240 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG A Q E+P++V + CGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVS--GSGNNTSITATGGV 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
+++ + VK KV + + D A++ L +P+ A + +
Sbjct: 55 VDLQSSSAVKVRSTKVLQAPGYNGTG-----KDWALIKLAQPINQPTLKIATTTAYNQGT 109
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--- 365
+ TV GWG+ RE G Q L K N+P ++A C++ YG + + +CAG
Sbjct: 110 F-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL---VANEEICAGYPD 161
Query: 366 RATKDSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
D C GDSGGP+ D +W QVGIVSWG GC + YPGVYT V+ F I +
Sbjct: 162 TGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 116 bits (290), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 80/240 (33%), Positives = 117/240 (48%), Gaps = 24/240 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG A Q E+P++V + CGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVS--GSGNNTSITATGGV 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
+++ VK KV + + D A++ L +P+ A + +
Sbjct: 55 VDLQSGAAVKVRSTKVLQAPGYNGTG-----KDWALIKLAQPINQPTLKIATTTAYNQGT 109
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--- 365
+ TV GWG+ RE G Q L K N+P ++A C++ YG + + +CAG
Sbjct: 110 F-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL---VANEEICAGYPD 161
Query: 366 RATKDSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLK 423
D+C GDSGGP+ D +W QVGIVSWG GC + YPGVYT V+ F I +
Sbjct: 162 TGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 115 bits (289), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 86/243 (35%), Positives = 118/243 (48%), Gaps = 19/243 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
+VGG A + WPW V++ G FCGG+LI + VLTAAHC+ S + V LG
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLE--KSPRPSSYKVILG 75
Query: 248 DHNIKQKNEVKHV-ERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
H ++ N HV E +V RL + D+A+L L P +D + CLP
Sbjct: 76 AH--QEVNLEPHVQEIEVSRLF------LEPTRKDIALLKLSSPAVITDKVIPACLPSPN 127
Query: 307 ASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
+ I GWG + + +L + +PV N C RY G + LCAG
Sbjct: 128 YVVADRTECFITGWGETQGTF-GAGLLMEAQLPVIENKVCN-RY-EFLNGRVQSTELCAG 184
Query: 366 RAT--KDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
DSC GDSGGPL+ K+ G+ SWG+GC + PGVY RV+ F+ WI +
Sbjct: 185 HLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 244
Query: 423 KKN 425
+ N
Sbjct: 245 RNN 247
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 114 bits (286), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 87/252 (34%), Positives = 118/252 (46%), Gaps = 31/252 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG N E+N PW VA++ + CGG L+D VLTAAHC V + V LG
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCY-------VDQYEVWLGK 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLY-----------NDVAILTLDKPVKYSDTI 297
+ + Q+ E R V + H F+M L +D+ +L L KP +D +
Sbjct: 54 NKLFQE-EPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVV 112
Query: 298 RAICLPRGRASYEGKIATVIGWGSLRESGPQ-PAVLQKVNIPVWTNADCKARYGPVAPGG 356
+ I LP + G GWGS+ + Q P LQ V I + N +C Y
Sbjct: 113 KPIALPT-KEPKPGSKCLASGWGSITPTRWQKPDDLQCVFITLLPNENCAKVYL----QK 167
Query: 357 IVDHFLCAGR--ATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTY 413
+ D LCAG KD+C DSGGPL+ DG G S+G + CGK P +YT +
Sbjct: 168 VTDVMLCAGEMGGGKDTCRDDSGGPLIC-DG--ILQGTTSYGPVPCGKPGVPAIYTNLIK 224
Query: 414 FMPWITKNLKKN 425
F WI + KN
Sbjct: 225 FNSWIKDTMMKN 236
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 79/243 (32%), Positives = 122/243 (50%), Gaps = 26/243 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+ G + PW VA+ + + CGG L++ + VLTAAHC M+ + V S LGD
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC--KMNEYTVHLGSDTLGD 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
++ K + RH + +T ND+ ++ L+ + S ++ + LP R
Sbjct: 59 RRAQRI--------KASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLP-SRCE 109
Query: 309 YEGKIATVIGWGSLRESGPQ---PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
G TV GWG+ + P P+ L V++ + + DC Y + + + LCAG
Sbjct: 110 PPGTTCTVSGWGT--TTSPDVTFPSDLMCVDVKLISPQDCTKVYKDL----LENSMLCAG 163
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNL 422
+ K++C GDSGGPL+ + T G+VSWG CG+ PGVYT+V F WI +
Sbjct: 164 IPDSKKNACNGDSGGPLVC---RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM 220
Query: 423 KKN 425
KK+
Sbjct: 221 KKH 223
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 84/243 (34%), Positives = 120/243 (49%), Gaps = 19/243 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
RI GGQ A+ ++PW V I G G+L+ VLTAAH V D + L + +G
Sbjct: 86 RIYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKH-DASALDIRMG 142
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLY-NDVAILTLDKPVKYSDTIRAICLPRGR 306
++ + + + + H+ + + ND+A++ L+ V + I ICLPR
Sbjct: 143 ---TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKE 199
Query: 307 AS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYG--PVAPGGIVDHF 361
A I T GWG L + G L V+IP+ + C A Y P G + +
Sbjct: 200 AESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 258
Query: 362 LCAGRAT--KDSCTGDSGGPLMVNDG---KWTQVGIVSWG-IGCGKGEYPGVYTRVTYFM 415
LCAG + KDSC GDSGG L+ D +W GIVSWG + CG+ GVYT+V ++
Sbjct: 259 LCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYI 318
Query: 416 PWI 418
PWI
Sbjct: 319 PWI 321
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 80/241 (33%), Positives = 120/241 (49%), Gaps = 20/241 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
++GG + NE P++ +++ G FCG +LI+ + V+TAAHC D + LG
Sbjct: 1 VLGGDECDINEHPFLAFLYSHG-YFCGLTLINQEWVVTAAHC-------DSTNFQMQLGV 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+ K NE + ++ + L D+ ++ LDKP+ S I + LP S
Sbjct: 53 HSKKVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPPS 112
Query: 309 YEGKIATVIGWGSLR-ESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + ++GWGS+ + P V NI + C+ Y G LCAG
Sbjct: 113 V-GSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYN----GLPAKTTLCAGVL 167
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGI-GCGKGEYPGVYTRVTYFMPWITKNLKK 424
KD+C GDSGGPL+ N G++ GIVS+G CG+G PG+YT V + WI +N+
Sbjct: 168 EGGKDTCVGDSGGPLICN-GQFQ--GIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNIAG 224
Query: 425 N 425
N
Sbjct: 225 N 225
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 126/242 (52%), Gaps = 23/242 (9%)
Query: 189 IVGGQNAEQNEWPW---VVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG A+ + P+ V + ++ CGG L+ VLTAAHC + ++V
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQG-------SSINVT 53
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
LG HNIK++ + VKR + H A++ + ND+ +L L++ K++ +R + LP
Sbjct: 54 LGAHNIKEQERTQQFI-PVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSS 112
Query: 306 RASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+A + G++ +V GWG + S LQ+V + V + C+ + +C
Sbjct: 113 KAQVKPGQLCSVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRATE---ICV 168
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G + T+ GDSGGPL+ D GI+S+ G KG PGVY +V++F+PWI + +
Sbjct: 169 GDPKKTQTGFKGDSGGPLVCKD---VAQGILSY--GNKKGTPPGVYIKVSHFLPWIKRTM 223
Query: 423 KK 424
K+
Sbjct: 224 KR 225
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 126/248 (50%), Gaps = 22/248 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG ++ PW+ AI+ G FC GSL+ T V++AAHC +H D +SV LG
Sbjct: 1 IIGGSSSLPGSHPWLAAIY-IGDSFCAGSLVHTCWVVSAAHCFSHSPPRD--SVSVVLGQ 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN----DVAILTL----DKPVKYSDTIRAI 300
H + +V + + ++ + + +++N D+ ++ L D+ S ++ I
Sbjct: 58 HFFNRTTDVT----QTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPI 113
Query: 301 CLPRGRASY-EGKIATVIGWGSLRES-GPQPAVLQKVNIPVWTNADCKARYGPVAPGGIV 358
CLP +++ G + GWG L E+ + L++ +P+ + C + V I
Sbjct: 114 CLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSP--EVYGADIS 171
Query: 359 DHFLCAGR--ATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFM 415
+ LCAG D+C GDSGGPL +G GI+SWG GCG+ PGVYTRV ++
Sbjct: 172 PNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYV 231
Query: 416 PWITKNLK 423
WI ++
Sbjct: 232 DWINDRIR 239
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 126/248 (50%), Gaps = 22/248 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG ++ PW+ AI+ G FC GSL+ T V++AAHC +H D +SV LG
Sbjct: 1 IIGGSSSLPGSHPWLAAIY-IGDSFCAGSLVHTCWVVSAAHCFSHSPPRD--SVSVVLGQ 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN----DVAILTL----DKPVKYSDTIRAI 300
H + +V + + ++ + + +++N D+ ++ L D+ S ++ I
Sbjct: 58 HFFNRTTDVT----QTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPI 113
Query: 301 CLPRGRASY-EGKIATVIGWGSLRES-GPQPAVLQKVNIPVWTNADCKARYGPVAPGGIV 358
CLP +++ G + GWG L E+ + L++ +P+ + C + V I
Sbjct: 114 CLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSP--EVYGADIS 171
Query: 359 DHFLCAGR--ATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFM 415
+ LCAG D+C GDSGGPL +G GI+SWG GCG+ PGVYTRV ++
Sbjct: 172 PNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYV 231
Query: 416 PWITKNLK 423
WI ++
Sbjct: 232 DWINDRIR 239
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 78/241 (32%), Positives = 120/241 (49%), Gaps = 26/241 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+ G + PW VA+ + + CGG L++ + VLTAAHC M+ + V S LGD
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC--KMNEYTVHLGSDTLGD 58
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
++ K + RH + +T ND+ ++ L+ + S ++ + LP R
Sbjct: 59 RRAQRI--------KASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLP-SRCE 109
Query: 309 YEGKIATVIGWGSLRESGPQ---PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
G TV GWG+ + P P+ L V++ + + DC Y + + + LCAG
Sbjct: 110 PPGTTCTVSGWGT--TTSPDVTFPSDLMCVDVKLISPQDCTKVYKDL----LENSMLCAG 163
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNL 422
+ K++C GDSGGPL+ + T G+VSWG CG+ PGVYT+V F WI +
Sbjct: 164 IPDSKKNACNGDSGGPLVC---RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM 220
Query: 423 K 423
K
Sbjct: 221 K 221
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 83/243 (34%), Positives = 120/243 (49%), Gaps = 19/243 (7%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
+I GGQ A+ ++PW V I G G+L+ VLTAAH V D + L + +G
Sbjct: 161 QIYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKH-DASALDIRMG 217
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLY-NDVAILTLDKPVKYSDTIRAICLPRGR 306
++ + + + + H+ + + ND+A++ L+ V + I ICLPR
Sbjct: 218 ---TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKE 274
Query: 307 AS---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYG--PVAPGGIVDHF 361
A I T GWG L + G L V+IP+ + C A Y P G + +
Sbjct: 275 AESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 333
Query: 362 LCAGRAT--KDSCTGDSGGPLMVNDG---KWTQVGIVSWG-IGCGKGEYPGVYTRVTYFM 415
LCAG + KDSC GDSGG L+ D +W GIVSWG + CG+ GVYT+V ++
Sbjct: 334 LCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYI 393
Query: 416 PWI 418
PWI
Sbjct: 394 PWI 396
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 82/235 (34%), Positives = 119/235 (50%), Gaps = 25/235 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+VGG A Q E+P++V + CGG+L VLTAAHCV+ S + ++ G
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVS--GSGNNTSITATGGV 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
+++ + VK KV + + D A++ L +P+ A + +
Sbjct: 55 VDLQSSSAVKVRSTKVLQAPGYNGTG-----KDWALIKLAQPINQPTLKIATTTAYNQGT 109
Query: 309 YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRAT 368
+ TV GWG+ RE G Q L K N+P ++A C++ YG + + +CAG T
Sbjct: 110 F-----TVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL---VANEEICAGYDT 161
Query: 369 K--DSCTGDSGGPLMVNDG--KWTQVGIVSWGIGCG-KGEYPGVYTRVTYFMPWI 418
D+C GDSGGP+ D +W QVGIVSWG GC KG+Y GVYT V+ F I
Sbjct: 162 GGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKY-GVYTEVSTFASAI 215
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 111 bits (278), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 75/242 (30%), Positives = 126/242 (52%), Gaps = 23/242 (9%)
Query: 189 IVGGQNAEQNEWPW---VVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG A+ + P+ V + ++ CGG L+ VLTAAHC + ++V
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQG-------SSINVT 53
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
LG HNIK++ + VKR + H A++ + N++ +L L++ K++ +R + LP
Sbjct: 54 LGAHNIKEQERTQQFI-PVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSS 112
Query: 306 RASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+A + G++ +V GWG + S LQ+V + V + C+ + +C
Sbjct: 113 KAQVKPGQLCSVAGWGYVSMST-LATTLQEVLLTVQKDCQCERLFHGNYSRATE---ICV 168
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G + T+ GDSGGPL+ D GI+S+G KG PGVY +V++F+PWI + +
Sbjct: 169 GDPKKTQTGFKGDSGGPLVCKD---VAQGILSYG--NKKGTPPGVYIKVSHFLPWIKRTM 223
Query: 423 KK 424
K+
Sbjct: 224 KR 225
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 111 bits (277), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 83/242 (34%), Positives = 119/242 (49%), Gaps = 19/242 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I GGQ A+ ++PW V I G G+L+ VLTAAH V D + L + +G
Sbjct: 1 IYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKH-DASALDIRMG- 56
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLY-NDVAILTLDKPVKYSDTIRAICLPRGRA 307
++ + + + + H+ + + ND+A++ L+ V + I ICLPR A
Sbjct: 57 --TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEA 114
Query: 308 S---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYG--PVAPGGIVDHFL 362
I T GWG L + G L V+IP+ + C A Y P G + + L
Sbjct: 115 ESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANML 173
Query: 363 CAGRAT--KDSCTGDSGGPLMVNDG---KWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMP 416
CAG + KDSC GDSGG L+ D +W GIVSWG + CG+ GVYT+V ++P
Sbjct: 174 CAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIP 233
Query: 417 WI 418
WI
Sbjct: 234 WI 235
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 111 bits (277), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 121/242 (50%), Gaps = 26/242 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+ G+ + PW A+F + CGG L+ + VLTAAHC K SV LGD
Sbjct: 1 ILEGRECIPHSQPWQAALFQGERLICGGVLVGDRWVLTAAHCKKQ-------KYSVRLGD 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRT---LYNDVAILTLDKPVKYSDTIRAICLPRG 305
H+++ +++ + E +V + ++H ++ +D+ ++ L D ++ + L
Sbjct: 54 HSLQSRDQPEQ-EIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLAN- 111
Query: 306 RASYEGKIATVIGWGSLRESGPQ---PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
G+ + GWG++ + PQ P L + +++ C+ Y PG I + +
Sbjct: 112 LCPKVGQKCIISGWGTV--TSPQENFPNTLNCAEVKIYSQNKCERAY----PGKITEGMV 165
Query: 363 CAGRAT-KDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITK 420
CAG + D+C GDSGGPL V DG GI SWG CGK E PGVYT++ + WI K
Sbjct: 166 CAGSSNGADTCQGDSGGPL-VCDGMLQ--GITSWGSDPCGKPEKPGVYTKICRYTTWIKK 222
Query: 421 NL 422
+
Sbjct: 223 TM 224
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 82/242 (33%), Positives = 119/242 (49%), Gaps = 19/242 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I GGQ A+ ++PW V I G G+L+ VLTAAH V D + L + +G
Sbjct: 1 IYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKH-DASALDIRMG- 56
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLY-NDVAILTLDKPVKYSDTIRAICLPRGRA 307
++ + + + + H+ + + ND+A++ L+ V + I ICLPR A
Sbjct: 57 --TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEA 114
Query: 308 S---YEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYG--PVAPGGIVDHFL 362
I T GWG L + G L V+IP+ + C A Y P G + + L
Sbjct: 115 ESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANML 173
Query: 363 CAGRAT--KDSCTGDSGGPLMVNDG---KWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMP 416
CAG + KDSC GD+GG L+ D +W GIVSWG + CG+ GVYT+V ++P
Sbjct: 174 CAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIP 233
Query: 417 WI 418
WI
Sbjct: 234 WI 235
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 109 bits (273), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 83/274 (30%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 170 KVDMSCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHV 224
++ CGQK +I+GG+ PW AI+ + CGGSL+ V
Sbjct: 8 ELKFQCGQKTLRPRF---KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWV 64
Query: 225 LTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDV 282
++A HC + + + N + E+K +V+ L+ HK + TL +ND+
Sbjct: 65 ISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDI 121
Query: 283 AILTLD----KPVKYSDTIRAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVN 336
A+L + + + S TI+ ICLP + G + G+G + P L+
Sbjct: 122 ALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV 181
Query: 337 IPVWTNADCKA--RYGPVAPGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVG 391
+ + ++ +C+ YG + LCA + DSC GDSGGPL+ + G+ T G
Sbjct: 182 VKLISHRECQQPHYYG----SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTG 237
Query: 392 IVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
IVSWG GC + PGVYTRV++F+PWI + K+
Sbjct: 238 IVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEE 271
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 108 bits (271), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 127/244 (52%), Gaps = 30/244 (12%)
Query: 189 IVGGQNAEQNEWPWVVAI---FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG+ + + P++ + +G+ CGG L+ VLTAAHC W + ++V
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHC------WG-SNINVT 53
Query: 246 LGDHNIKQK-NEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HNI+++ N +H+ +R +RH ++ RT+ ND+ +L L + V+ + + + LPR
Sbjct: 54 LGAHNIQRRENTQQHI--TARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPR 111
Query: 305 GRASYE-GKIATVIGWG--SLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ G + TV GWG S+R L++V + V + C +G P
Sbjct: 112 AQEGLRPGTLCTVAGWGRVSMRRG---TDTLREVQLRVQRDRQCLRIFGSYDP----RRQ 164
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
+C G R K + GDSGGPL+ N+ GIVS+G G P V+TRV+ F+PWI
Sbjct: 165 ICVGDRRERKAAFKGDSGGPLLCNN---VAHGIVSYGKSSGVP--PEVFTRVSSFLPWIR 219
Query: 420 KNLK 423
++
Sbjct: 220 TTMR 223
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 127/244 (52%), Gaps = 30/244 (12%)
Query: 189 IVGGQNAEQNEWPWVVAI---FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG+ + + P++ + +G+ CGG L+ VLTAAHC W + ++V
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHC------WG-SNINVT 53
Query: 246 LGDHNIKQK-NEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HNI+++ N +H+ +R +RH ++ RT+ ND+ +L L + V+ + + + LPR
Sbjct: 54 LGAHNIQRRENTQQHI--TARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPR 111
Query: 305 GRASYE-GKIATVIGWG--SLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
+ G + TV GWG S+R L++V + V + C +G P
Sbjct: 112 AQEGLRPGTLCTVAGWGRVSMRRG---TDTLREVQLRVQRDRQCLRIFGSYDP----RRQ 164
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
+C G R K + GDSGGPL+ N+ GIVS+G G P V+TRV+ F+PWI
Sbjct: 165 ICVGDRRERKAAFKGDSGGPLLCNN---VAHGIVSYGK--SSGVPPEVFTRVSSFLPWIR 219
Query: 420 KNLK 423
++
Sbjct: 220 TTMR 223
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 107 bits (268), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 83/244 (34%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 197 QNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNE 256
+N PW VA++ K CGG L+D VLTAAHC K V LG +N + +E
Sbjct: 12 ENSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYND-------KYQVWLGKNNFLE-DE 63
Query: 257 VKHVERKVKRLVRHKAFDMRTL-----------YNDVAILTLDKPVKYSDTIRAICLPRG 305
R V + + H F+M L ND+ +L L KP +D ++ I LP
Sbjct: 64 PSDQHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTE 123
Query: 306 RASYEGKIATVIGWGSLRE-SGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
G GWGS P LQ VN+ + N DC + + D LCA
Sbjct: 124 EPKL-GSTCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDKAHE----MKVTDAMLCA 178
Query: 365 GRATKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKN 421
G S C DSGGPL+ DG GI SWG CG+ P VYT++ F WI +
Sbjct: 179 GEMDGGSYTCEHDSGGPLIC-DG--ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIRET 235
Query: 422 LKKN 425
+ N
Sbjct: 236 MANN 239
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 107 bits (268), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/251 (31%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 186 QERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCV--AHMSSWDVAKLS 243
++RI+GGQ A+ +PW V G+ GG+L+ + +LTAAH + + A L
Sbjct: 87 RQRIIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKEHEAQSNASLD 144
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN---DVAILTLDKPVKYSDTIRAI 300
V LG N+++ +K ++R+ H + YN D+A+L L+ V + I
Sbjct: 145 VFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 202
Query: 301 CLPRGRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKA-RYGPVAPGGIV 358
CLP Y+ G + V G+G + E L+ V +PV C+ G
Sbjct: 203 CLPDNDTFYDLGLMGYVSGFGVMEEKIAHD--LRFVRLPVANPQACENWLRGKNRMDVFS 260
Query: 359 DHFLCAGRAT--KDSCTGDSGGPLMVND---GKWTQVGIVSWGIGCGKGEYPGVYTRVTY 413
+ CAG + +D+C GDSGG V D +W GIVSWGIGC +G G YT+V
Sbjct: 261 QNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLN 318
Query: 414 FMPWITKNLKK 424
++ WI K +++
Sbjct: 319 YVDWIKKEMEE 329
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 107 bits (268), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 117/254 (46%), Gaps = 34/254 (13%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG EQ+ PW A+++ CGG L+ Q VLTAAHC++ + LG
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCIS-------DNYQLWLGR 53
Query: 249 HNI-KQKNEVKHVERKVKRLVRHKAFDMRTLYN-----------DVAILTLDKPVK-YSD 295
HN+ +N + V V H F+M L N D+ +L L +P +D
Sbjct: 54 HNLFDDENTAQFV--HVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITD 111
Query: 296 TIRAICLPRGRASYEGKIATVIGWGSLR-ESGPQPAVLQKVNIPVWTNADCKARYGPVAP 354
++ + LP G GWGS+ E+ P LQ V++ + N +CK +
Sbjct: 112 AVKVVELPTEEPEV-GSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAH----V 166
Query: 355 GGIVDHFLCAGRAT--KDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRV 411
+ D LC G KD+C GDSGGPLM DG G+ SWG + CG P V RV
Sbjct: 167 QKVTDFMLCVGHLEGGKDTCVGDSGGPLMC-DG--VLQGVTSWGYVPCGTPNKPSVAVRV 223
Query: 412 TYFMPWITKNLKKN 425
++ WI + +N
Sbjct: 224 LSYVKWIEDTIAEN 237
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 107 bits (266), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/255 (31%), Positives = 124/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 84/243 (34%), Positives = 123/243 (50%), Gaps = 28/243 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+ G A +P+ + + + + +CGGSLID + +LTAAHCV D + V
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVH-----DAVSVVV 55
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG + V + E R++ H F+ T NDVA++ + V+Y+D I+ I LP
Sbjct: 56 YLGSAVQYEGEAVVNSE----RIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPIRLPS 110
Query: 305 GRA---SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
G +E ATV GWG +S +LQ V N C Y PG IV+
Sbjct: 111 GEELNNKFENIWATVSGWG---QSNTDTVILQYTYNLVIDNDRCAQEY---PPGIIVEST 164
Query: 362 LCAGRAT-KDSCTGDSGGPLMVNDGKWTQVGIVSW--GIGCGKGEYPGVYTRVTYFMPWI 418
+C + K C GDSGGP +++D K +G+VS+ G GC G+ P ++RVT +M WI
Sbjct: 165 ICGDTSDGKSPCFGDSGGPFVLSD-KNLLIGVVSFVSGAGCESGK-PVGFSRVTSYMDWI 222
Query: 419 TKN 421
+N
Sbjct: 223 QQN 225
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 79/251 (31%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 186 QERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCV--AHMSSWDVAKLS 243
+++I+GGQ A+ +PW V G+ GG+L+ + +LTAAH + + A L
Sbjct: 155 RQQIIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKEHEAQSNASLD 212
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN---DVAILTLDKPVKYSDTIRAI 300
V LG N+++ +K ++R+ H + YN D+A+L L+ V + I
Sbjct: 213 VFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 270
Query: 301 CLPRGRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKA-RYGPVAPGGIV 358
CLP Y+ G + V G+G + E L+ V +PV C+ G
Sbjct: 271 CLPDNDTFYDLGLMGYVSGFGVMEEKIAHD--LRFVRLPVANPQACENWLRGKNRMDVFS 328
Query: 359 DHFLCAGRAT--KDSCTGDSGGPLMVND---GKWTQVGIVSWGIGCGKGEYPGVYTRVTY 413
+ CAG + +D+C GDSGG V D +W GIVSWGIGC +G G YT+V
Sbjct: 329 QNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLN 386
Query: 414 FMPWITKNLKK 424
++ WI K +++
Sbjct: 387 YVDWIKKEMEE 397
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 79/250 (31%), Positives = 122/250 (48%), Gaps = 20/250 (8%)
Query: 186 QERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCV--AHMSSWDVAKLS 243
++RI+GGQ A+ +PW V G+ GG+L+ + +LTAAH + + A L
Sbjct: 87 RQRIIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKEHEAQSNASLD 144
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN---DVAILTLDKPVKYSDTIRAI 300
V LG N+++ +K ++R+ H + YN D+A+L L+ V + I
Sbjct: 145 VFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 202
Query: 301 CLPRGRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKA-RYGPVAPGGIV 358
CLP Y+ G + V G+G + E L+ V +PV C+ G
Sbjct: 203 CLPDNDTFYDLGLMGYVSGFGVMEEKIAHD--LRFVRLPVANPQACENWLRGKNRMDVFS 260
Query: 359 DHFLCAGRAT--KDSCTGDSGGPLMVND---GKWTQVGIVSWGIGCGKGEYPGVYTRVTY 413
+ CAG + +D+C GD+GG V D +W GIVSWGIGC +G G YT+V
Sbjct: 261 QNMFCAGHPSLKQDACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLN 318
Query: 414 FMPWITKNLK 423
++ WI K ++
Sbjct: 319 YVDWIKKEME 328
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 79/255 (30%), Positives = 124/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 105 bits (263), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 83/272 (30%), Positives = 129/272 (47%), Gaps = 28/272 (10%)
Query: 171 VDMSCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVL 225
+ CGQK +I+GG+ PW AI+ + CGGSLI V+
Sbjct: 1 LKFQCGQKTLRPRF---KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVI 57
Query: 226 TAAHCVAHMSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVA 283
+A HC + + + N + E+K +V+ L+ HK + TL +ND+A
Sbjct: 58 SATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIA 114
Query: 284 ILTLD----KPVKYSDTIRAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNI 337
+L + + + S TI+ I LP + G + G+G + P L+ +
Sbjct: 115 LLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVV 174
Query: 338 PVWTNADCKA--RYGPVAPGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGI 392
+ ++ +C+ YG + LCA + DSC GDSGGPL+ + G+ T GI
Sbjct: 175 KLISHRECQQPHYYG----SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGI 230
Query: 393 VSWGIGCGKGEYPGVYTRVTYFMPWITKNLKK 424
VSWG GC + PGVYTRV++F+PWI + K+
Sbjct: 231 VSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 262
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 79/255 (30%), Positives = 124/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 105 bits (262), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 87/255 (34%), Positives = 119/255 (46%), Gaps = 39/255 (15%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG E+N PW VA+ N + CGG LID V+TAAHC ++ V LG
Sbjct: 1 IVGGYKCEKNSQPWQVAVIN--EYLCGGVLIDPSWVITAAHCYSN-------NYQVLLGR 51
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAF-----------DMRTLYNDVAILTLDKPVKYSDTI 297
+N+ K+E R V++ RH + + ND+ +L L +P + +
Sbjct: 52 NNLF-KDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGV 110
Query: 298 RAICLPRGRASYEGKIATVIGWGSLRESGPQPAV----LQKVNIPVWTNADCKARYGPVA 353
+ I LP + G GWGS + P V LQ VNI + +N C Y
Sbjct: 111 KVIDLPT-KEPKVGSTCLASGWGS---TNPSEMVVSHDLQCVNIHLLSNEKCIETY---- 162
Query: 354 PGGIVDHFLCAGRAT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTR 410
+ D LCAG KD+C GDSGGPL+ DG GI S G C K + P +Y +
Sbjct: 163 KDNVTDVMLCAGEMEGGKDTCAGDSGGPLIC-DGVLQ--GITSGGATPCAKPKTPAIYAK 219
Query: 411 VTYFMPWITKNLKKN 425
+ F WI K +K+N
Sbjct: 220 LIKFTSWIKKVMKEN 234
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 77/242 (31%), Positives = 118/242 (48%), Gaps = 22/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIF---NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG A+ + P++ + + CGG LI VLTAAHC W + ++V
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHC------WG-SSINVT 53
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
LG HNIK++ + VKR + H A++ + ND+ +L L++ K + ++ + LP
Sbjct: 54 LGAHNIKEQEPTQQFI-PVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSN 112
Query: 306 RASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+A + G+ +V GWG G LQ+V + V + C++ I LC
Sbjct: 113 KAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIE---LCV 169
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G K S GDSGGPL+ N GIVS+G G P T+V+ F+ WI K +
Sbjct: 170 GDPEIKKTSFKGDSGGPLVCNK---VAQGIVSYGR--NNGMPPRACTKVSSFVHWIKKTM 224
Query: 423 KK 424
K+
Sbjct: 225 KR 226
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 122/248 (49%), Gaps = 25/248 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWI 418
V++F+PWI
Sbjct: 234 VSHFLPWI 241
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 104 bits (260), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 77/242 (31%), Positives = 118/242 (48%), Gaps = 22/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIF---NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
I+GG A+ + P++ + + CGG LI VLTAAHC W + ++V
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHC------WG-SSINVT 53
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
LG HNIK++ + VKR + H A++ + ND+ +L L++ K + ++ + LP
Sbjct: 54 LGAHNIKEQEPTQQFI-PVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSN 112
Query: 306 RASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
+A + G+ +V GWG G LQ+V + V + C++ I LC
Sbjct: 113 KAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIE---LCV 169
Query: 365 G--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
G K S GDSGGPL+ N GIVS+G G P T+V+ F+ WI K +
Sbjct: 170 GDPEIKKTSFKGDSGGPLVCNK---VAQGIVSYGR--NNGMPPRACTKVSSFVHWIKKTM 224
Query: 423 KK 424
K+
Sbjct: 225 KR 226
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 104 bits (260), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + D+C GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 104 bits (259), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 121/248 (48%), Gaps = 25/248 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWI 418
V++F+PWI
Sbjct: 234 VSHFLPWI 241
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 79/255 (30%), Positives = 124/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + + P L+ + + ++ +C+ YG
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 78/246 (31%), Positives = 123/246 (50%), Gaps = 31/246 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
++GG NE ++ ++ +G CGG+LI+ + VLTA HC D + + LG
Sbjct: 1 VIGGDECNINEHRFLALVYANG-SLCGGTLINQEWVLTARHC-------DRGNMRIYLGM 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN-----DVAILTLDKPVKYSDTIRAICLP 303
HN+K N + ++R + K F + T + D+ ++ L++PV+ S I + LP
Sbjct: 53 HNLKVLN-----KDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLP 107
Query: 304 RGRASYEGKIATVIGWGSLRE-SGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
S G + ++GWG++ + P V NI + A C+A Y G+ L
Sbjct: 108 SNPPSV-GSVCRIMGWGTITSPNATLPDVPHCANINILDYAVCQAAY-----KGLAATTL 161
Query: 363 CAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWIT 419
CAG KD+C GDSGGPL+ N G++ GI+S G C + PG+YT+V + WI
Sbjct: 162 CAGILEGGKDTCKGDSGGPLICN-GQFQ--GILSVGGNPCAQPRKPGIYTKVFDYTDWIQ 218
Query: 420 KNLKKN 425
+ N
Sbjct: 219 SIISGN 224
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 121/248 (48%), Gaps = 25/248 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ ICLP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWI 418
V++F+PWI
Sbjct: 234 VSHFLPWI 241
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 116/243 (47%), Gaps = 23/243 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ-FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
I+ G + + + PW A+ Q +CG L+ Q +LTAAHC + V LG
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKV-------FRVRLG 53
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
+++ E + + + H + ND+ ++ L++ ++ + +R I +
Sbjct: 54 HYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINV-SSHC 112
Query: 308 SYEGKIATVIGWGSLRESGPQ---PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
G V GWG+ + PQ P VLQ +NI V + C+ Y P I D CA
Sbjct: 113 PSAGTKCLVSGWGTTKS--PQVHFPKVLQCLNISVLSQKRCEDAY----PRQIDDTMFCA 166
Query: 365 G-RATKDSCTGDSGGPLMVNDGKWTQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNL 422
G +A +DSC GDSGGP++ N + G+VSWG C + PGVYT + F WI + +
Sbjct: 167 GDKAGRDSCQGDSGGPVVCNG---SLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETI 223
Query: 423 KKN 425
+ N
Sbjct: 224 QAN 226
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 79/248 (31%), Positives = 120/248 (48%), Gaps = 20/248 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCV--AHMSSWDVAKLSVNL 246
I+GGQ A+ +PW V G+ GG+L+ + +LTAAH + + A L V L
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKEHEAQSNASLDVFL 58
Query: 247 GDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN---DVAILTLDKPVKYSDTIRAICLP 303
G N+++ +K ++R+ H + YN D+A+L L+ V + ICLP
Sbjct: 59 GHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLP 116
Query: 304 RGRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKA-RYGPVAPGGIVDHF 361
Y+ G + V G+G + E L+ V +PV C+ G +
Sbjct: 117 DNDTFYDLGLMGYVSGFGVMEEKIAHD--LRFVRLPVANPQACENWLRGKNRMDVFSQNM 174
Query: 362 LCAGRAT--KDSCTGDSGGPLMVND---GKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMP 416
CAG + +D+C GDSGG V D +W GIVSWGIGC +G G YT+V ++
Sbjct: 175 FCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVD 232
Query: 417 WITKNLKK 424
WI K +++
Sbjct: 233 WIKKEMEE 240
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 79/253 (31%), Positives = 123/253 (48%), Gaps = 25/253 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + + P L+ + + ++ +C+ YG
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLK 423
V++F+PWI + K
Sbjct: 234 VSHFLPWIRSHTK 246
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 80/243 (32%), Positives = 114/243 (46%), Gaps = 18/243 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
I+GG NE ++VA++ S + FCGG+LI+ + VLTAAHC D + L
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHC-------DRKNFRIKL 53
Query: 247 GDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGR 306
G H+ K NE + ++ + + D+ ++ LD PVK S I A
Sbjct: 54 GMHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHI-APFSLPSS 112
Query: 307 ASYEGKIATVIGWGSLRES-GPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG 365
G + ++GWG + + G P V VNI + C+A Y P LCAG
Sbjct: 113 PPSVGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPY-PEFELPATSRTLCAG 171
Query: 366 --RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKNL 422
KD+C GDSGGPL+ N G++ GI SWG C + P YT+V + WI +
Sbjct: 172 ILEGGKDTCKGDSGGPLICN-GQFQ--GIASWGDDPCAQPHKPAAYTKVFDHLDWIENII 228
Query: 423 KKN 425
N
Sbjct: 229 AGN 231
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 79/254 (31%), Positives = 123/254 (48%), Gaps = 25/254 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKK 424
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKE 247
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 79/255 (30%), Positives = 123/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 79/253 (31%), Positives = 122/253 (48%), Gaps = 25/253 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLK 423
V++F+PWI + K
Sbjct: 234 VSHFLPWIRSHTK 246
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 25/255 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSLI V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + + P L+ + + ++ +C+ YG
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GD+GGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWITKNLKKN 425
V++F+PWI + K+
Sbjct: 234 VSHFLPWIRSHTKEE 248
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 82/263 (31%), Positives = 131/263 (49%), Gaps = 23/263 (8%)
Query: 173 MSCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCV- 231
+SCG KN + ++RIVGG+ A+ + PW VAI ++ CGG I +LTAAHC+
Sbjct: 307 LSCGVKNRMH-IRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLR 365
Query: 232 -AHMSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKP 290
+ + + V+ ++K + V V R++ H+ ++ T ND+A++ + K
Sbjct: 366 ASKTHRYQIWTTVVDWIHPDLK-----RIVIEYVDRIIFHENYNAGTYQNDIALIEMKKD 420
Query: 291 VKYSDTI--RAI--CLPRGRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADC 345
D R+I C+P ++ V GWG +++ + LQ + + +N C
Sbjct: 421 GNKKDCELPRSIPACVPWSPYLFQPNDTCIVSGWGREKDN-ERVFSLQWGEVKLISN--C 477
Query: 346 KARYGPVAPGGIVDHFLCAGR--ATKDSCTGDSGGPLMVNDGKWTQV--GIVSWGIGCGK 401
YG CAG + D+C GDSGGPL+ D G+VSWG CGK
Sbjct: 478 SKFYGNRF---YEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGK 534
Query: 402 GEYPGVYTRVTYFMPWITKNLKK 424
E+PGVYT+V + WI+ ++ +
Sbjct: 535 PEFPGVYTKVANYFDWISYHVGR 557
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 73/239 (30%), Positives = 111/239 (46%), Gaps = 10/239 (4%)
Query: 188 RIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
I+GG+ + P++ +I G CGG LID Q VLTAAHC + +V LG
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSP--TVVLG 59
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
H++ KNE ++K+ + ND+ ++ L K + ++ + + +
Sbjct: 60 AHSL-SKNEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSKTS 118
Query: 308 SYEGKIATVIGWGSLRESGPQPA-VLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGR 366
G V GWG+ +P+ L++V + V + C ++ I +CAG
Sbjct: 119 LRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVCAGD 178
Query: 367 AT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVT-YFMPWITKNL 422
A KDSC GD+GGPL+ K IVS G CG PG+YT +T + WI NL
Sbjct: 179 AKGQKDSCKGDAGGPLIC---KGVFHAIVSGGHECGVATKPGIYTLLTKKYQTWIKSNL 234
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAI----FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + P++ K FCGG L+ + VLTAAHC ++V
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHCKGR-------SMTV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HNIK K E + + V + + H ++ ND+ +L L + K + +R + LPR
Sbjct: 54 TLGAHNIKAKEETQQII-PVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPR 112
Query: 305 GRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
A + G V GWG + G P L +V + V + C++++ + +C
Sbjct: 113 RNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRA---NEIC 169
Query: 364 AG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G + S GDSGGPL+ K GIVS+G G P V+TRV F+ WI K
Sbjct: 170 VGDSKIKGASFRGDSGGPLVC---KRAAAGIVSYGQ--TDGSAPQVFTRVLSFVSWIKKT 224
Query: 422 LK 423
+K
Sbjct: 225 MK 226
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 102 bits (253), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 81/242 (33%), Positives = 118/242 (48%), Gaps = 20/242 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
++GG NE +VA FNS FC G+LI+ + VLTAAHC D + LG
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHC-------DNTNFQMKLGV 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+ K NE + ++ + + L D+ ++ LD V S+ I +
Sbjct: 54 HSKKVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPL-SLPSSPP 112
Query: 309 YEGKIATVIGWGSLRE-SGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDH-FLCAG- 365
G + ++GWGS+ P V I + +A C+A Y P + ++ LCAG
Sbjct: 113 SVGSVCHIMGWGSITPIKVTYPDVPYCAYINLLDDAVCQAGY----PELLTEYRTLCAGI 168
Query: 366 -RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKNLK 423
KD+C GDSGGPL+ N G++ GIVS+G CG+G PGVYT+V + WI +
Sbjct: 169 LEGGKDTCGGDSGGPLICN-GQFQ--GIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIA 225
Query: 424 KN 425
N
Sbjct: 226 GN 227
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 101 bits (251), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 82/247 (33%), Positives = 120/247 (48%), Gaps = 30/247 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNL 246
+VGG NE P++VA++ S C G+LI+ + VLTAAHC D + + L
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHC-------DRRNIRIKL 53
Query: 247 GDHNIKQKNEVKHVERKVKRLVRHKAFDMRT-----LYNDVAILTLDKPVKYSDTIRAIC 301
G H+ +NE + + R+ R K F + T L D+ ++ L +PV YS I +
Sbjct: 54 GMHSKNIRNEDEQI-----RVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVS 108
Query: 302 LPRGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
LP R+ G ++GWG + + P V NI + + C+ Y P P
Sbjct: 109 LP-SRSRGVGSRCRIMGWGKI-STTTYPDVPHCTNIFIVKHKWCEPLY-PWVPAD--SRT 163
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWI 418
LCAG + +D+C GDSGGPL+ N GIV+ G CG+ P VYT+V + WI
Sbjct: 164 LCAGILKGGRDTCHGDSGGPLICNG---EMHGIVAGGSEPCGQHLKPAVYTKVFDYNNWI 220
Query: 419 TKNLKKN 425
+ N
Sbjct: 221 QSIIAGN 227
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 101 bits (251), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 77/248 (31%), Positives = 120/248 (48%), Gaps = 25/248 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGK-----QFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLS 243
I+GG+ PW AI+ + CGGSL+ V++A HC + +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 244 VNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTL--YNDVAILTLD----KPVKYSDTI 297
+ N + E+K +V+ L+ HK + TL +ND+A+L + + + S TI
Sbjct: 61 LGRSRLNSNTQGEMKF---EVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 298 RAICLPRGRASYE-GKIATVIGWGSLRESG-PQPAVLQKVNIPVWTNADCKA--RYGPVA 353
+ I LP + G + G+G + P L+ + + ++ +C+ YG
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG--- 174
Query: 354 PGGIVDHFLCAG--RATKDSCTGDSGGPLMVN-DGKWTQVGIVSWGIGCGKGEYPGVYTR 410
+ LCA + DSC GDSGGPL+ + G+ T GIVSWG GC + PGVYTR
Sbjct: 175 -SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 411 VTYFMPWI 418
V++F+PWI
Sbjct: 234 VSHFLPWI 241
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 72/242 (29%), Positives = 114/242 (47%), Gaps = 22/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+VGG+ A+ N WPW +++ + SG + CGGSLI V+TAAHCV +W V
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDSARTWRVV---- 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN--DVAILTLDKPVKYSDTIRAICL 302
LG+HN+ NE K V + H ++ + D+A+L L+ + ++ L
Sbjct: 57 -LGEHNLN-TNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAAL 114
Query: 303 -PRGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGIVD 359
P + + GWG GP L++ +P +A C + +G +
Sbjct: 115 PPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGST----VKT 170
Query: 360 HFLCAGRATKDSCTGDSGGPLMVN-DGKWTQVGIVSW--GIGCGKGEYPGVYTRVTYFMP 416
+CAG C GDSGGPL +G + G+ S+ GC + P V+TRV+ ++
Sbjct: 171 TMVCAGGGANSGCNGDSGGPLNCQVNGSYYVHGVTSFVSSSGCNASKKPTVFTRVSAYIS 230
Query: 417 WI 418
W+
Sbjct: 231 WM 232
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 75/242 (30%), Positives = 112/242 (46%), Gaps = 23/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAI----FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + P++ K FCGG L+ + VLTAAHC ++V
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHCKGR-------SMTV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HNIK K E + + V + + H ++ ND+ +L L + K + +R + LPR
Sbjct: 54 TLGAHNIKAKEETQQII-PVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPR 112
Query: 305 GRASYE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLC 363
A + G V GWG + G P L +V + V + C++++ + +C
Sbjct: 113 RNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRA---NEIC 169
Query: 364 AG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
G + S DSGGPL+ K GIVS+G G P V+TRV F+ WI K
Sbjct: 170 VGDSKIKGASFEEDSGGPLVC---KRAAAGIVSYGQ--TDGSAPQVFTRVLSFVSWIKKT 224
Query: 422 LK 423
+K
Sbjct: 225 MK 226
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 77/246 (31%), Positives = 114/246 (46%), Gaps = 19/246 (7%)
Query: 189 IVGGQNAEQNEWPWVVAI---FNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
++GG NA E+PW ++ S CG SL+ + L+A+HCV + ++ ++
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIA-- 58
Query: 246 LGDHNIKQKNEVKHVE-RKVKRLVRHKAFDMRT--LYNDVAILTLDKPVKYSDTIRAICL 302
+ Q+++ + V H+ + T ND+AIL L + I+A L
Sbjct: 59 ----GLWQQSDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVL 114
Query: 303 P-RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
P Y G + GWG + P +LQK +IPV T A C A V I D+
Sbjct: 115 PANNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNH 174
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKG----EYPGVYTRVTYFM 415
+C +C GDSGGPL DG VG+ SW + G G +YP VYTRV+ ++
Sbjct: 175 ICVQDPAGNTGACNGDSGGPLNCPDGGTRVVGVTSWVVSSGLGACLPDYPSVYTRVSAYL 234
Query: 416 PWITKN 421
WI N
Sbjct: 235 GWIGDN 240
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 27/252 (10%)
Query: 189 IVGGQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+VGG A++N WP +++ + SG + CGG+LI V+TAAHCV ++ V
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVV---- 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAF---DMRTLYNDVAILTLDKPVKYSDTIRAIC 301
+G+HN+ Q N + V+++V H + D+ Y D+A+L L + V + ++
Sbjct: 57 -VGEHNLNQNNGTEQYV-GVQKIVVHPYWNTDDVAAGY-DIALLRLAQSVTLNSYVQLGV 113
Query: 302 LPR-GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGIV 358
LPR G + GWG R +G LQ+ +P A C + +G +
Sbjct: 114 LPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGST----VK 169
Query: 359 DHFLCA-GRATKDSCTGDSGGPL--MVNDGKWTQVGIVSW--GIGCGKGEYPGVYTRVTY 413
+ +CA G + C GDSGGPL +VN G++ G+ S+ +GC P V+TRV+
Sbjct: 170 NSMVCAGGDGVRSGCQGDSGGPLHCLVN-GQYAVHGVTSFVSRLGCNVTRKPTVFTRVSA 228
Query: 414 FMPWITKNLKKN 425
++ WI + N
Sbjct: 229 YISWINNVIASN 240
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 27/252 (10%)
Query: 189 IVGGQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+VGG A++N WP +++ + SG + CGG+LI V+TAAHCV ++ V
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVV---- 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAF---DMRTLYNDVAILTLDKPVKYSDTIRAIC 301
+G+HN+ Q N + V+++V H + D+ Y D+A+L L + V + ++
Sbjct: 57 -VGEHNLNQNNGTEQYV-GVQKIVVHPYWNTDDVAAGY-DIALLRLAQSVTLNSYVQLGV 113
Query: 302 LPR-GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGIV 358
LPR G + GWG R +G LQ+ +P A C + +G +
Sbjct: 114 LPRAGTILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGST----VK 169
Query: 359 DHFLCA-GRATKDSCTGDSGGPL--MVNDGKWTQVGIVSW--GIGCGKGEYPGVYTRVTY 413
+ +CA G + C GDSGGPL +VN G++ G+ S+ +GC P V+TRV+
Sbjct: 170 NSMVCAGGDGVRSGCQGDSGGPLHCLVN-GQYAVHGVTSFVSRLGCNVTRKPTVFTRVSA 228
Query: 414 FMPWITKNLKKN 425
++ WI + N
Sbjct: 229 YISWINNVIASN 240
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 99.0 bits (245), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 80/261 (30%), Positives = 123/261 (47%), Gaps = 32/261 (12%)
Query: 185 DQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+++RI+GG +A+ +PW V N + GG+LI+ VLTAAH V + ++
Sbjct: 79 EKQRIIGGSDADIKNFPWQVFFDNP---WAGGALINEYWVLTAAHVVEGNR-----EPTM 130
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDM------RTLY-NDVAILTLDKPVKYSDTI 297
+G +++ K + + H + + RT + ND+A++ L PVK T+
Sbjct: 131 YVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTV 190
Query: 298 RAICLPRGRASY---EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKA--RYGPV 352
ICLP + Y +G + + GWG E + L+ +PV CK P
Sbjct: 191 SPICLPGTSSDYNLMDGDLGLISGWGRT-EKRDRAVRLKAARLPVAPLRKCKEVKVEKPT 249
Query: 353 APGG---IVDHFLCA-GRATKDSCTGDSGGPLMVND----GKWTQVGIVSWGIGCGKGEY 404
A + +CA G DSC GDSGG V D K+ G+VSWG CG
Sbjct: 250 ADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCGTY-- 307
Query: 405 PGVYTRVTYFMPWITKNLKKN 425
G+YTRV ++ WI K +++N
Sbjct: 308 -GLYTRVKNYVDWIMKTMQEN 327
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 75/240 (31%), Positives = 119/240 (49%), Gaps = 22/240 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ + P++ ++ +G CGG L+ + VLTAAHC+A +A+L + LG
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQ----RMAQLRLVLGL 56
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFD-MRTLYNDVAILTLDKPVKYSDTIRAICLPRGR- 306
H + H +K ++H + + L ND+A+L LD VK S TIR + LP R
Sbjct: 57 HTLDSPGLTFH----IKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQ 112
Query: 307 ASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADC-KARY--GPVAPGGIVDHFLC 363
G ++ GWG + G VL+++++ V C +R+ G ++P +C
Sbjct: 113 VVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPS-----MVC 167
Query: 364 AGRATKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITK 420
+KD C GDSGGPL+ G+ G++S+ C P V T V ++ WI K
Sbjct: 168 LAADSKDQAPCKGDSGGPLVCGKGR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRK 226
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 25/234 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A ++P++ +I N G+ FCGG+LI + V+TAA C S + +V LG
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASC---FQSQNPGVSTVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
++++++ + + +D + ND+ +L LD+ + ++ + LP A+
Sbjct: 58 YDLRRRERQSRQTFSISSM-SENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNAT 116
Query: 309 YE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
E G V GWGS R G + VN+ V C+ + +C G
Sbjct: 117 VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP------------NNVCTGVL 164
Query: 368 TKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWI 418
T+ C GD G PL+ + G+ S+ +G CG+G P +TRV F WI
Sbjct: 165 TRRGGICNGDGGTPLVC---EGLAHGVASFSLGPCGRG--PDFFTRVALFRDWI 213
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 98.2 bits (243), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 25/234 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A ++P++ +I N G+ FCGG+LI + V+TAA C S + +V LG
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASC---FQSQNPGVSTVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
++++++ + + +D + ND+ +L LD+ + ++ + LP A+
Sbjct: 58 YDLRRRERQSRQTFSISSM-SENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNAT 116
Query: 309 YE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
E G V GWGS R G + VN+ V C+ + +C G
Sbjct: 117 VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP------------NNVCTGVL 164
Query: 368 TKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWI 418
T+ C GD G PL+ + G+ S+ +G CG+G P +TRV F WI
Sbjct: 165 TRRGGICNGDQGTPLVC---EGLAHGVASFSLGPCGRG--PDFFTRVALFRDWI 213
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 98.2 bits (243), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 29/246 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + + P++ + N +FCGG LI VLTAAHC ++V
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGR-------SITV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HNI ++ + +K+ RH ++ TL++D+ +L L + + + + P
Sbjct: 54 TLGAHNITEEEDTWQKLEVIKQF-RHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 305 GRASY-EGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF-- 361
+ G++ V GWG P LQ+V + + C DH
Sbjct: 113 QKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRD-------FDHNLQ 165
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
LC G R TK + GDSGGPL+ GIVS+G K P V+TR++++ PWI
Sbjct: 166 LCVGNPRKTKSAFKGDSGGPLLCAGAAQ---GIVSYGRSDAKP--PAVFTRISHYQPWIN 220
Query: 420 KNLKKN 425
+ L+ N
Sbjct: 221 QILQAN 226
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 77/252 (30%), Positives = 126/252 (50%), Gaps = 27/252 (10%)
Query: 189 IVGGQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
+VGG A++N WP +++ + SG + CGG+LI V+TAAHCV ++ V
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVV---- 56
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAF---DMRTLYNDVAILTLDKPVKYSDTIRAIC 301
+G+HN+ Q + + V+++V H + D+ Y D+A+L L + V + ++
Sbjct: 57 -VGEHNLNQNDGTEQYV-GVQKIVVHPYWNTDDVAAGY-DIALLRLAQSVTLNSYVQLGV 113
Query: 302 LPR-GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGIV 358
LPR G + GWG R +G LQ+ +P A C + +G +
Sbjct: 114 LPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGST----VK 169
Query: 359 DHFLCA-GRATKDSCTGDSGGPL--MVNDGKWTQVGIVSW--GIGCGKGEYPGVYTRVTY 413
+ +CA G + C GDSGGPL +VN G++ G+ S+ +GC P V+TRV+
Sbjct: 170 NSMVCAGGDGVRSGCQGDSGGPLHCLVN-GQYAVHGVTSFVSRLGCNVTRKPTVFTRVSA 228
Query: 414 FMPWITKNLKKN 425
++ WI + N
Sbjct: 229 YISWINNVIASN 240
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 29/246 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + + P++ + N +FCGG LI VLTAAHC ++V
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGR-------SITV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
LG HNI ++ + +K+ RH ++ TL++D+ +L L + + + + P
Sbjct: 54 TLGAHNITEEEDTWQKLEVIKQF-RHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF-- 361
+ G++ V GWG P LQ+V + + C DH
Sbjct: 113 QFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRD-------FDHNLQ 165
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
LC G R TK + GDSGGPL+ GIVS+G K P V+TR++++ PWI
Sbjct: 166 LCVGNPRKTKSAFKGDSGGPLLCAGAAQ---GIVSYGRSDAKP--PAVFTRISHYQPWIN 220
Query: 420 KNLKKN 425
+ L+ N
Sbjct: 221 QILQAN 226
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 114/246 (46%), Gaps = 29/246 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG ++ + P++ + N +FCGG LI VLTAAHC ++V
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGR-------SITV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
LG HNI ++ + +K+ RH ++ TL++D+ +L L + + + + P
Sbjct: 54 TLGAHNITEEEDTWQKLEVIKQF-RHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF-- 361
+ G++ V GWG P LQ+V + + C DH
Sbjct: 113 QFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRD-------FDHNLQ 165
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
LC G R TK + GDSGGPL+ GIVS+G K P V+TR++++ PWI
Sbjct: 166 LCVGNPRKTKSAFKGDSGGPLLCAG---VAQGIVSYGRSDAKP--PAVFTRISHYRPWIN 220
Query: 420 KNLKKN 425
+ L+ N
Sbjct: 221 QILQAN 226
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 74/240 (30%), Positives = 119/240 (49%), Gaps = 22/240 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ + P++ ++ +G CGG L+ + VLTAAHC+A +A+L + LG
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQ----RMAQLRLVLGL 56
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFD-MRTLYNDVAILTLDKPVKYSDTIRAICLPRGR- 306
H + H +K ++H + + L N++A+L LD VK S TIR + LP R
Sbjct: 57 HTLDSPGLTFH----IKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQ 112
Query: 307 ASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADC-KARY--GPVAPGGIVDHFLC 363
G ++ GWG + G VL+++++ V C +R+ G ++P +C
Sbjct: 113 VVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPS-----MVC 167
Query: 364 AGRATKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITK 420
+KD C GDSGGPL+ G+ G++S+ C P V T V ++ WI K
Sbjct: 168 LAADSKDQAPCKGDSGGPLVCGKGR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRK 226
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 75/252 (29%), Positives = 116/252 (46%), Gaps = 21/252 (8%)
Query: 187 ERIVGGQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKL 242
R+V G++A W W V++ + F CGGSLI V+TA HC++ ++ V
Sbjct: 10 SRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQVV-- 67
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLY--NDVAILTLDKPVKYSDTIRAI 300
+ D ++ Q +E + + L H ++ + ND+A++ L + + D ++
Sbjct: 68 -LGEYDRSVLQGSE-QVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLA 125
Query: 301 CLPRGRASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGI 357
LP + I GWG L GP P LQ+ +PV C +G +
Sbjct: 126 NLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQYDWWGITVKKTM 185
Query: 358 VDHFLCAGRATKDSCTGDSGGPLM--VNDGKWTQVGIVSW--GIGCGKGEYPGVYTRVTY 413
V CAG T+ C GDSGGPL DG W G+ S+ GC + P V+TRV+
Sbjct: 186 V----CAGGDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSA 241
Query: 414 FMPWITKNLKKN 425
F+ WI + + N
Sbjct: 242 FIDWINETIASN 253
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 29/246 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + + P++ + N +FCGG LI VLTAAHC ++V
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGR-------SITV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
LG HNI ++ + +K+ RH ++ TL++D+ +L L + + + + P
Sbjct: 54 TLGAHNITEEEDTWQKLEVIKQF-RHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF-- 361
+ G++ V GWG P LQ+V + + C DH
Sbjct: 113 QFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRD-------FDHNLQ 165
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
LC G R TK + GDSGGPL+ GIVS+G K P V+TR++++ PWI
Sbjct: 166 LCVGNPRKTKSAFKGDSGGPLLCAG---VAQGIVSYGRSDAKP--PAVFTRISHYRPWIN 220
Query: 420 KNLKKN 425
+ L+ N
Sbjct: 221 QILQAN 226
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 29/246 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + + P++ + N +FCGG LI VLTAAHC ++V
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGR-------SITV 55
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP- 303
LG HNI ++ + +K+ RH ++ TL++D+ +L L + + + + P
Sbjct: 56 TLGAHNITEEEDTWQKLEVIKQF-RHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 114
Query: 304 RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF-- 361
+ G++ V GWG P LQ+V + + C DH
Sbjct: 115 QFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRD-------FDHNLQ 167
Query: 362 LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWIT 419
LC G R TK + GDSGGPL+ GIVS+G K P V+TR++++ PWI
Sbjct: 168 LCVGNPRKTKSAFKGDSGGPLLCAG---VAQGIVSYGRSDAKP--PAVFTRISHYRPWIN 222
Query: 420 KNLKKN 425
+ L+ N
Sbjct: 223 QILQAN 228
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 30/243 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIF---NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVN 245
IVGG A+ + P++ ++ N G FCGG+LI VLTAAHC+ D+ + VN
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLR-----DIPQRLVN 55
Query: 246 --LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP 303
LG HN++ + + + + + +D ND+ ++ L P S ++ + LP
Sbjct: 56 VVLGAHNVRTQEPTQQHFSVAQVFLNN--YDAENKLNDILLIQLSSPANLSASVATVQLP 113
Query: 304 -RGRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
+ + G +GWG + P VLQ++N+ V T C+ H +
Sbjct: 114 QQDQPVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTFF-CRP------------HNI 160
Query: 363 C--AGRATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
C R C GDSGGPL+ + V W GC +P +TRV ++ WI
Sbjct: 161 CTFVPRRKAGICFGDSGGPLICDGIIQGIDSFVIW--GCATRLFPDFFTRVALYVDWIRS 218
Query: 421 NLK 423
L+
Sbjct: 219 TLR 221
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 25/234 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A ++P++ +I N G CGG+LI + V+TAA C S + +V LG
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASC---FQSQNPGVSTVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
++++++ + + +D + ND+ +L LD+ + ++ + LP A+
Sbjct: 58 YDLRRRERQSRQTFSISSM-SENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNAT 116
Query: 309 YE-GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
E G V GWGS R G + VN+ V C+ + +C G
Sbjct: 117 VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP------------NNVCTGVL 164
Query: 368 TKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWI 418
T+ C GD G PL+ + G+ S+ +G CG+G P +TRV F WI
Sbjct: 165 TRRGGICNGDGGTPLVC---EGLAHGVASFSLGPCGRG--PDFFTRVALFRDWI 213
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 71/231 (30%), Positives = 112/231 (48%), Gaps = 19/231 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A + WP++V++ +G FCG +LI V++AAHCVA+++ + V LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHCVANVNV---RAVRVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
HN+ ++ + V V+R+ +D L ND+ IL L+ + ++ LP +GR
Sbjct: 58 HNLSRREPTRQVF-AVQRIF-EDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRR 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G +GWG L + +VLQ++N+ V T+ ++ + G
Sbjct: 116 LGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRG-----------R 164
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
C GDSG PL+ N G + G GC G YP + V F+ WI
Sbjct: 165 QAGVCFGDSGSPLVCN-GLIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 76/245 (31%), Positives = 115/245 (46%), Gaps = 24/245 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG + P++V + K C G+LI VLTAAHC + S V LG
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRS------QVILGA 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
H+I ++ K + VK+ + +D T D+ +L L + K + + + LP +G
Sbjct: 55 HSITREEPTKQIML-VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDD 113
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR----YGPVAPGGIVDHFLC 363
G + V GWG S L++VNI + C R + PV I + +C
Sbjct: 114 VKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPV----IGMNMVC 169
Query: 364 AG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGI--GCGKGEYPGVYTRVT-YFMPWI 418
AG R +DSC GDSG PL+ +G + G+ S+G+ CG PGVY ++ + WI
Sbjct: 170 AGSLRGGRDSCNGDSGSPLLC-EGVFR--GVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
Query: 419 TKNLK 423
+K
Sbjct: 227 IMTIK 231
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 71/231 (30%), Positives = 111/231 (48%), Gaps = 19/231 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A + WP++V++ G FCG +LI V++AAHCVA+++ + V LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNV---RAVRVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
HN+ ++ + V V+R+ +D L ND+ IL L+ + ++ LP +GR
Sbjct: 58 HNLSRREPTRQVF-AVQRIF-ENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRR 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G +GWG L + +VLQ++N+ V T+ ++ + G
Sbjct: 116 LGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRG-----------R 164
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
C GDSG PL+ N G + G GC G YP + V F+ WI
Sbjct: 165 QAGVCFGDSGSPLVCN-GLIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 71/231 (30%), Positives = 111/231 (48%), Gaps = 19/231 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A + WP++V++ G FCG +LI V++AAHCVA+++ + V LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNV---RAVRVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
HN+ ++ + V V+R+ +D L ND+ IL L+ + ++ LP +GR
Sbjct: 58 HNLSRREPTRQVF-AVQRIF-ENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRR 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G +GWG L + +VLQ++N+ V T+ ++ + G
Sbjct: 116 LGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRG-----------R 164
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
C GDSG PL+ N G + G GC G YP + V F+ WI
Sbjct: 165 QAGVCFGDSGSPLVCN-GLIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 71/231 (30%), Positives = 111/231 (48%), Gaps = 19/231 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A + WP++V++ G FCG +LI V++AAHCVA+++ + V LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNV---RAVRVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
HN+ ++ + V V+R+ +D L ND+ IL L+ + ++ LP +GR
Sbjct: 58 HNLSRREPTRQVF-AVQRIF-EDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRR 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G +GWG L + +VLQ++N+ V T+ ++ + G
Sbjct: 116 LGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRG-----------R 164
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
C GDSG PL+ N G + G GC G YP + V F+ WI
Sbjct: 165 QAGVCFGDSGSPLVCN-GLIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 73/241 (30%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+ GG NE +V +FNS CGG+LI+ V+TAAHC D + G
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHC-------DSNNFQLLFGV 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
H+ K NE + ++ + D+ ++ LD V S+ I A
Sbjct: 54 HSKKILNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHI-APLSLPSSPP 112
Query: 309 YEGKIATVIGWG-SLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG-- 365
G + ++GWG ++ P V NI + +A C+ Y + + + LCAG
Sbjct: 113 SVGSVCRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAY---SWRQVANTTLCAGIL 169
Query: 366 RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTYFMPWITKNLKK 424
+ +D+C DSGGPL+ N GIVSWG CG+ PGVYT+V ++ WI +
Sbjct: 170 QGGRDTCHFDSGGPLICNG---IFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSIIAG 226
Query: 425 N 425
N
Sbjct: 227 N 227
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 47/98 (47%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 329 PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRATKDSCTGDSGGPLMVN-DGKW 387
P LQ+ +P+ + ADCK +G I D CAG + DSC GDSGGPL+ DG W
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGS----KITDVMTCAGASGVDSCMGDSGGPLVCQKDGVW 61
Query: 388 TQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
T GIVSWG G PGVY+RVT MPW+ + L+ N
Sbjct: 62 TLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQILEAN 99
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 73/252 (28%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG E++ PW VA+++ G CGG L+ Q VLTAAHC++ + LG
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMS-------DDYQIWLGR 53
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTL-------YNDVA----ILTLDKPVKYSDTI 297
HN+ + + +V FD+ L Y+D++ +L L +P + +D +
Sbjct: 54 HNLSKDEDTAQF-HQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAV 112
Query: 298 RAICLPRGRASYEGKIATVIGWGSLRE-SGPQPAVLQKVNIPVWTNADCKARYGPVAPGG 356
+ + LP G GWG + + LQ V + + +N C Y P
Sbjct: 113 KILDLPTQEPKL-GSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCARAY----PEK 167
Query: 357 IVDHFLCAGRATKDS--CTGDSGGPLMVNDGKWTQVGIVSWGIG-CGKGEYPGVYTRVTY 413
+ + LCA C GDSGG L+ DG + GI SWG C V+T+V
Sbjct: 168 MTEFVLCATHRDDSGSICLGDSGGALIC-DGVFQ--GITSWGYSECADFNDNFVFTKVMP 224
Query: 414 FMPWITKNLKKN 425
WI + ++KN
Sbjct: 225 HKKWIKETIEKN 236
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 70/231 (30%), Positives = 110/231 (47%), Gaps = 19/231 (8%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG+ A + WP++V++ G FCG +LI V++AAHCVA+++ + V LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNV---RAVRVVLGA 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
HN+ ++ + V V+R+ +D L ND+ IL L+ + ++ LP +GR
Sbjct: 58 HNLSRREPTRQVF-AVQRIF-ENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRR 115
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA 367
G +GWG L + +VLQ++N+ V T+ ++ + G
Sbjct: 116 LGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRG-----------R 164
Query: 368 TKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
C GD G PL+ N G + G GC G YP + V F+ WI
Sbjct: 165 QAGVCFGDXGSPLVCN-GLIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 75/245 (30%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG + P++V + K C G+LI VLTAAHC + S V LG
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRS------QVILGA 54
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-RGRA 307
H+I ++ K + VK+ + +D T D+ +L L + K + + + LP +G
Sbjct: 55 HSITREEPTKQI-MLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDD 113
Query: 308 SYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKAR----YGPVAPGGIVDHFLC 363
G + V GWG S L++V I + C R + PV I + +C
Sbjct: 114 VKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPV----IGMNMVC 169
Query: 364 AG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGI--GCGKGEYPGVYTRVT-YFMPWI 418
AG R +DSC GDSG PL+ +G + G+ S+G+ CG PGVY ++ + WI
Sbjct: 170 AGSLRGGRDSCNGDSGSPLLC-EGVFR--GVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
Query: 419 TKNLK 423
+K
Sbjct: 227 IMTIK 231
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 46/98 (46%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 329 PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRATKDSCTGDSGGPLMVN-DGKW 387
P LQ+ +P+ + ADCK +G I D CAG + DSC GDSGGPL+ DG W
Sbjct: 6 PEKLQQAALPIVSEADCKKSWG----SKITDVMTCAGASGVDSCMGDSGGPLVCQKDGVW 61
Query: 388 TQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
T GIVSWG G P VY+RVT MPW+ + L+ N
Sbjct: 62 TLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQILEAN 99
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 70/247 (28%), Positives = 112/247 (45%), Gaps = 21/247 (8%)
Query: 192 GQNAEQNEWPWVVAI-FNSGKQF---CGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
G++A W W V++ + F CGGSLI V+TA HC++ ++ V +
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQVV---LGEY 58
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLY--NDVAILTLDKPVKYSDTIRAICLPRG 305
D ++ + +E + + L H ++ + ND+A++ L + + D ++ LP
Sbjct: 59 DRSVLEGSE-QVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPPA 117
Query: 306 RASYEGKIATVI-GWGSLRESGPQPAVLQKVNIPVWTNADCKAR--YGPVAPGGIVDHFL 362
+ I GWG L GP P LQ+ +P C +G + +
Sbjct: 118 GDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGIT----VKKTMV 173
Query: 363 CAGRATKDSCTGDSGGPLM--VNDGKWTQVGIVSW--GIGCGKGEYPGVYTRVTYFMPWI 418
CAG T+ C GDSGGPL DG W G+ S+ GC + P V+TRV+ F+ WI
Sbjct: 174 CAGGDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWI 233
Query: 419 TKNLKKN 425
+ + N
Sbjct: 234 DETIASN 240
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 274 DMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRASYEGKIATVIGWGSLRESGPQ----P 329
D + +D+ +L L P K +D ++ + LP G GWGS+ E GP P
Sbjct: 2 DGKDYSHDLMLLRLQSPAKITDAVKVLELPTQEPEL-GSTCEASGWGSI-EPGPDDFEFP 59
Query: 330 AVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGR--ATKDSCTGDSGGPLMVNDGKW 387
+Q V + + N C + P + + LCAG KD+C GDSGGPL+ N G W
Sbjct: 60 DEIQCVQLTLLQNTFCADAH----PDKVTESMLCAGYLPGGKDTCMGDSGGPLICN-GMW 114
Query: 388 TQVGIVSWG-IGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
GI SWG CG P +YT++ +++ WI + +N
Sbjct: 115 Q--GITSWGHTPCGSANKPSIYTKLIFYLDWIDDTITEN 151
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 18/233 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
I+GG+ ++ + PW V + K FCGGS++ V+TAA CV D+ S++ G
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTKPSDI---SIHYGS 57
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSD-TIRAICLPRGRA 307
K V K +VR+ M+ N+ A++ + P+K D T + I LP
Sbjct: 58 SYRTTKG--TSVMAKKIYIVRYHPLTMQ---NNYAVIETEMPIKLDDKTTKKIELPSLLY 112
Query: 308 SYEGKIATVI-GWGSLR-ESGPQPAVLQKVNIPVWTNADCKARYGPV-APGGIVDHFLCA 364
E + ++ GWGS +S L + N V C+ +Y + A I D CA
Sbjct: 113 DPEPDTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIYDGVFCA 172
Query: 365 GRATKDSCT--GDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFM 415
G ++ GD+G P + N T VG+ S+ I E+P V+ RV Y++
Sbjct: 173 GGEYDETYIGYGDAGDPAVQN---GTLVGVASY-ISSMPSEFPSVFLRVGYYV 221
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 42/99 (42%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 329 PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--RATKDSCTGDSGGPLMVNDGK 386
P++LQ + PV +N+ CK+ Y PG I + +C G + KDSC GDSGGP++ N
Sbjct: 7 PSLLQCLKAPVLSNSSCKSSY----PGQITGNMICVGFLQGGKDSCQGDSGGPVVCNG-- 60
Query: 387 WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 61 -QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 98
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + + P++ + + CGG LI Q VLTAAHC +++V
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHCKGR-------EITV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG H+++++ + + KV++ + H++++ +D+ +L L+K V+ + + + LP
Sbjct: 54 ILGAHDVRKRESTQQ-KIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPS 112
Query: 305 -GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADC-KARYGPVAPGGIVDHFL 362
+ G + GWG P L++V + + C RY +
Sbjct: 113 PSDFIHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYE------YKFQV 166
Query: 363 CAGRAT--KDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWI 418
C G T + + GDSGGPL+ GIVS+G K P ++TRV+ ++PWI
Sbjct: 167 CVGSPTTLRAAFMGDSGGPLLCAG---VAHGIVSYGHPDAKP--PAIFTRVSTYVPWI 219
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 70/254 (27%), Positives = 111/254 (43%), Gaps = 45/254 (17%)
Query: 189 IVGGQNAEQNEWPWV----VAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSV 244
I+GG + P++ + + C G LI V+TAAHC ++V
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAGR-------SITV 53
Query: 245 NLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
LG HN K K + + +V++ H +D R + ND+ +L L + K + T+ LP
Sbjct: 54 LLGAHNKKVKEDTWQ-KLEVEKQFPHPKYDDRLVLNDIMLLKLKE--KANLTLGVGTLPI 110
Query: 305 GRASYE---GKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHF 361
S G++ +GWG + P LQ+V + + CK HF
Sbjct: 111 SAKSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACK-------------HF 157
Query: 362 --------LCAG--RATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRV 411
LC G + ++ GDSGGPL+ GI S+ + K P V+TR+
Sbjct: 158 EDFHQEPQLCVGNPKKIRNVYKGDSGGPLLCAG---IAQGIASYVLRNAKP--PSVFTRI 212
Query: 412 TYFMPWITKNLKKN 425
+++ PWI K L++N
Sbjct: 213 SHYRPWINKILREN 226
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 42/98 (42%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 329 PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRATKDSCTGDSGGPLMVN-DGKW 387
P LQ+ ++P+ +N +CK +G I D +CAG + SC GDSGGPL+ +G W
Sbjct: 4 PDRLQQASLPLLSNTNCKKYWGT----KIKDAMICAGASGVSSCMGDSGGPLVCKKNGAW 59
Query: 388 TQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
T VGIVSWG PGVY RVT + W+ + L N
Sbjct: 60 TLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN 97
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 42/98 (42%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 329 PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRATKDSCTGDSGGPLMVN-DGKW 387
P LQ+ ++P+ +N +CK +G I D +CAG + SC GDSGGPL+ +G W
Sbjct: 3 PDRLQQASLPLLSNTNCKKYWGT----KIKDAMICAGASGVSSCMGDSGGPLVCKKNGAW 58
Query: 388 TQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
T VGIVSWG PGVY RVT + W+ + L N
Sbjct: 59 TLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN 96
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 49/291 (16%)
Query: 163 VTTTEAGKVDMSCGQKNGYQDLDQERIVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQ 222
VT + + + CG+ D Q RI+GG + +PW + + G +LI+ Q
Sbjct: 78 VTGEKLPECEAVCGKPKNPVDQVQ-RIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQ 136
Query: 223 HVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNEV---------KHVERKVKRLVRHKAF 273
+LT A ++ LG N + ++ K E ++++++ H
Sbjct: 137 WLLTTAK-------------NLRLGHKNDTKAKDIAPTLRLYVGKKQEVEIEKVIFHP-- 181
Query: 274 DMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRASYEGKIATVIGWGSLRESGPQ-PAVL 332
D T+ D+ ++ L + V ++ + ICLP G + V GWG R + L
Sbjct: 182 DNSTV--DIGLIKLKQKVPVNERVMPICLPSKDYVNVGLVGYVSGWG--RNANLNFTEHL 237
Query: 333 QKVNIPVWTNADCKARY---------GPVAPGGIV----DHFLCAG--RATKDSCTGDSG 377
+ V +PV C Y P +P G+ +H CAG + +D+C GD+G
Sbjct: 238 KYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAG 297
Query: 378 GPLMV---NDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
V +D W GI+S+ C EY GVY RVT + WI + N
Sbjct: 298 SAFAVHDKDDDTWYAAGILSFDKSCRTAEY-GVYVRVTSILDWIQTTIADN 347
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 192 GQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHN 250
G++A WPW V++ + +G FCGGSLI V+TAAHC S VA G+ +
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVA------GEFD 54
Query: 251 IKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRASY- 309
E V K+ ++ ++ F+M T+ ND+ +L L P ++S+T+ A+CLP +
Sbjct: 55 QGSDEENIQV-LKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDFP 113
Query: 310 EGKIATVIGWGSLR 323
G + GWG +
Sbjct: 114 PGTVCATTGWGKTK 127
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 41/99 (41%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 329 PAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAG--RATKDSCTGDSGGPLMVNDGK 386
P++LQ + PV +++ CK+ Y PG I + +C G KDSC GDSGGP++ N
Sbjct: 7 PSLLQCLKAPVLSDSSCKSSY----PGQITGNMICVGFLEGGKDSCQGDSGGPVVCNG-- 60
Query: 387 WTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKKN 425
GIVSWG GC + PGVYT+V ++ WI + + N
Sbjct: 61 -QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 98
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 46/137 (33%), Positives = 72/137 (52%), Gaps = 9/137 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IV G++A WPW V++ + +G FCGGSLI V+TAAHC S VA G
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVA------G 54
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
+ + E V K+ ++ ++ F+M T+ ND+ +L L P ++S+T+ A+ LP
Sbjct: 55 EFDQGSDEENIQV-LKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVDD 113
Query: 308 SY-EGKIATVIGWGSLR 323
+ G + GWG +
Sbjct: 114 DFPPGTVCATTGWGKTK 130
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 77.0 bits (188), Expect = 2e-14, Method: Composition-based stats.
Identities = 46/135 (34%), Positives = 71/135 (52%), Gaps = 10/135 (7%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC +++ V LG+
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK-------SRIQVRLGE 52
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRAS 308
HNI + K ++ H F+ TL ND+ ++ L P + + + LPR A+
Sbjct: 53 HNIDVLEGNEQFINAAK-IITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA 111
Query: 309 YEGKIATVIGWGSLR 323
G + GWG+ +
Sbjct: 112 -AGTECLISGWGNTK 125
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 68/242 (28%), Positives = 108/242 (44%), Gaps = 23/242 (9%)
Query: 189 IVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVA--HMSSWDVAKLSVN 245
+VGG PW V++ N G+ FCGGSL+ Q +LTA C + HM + V
Sbjct: 1 VVGGHPGNS---PWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHM---PLTGYEVW 54
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLP-R 304
LG +H E ++R+ K + + + +L L++ V + + ICLP
Sbjct: 55 LGT----LFQNPQHGEPSLQRVPVAKMVCGPS-GSQLVLLKLERSVTLNQRVALICLPPE 109
Query: 305 GRASYEGKIATVIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCA 364
G + GWG + +G VL + V +N +C ++ G + + +C
Sbjct: 110 WYVVPPGTKCEIAGWGETKGTG-NDTVLNVALLNVISNQECNIKH----RGRVRESEMCT 164
Query: 365 G--RATKDSCTGDSGGPLM-VNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKN 421
A +C GD GGPL W GI+ C + +P V+TRV+ F+ WI K
Sbjct: 165 EGLLAPVGACEGDYGGPLACFTHNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWIHKV 224
Query: 422 LK 423
++
Sbjct: 225 MR 226
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 9/137 (6%)
Query: 189 IVGGQNAEQNEWPWVVAIFN-SGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLG 247
IV G+ A WPW V++ + +G FCGGSLI+ V+TAAHC S VA G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA------G 54
Query: 248 DHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRGRA 307
+ + +E K + K+ ++ ++ ++ T+ ND+ +L L +S T+ A+CLP
Sbjct: 55 EFDQGSSSE-KIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD 113
Query: 308 SY-EGKIATVIGWGSLR 323
+ G GWG R
Sbjct: 114 DFAAGTTCVTTGWGLTR 130
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 54/154 (35%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWD----VAKL 242
IV GQ+AE PW V +F Q CG SLI + VLTAAHC+ + WD V L
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTVDDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYN-------DVAILTLDKPVKYSD 295
V +G H+ + ERKV+++ + YN D+A+L L +P++ SD
Sbjct: 60 LVRIGKHSRTR------YERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSD 113
Query: 296 TIRAICLPRGRAS----YEGKIATVIGWGSLRES 325
I +CLP + + + G V GWG+ RE+
Sbjct: 114 YIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRET 147
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 202 WVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNEVKHVE 261
W+V++ K CGGSLI VLTA C S D+ LG H++ + +
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQC---FPSRDLKDYEAWLGIHDVHGRG-----D 64
Query: 262 RKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GRASYEGKIATVIGWG 320
K K+++ +D+ ++ L +P D + I LP G E +V GWG
Sbjct: 65 EKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWG 124
Query: 321 SLRESGPQPAVLQKVNIPVWTNADCKARY-GPVAPGGIVDHFLCAGRATKDS--CTGDSG 377
+L+ ++ + N C + G V + + +CAG S C GD G
Sbjct: 125 YTGLIN-YDGLLRVAHLYIMGNEKCSQHHRGKVT---LNESEICAGAEKIGSGPCEGDYG 180
Query: 378 GPLMVNDGKWTQV-GIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
GPL+ K V G++ G GC PG++ RV Y+ WI K
Sbjct: 181 GPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHK 224
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 202 WVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNEVKHVE 261
W+V++ K CGGSLI VLTA C S D+ LG H++ + +
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQC---FPSRDLKDYEAWLGIHDVHGRG-----D 64
Query: 262 RKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR-GRASYEGKIATVIGWG 320
K K+++ +D+ ++ L +P D + I LP G E +V GWG
Sbjct: 65 EKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWG 124
Query: 321 SLRESGPQPAVLQKVNIPVWTNADCKARY-GPVAPGGIVDHFLCAGRATKDS--CTGDSG 377
+L+ ++ + N C + G V + + +CAG S C GD G
Sbjct: 125 YTGLIN-YDGLLRVAHLYIMGNEKCSQHHRGKVT---LNESEICAGAEKIGSGPCEGDYG 180
Query: 378 GPLMVNDGKWTQV-GIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
GPL+ K V G++ G GC PG++ RV Y+ WI K
Sbjct: 181 GPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHK 224
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 18/151 (11%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWDVA----KL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAIC 301
V +G H+ + ++++ H ++ R L D+A++ L KPV +SD I +C
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 302 LPRG-------RASYEGKIATVIGWGSLRES 325
LP +A Y+G+ V GWG+L+E+
Sbjct: 120 LPDRETAASLLQAGYKGR---VTGWGNLKET 147
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 24/243 (9%)
Query: 191 GGQNAEQNEWPWVVAIFN-SGKQ--FCGGSLIDTQHVLTAAHCVAHM--SSWDVAKLSVN 245
GG+ + + PW VA+ G++ CGG+++ VLTAAHCV + + S N
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVIQYESTN 61
Query: 246 LGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPRG 305
L + K V HV R T+ ND+AIL L +P+K D +++
Sbjct: 62 LWEDPGKSDPYVSHVYLSFYR--------QETMENDIAILELSRPLKL-DGLKSKPAKLP 112
Query: 306 RASYEGKIAT---VIGWGSLRESGPQPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFL 362
+ K + V G+G + P+ L+ + V +C+ +YGP+ +
Sbjct: 113 DIEFRPKTGSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECRTKYGPIF---LSLQVF 169
Query: 363 CAGRATKDSCTGDSGGPLMVNDGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNL 422
CA + +GD+G P + D T VG+ ++ +G P V+T+V ++ WI +
Sbjct: 170 CAQKVGVSLESGDAGDPTVQQD---TLVGVAAYFPKRPEGA-PEVFTKVGSYVSWIQDII 225
Query: 423 KKN 425
KK
Sbjct: 226 KKK 228
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 71/239 (29%), Positives = 108/239 (45%), Gaps = 46/239 (19%)
Query: 195 AEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQK 254
++Q PW V I ++ C G+LI Q VLTAAHC + D + VN+GD +
Sbjct: 230 SDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGN--DHSLWRVNVGDPKSQWG 287
Query: 255 NEVKHVERKVKRLVRHKAFDMRTLYN---------DVAILTLDKPVKYSDTIRAICLPRG 305
E +++ V FD+ N D+A+L L + VK S R ICLP
Sbjct: 288 KEF-----LIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP-- 340
Query: 306 RASYEGKIATVIGWGSL----------RESGPQPAVL---QKVNIPV-----WTN-ADCK 346
+ E +A GS ++S P V K+NI + WT+ A+
Sbjct: 341 -CTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVV 399
Query: 347 ARYGPVAPG------GIVDHFLCAGRATKDS-CTGDSGGPLMVNDG-KWTQVGIVSWGI 397
++ + P + D FLC+G +S C G+SGG + + ++ QVG+VSWG+
Sbjct: 400 SQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGL 458
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/239 (29%), Positives = 108/239 (45%), Gaps = 46/239 (19%)
Query: 195 AEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQK 254
++Q PW V I ++ C G+LI Q VLTAAHC + D + VN+GD +
Sbjct: 238 SDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGN--DHSLWRVNVGDPKSQWG 295
Query: 255 NEVKHVERKVKRLVRHKAFDMRTLYN---------DVAILTLDKPVKYSDTIRAICLPRG 305
E +++ V FD+ N D+A+L L + VK S R ICLP
Sbjct: 296 KEF-----LIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP-- 348
Query: 306 RASYEGKIATVIGWGSL----------RESGPQPAVL---QKVNIPV-----WTN-ADCK 346
+ E +A GS ++S P V K+NI + WT+ A+
Sbjct: 349 -CTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVV 407
Query: 347 ARYGPVAPG------GIVDHFLCAGRATKDS-CTGDSGGPLMVNDG-KWTQVGIVSWGI 397
++ + P + D FLC+G +S C G+SGG + + ++ QVG+VSWG+
Sbjct: 408 SQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGL 466
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 41/105 (39%), Positives = 54/105 (51%), Gaps = 12/105 (11%)
Query: 328 QPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRA-----TKDSCTGDSGGPLMV 382
QP+VLQ VN+P+ CKA I D+ CAG D+C GDSGGP ++
Sbjct: 6 QPSVLQVVNLPLVERPVCKAS----TRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVM 61
Query: 383 N---DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITKNLKK 424
+ +W Q+GIVSWG GC + G YT V WI K + +
Sbjct: 62 KSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR 106
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 40/101 (39%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 328 QPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMV 382
QP+VLQ VN+P+ CK I D+ CAG D+C GDSGGP ++
Sbjct: 2 QPSVLQVVNLPIVERPVCKDS----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVM 57
Query: 383 N---DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
+ +W Q+GIVSWG GC + G YT V WI K
Sbjct: 58 KSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 40/101 (39%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 328 QPAVLQKVNIPVWTNADCKARYGPVAPGGIVDHFLCAGRATK-----DSCTGDSGGPLMV 382
QP+VLQ VN+P+ CK I D+ CAG D+C GDSGGP ++
Sbjct: 2 QPSVLQVVNLPIVERPVCKDS----TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVM 57
Query: 383 N---DGKWTQVGIVSWGIGCGKGEYPGVYTRVTYFMPWITK 420
+ +W Q+GIVSWG GC + G YT V WI K
Sbjct: 58 KSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 61/276 (22%)
Query: 172 DMSCGQKNGYQDLDQERIVG----------GQNAEQNEWPWVVAIF--NSGKQFCGGSLI 219
DM C + YQ +D+ + + G + + W +++ + G + C G+++
Sbjct: 190 DMECLEDVFYQMIDESQSLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVV 249
Query: 220 DTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMR--- 276
VLTAAHC +V+ +H+IK + + +++ ++ H +++
Sbjct: 250 SEYFVLTAAHC-----------FTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKK 298
Query: 277 -----TLYN-DVAILTLDKPVKYSDTIRAICLPRGRASYEG--------------KIATV 316
Y+ DVA++ L +KY TIR ICLP + ++
Sbjct: 299 EAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPA 358
Query: 317 IGWGSLRESGPQPAVLQK-VNIPVWTNADCKARYGPVAPGG---------IVDHFLCAG- 365
+L S + + +K V I R APG + FLC G
Sbjct: 359 QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGG 418
Query: 366 ---RATKDSCTGDSGGPLMVND-GKWTQVGIVSWGI 397
A ++C GDSGGPL+V+ ++ QVG++SWG+
Sbjct: 419 VSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGV 454
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 51/246 (20%)
Query: 192 GQNAEQNEWPWVVAIF--NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDH 249
G + + W +++ + G + C G+++ VLTAAHC +V+ +H
Sbjct: 21 GTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-----------FTVDDKEH 69
Query: 250 NIKQKNEVKHVERKVKRLVRHKAFDMR--------TLYN-DVAILTLDKPVKYSDTIRAI 300
+IK + + +++ ++ H +++ Y+ DVA++ L +KY TIR I
Sbjct: 70 SIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 129
Query: 301 CLPRGRASYEG--------------KIATVIGWGSLRESGPQPAVLQK-VNIPVWTNADC 345
CLP + ++ +L S + + +K V I
Sbjct: 130 CLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGS 189
Query: 346 KARYGPVAPGG---------IVDHFLCAG----RATKDSCTGDSGGPLMVND-GKWTQVG 391
R APG + FLC G A ++C GDSGGPL+V+ ++ QVG
Sbjct: 190 CERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVG 249
Query: 392 IVSWGI 397
++SWG+
Sbjct: 250 VISWGV 255
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 55/248 (22%)
Query: 193 QNAEQNEWPWVVAIF----NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGD 248
+ + ++ PW I + G + C G+++ VLTAAHC +V+ +
Sbjct: 452 KGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-----------FTVDDKE 500
Query: 249 HNIKQKNEVKHVERKVKRLVRHKAFDMR--------TLYN-DVAILTLDKPVKYSDTIRA 299
H+IK + + +++ ++ H +++ Y+ DVA++ L +KY TIR
Sbjct: 501 HSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 560
Query: 300 ICLPRGRASYEG-KIATVIGWGSLRES------------GPQPAVLQKVNIPVWTNADCK 346
ICLP + ++ +E + L + + + N D K
Sbjct: 561 ICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYI-KNGDKK 619
Query: 347 A---RYGPVAPGG---------IVDHFLCAG----RATKDSCTGDSGGPLMVND-GKWTQ 389
R APG + FLC G A ++C GDSGGPL+V+ ++ Q
Sbjct: 620 GSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQ 679
Query: 390 VGIVSWGI 397
VG++SWG+
Sbjct: 680 VGVISWGV 687
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 55/240 (22%)
Query: 201 PWVVAIF----NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNE 256
PW I + G + C G+++ VLTAAHC +V+ +H+IK
Sbjct: 469 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-----------FTVDDKEHSIKVSVG 517
Query: 257 VKHVERKVKRLVRHKAFDMR--------TLYN-DVAILTLDKPVKYSDTIRAICLPRGRA 307
+ + +++ ++ H +++ Y+ DVA++ L +KY TIR ICLP
Sbjct: 518 GEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEG 577
Query: 308 SYEG-KIATVIGWGSLRES------------GPQPAVLQKVNIPVWTNADCKA---RYGP 351
+ ++ +E + L + + + N D K R
Sbjct: 578 TTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYI-KNGDKKGSCERDAQ 636
Query: 352 VAPGG---------IVDHFLCAG----RATKDSCTGDSGGPLMVND-GKWTQVGIVSWGI 397
APG + FLC G A ++C GDSGGPL+V+ ++ QVG++SWG+
Sbjct: 637 YAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGV 696
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 55/240 (22%)
Query: 201 PWVVAIF----NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNE 256
PW I + G + C G+++ VLTAAHC +V+ +H+IK
Sbjct: 479 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-----------FTVDDKEHSIKVSVG 527
Query: 257 VKHVERKVKRLVRHKAFDMR--------TLYN-DVAILTLDKPVKYSDTIRAICLPRGRA 307
+ + +++ ++ H +++ Y+ DVA++ L +KY TIR ICLP
Sbjct: 528 GEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEG 587
Query: 308 SYEG-KIATVIGWGSLRES------------GPQPAVLQKVNIPVWTNADCKA---RYGP 351
+ ++ +E + L + + + N D K R
Sbjct: 588 TTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYI-KNGDKKGSCERDAQ 646
Query: 352 VAPGG---------IVDHFLCAG----RATKDSCTGDSGGPLMVND-GKWTQVGIVSWGI 397
APG + FLC G A ++C GDSGGPL+V+ ++ QVG++SWG+
Sbjct: 647 YAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGV 706
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 51/246 (20%)
Query: 192 GQNAEQNEWPWVVAIF--NSGKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDH 249
G + + W +++ + G + C G+++ VLTAAHC +V+ +H
Sbjct: 228 GTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC-----------FTVDDKEH 276
Query: 250 NIKQKNEVKHVERKVKRLVRHKAFDMR--------TLYN-DVAILTLDKPVKYSDTIRAI 300
+IK + + +++ ++ H +++ Y+ DVA++ L +KY TIR I
Sbjct: 277 SIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 336
Query: 301 CLPRGRASYEG--------------KIATVIGWGSLRESGPQPAVLQK-VNIPVWTNADC 345
CLP + ++ +L S + + +K V I
Sbjct: 337 CLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGS 396
Query: 346 KARYGPVAPGG---------IVDHFLCAG----RATKDSCTGDSGGPLMVND-GKWTQVG 391
R APG + FLC G A ++C GDSGGPL+V+ ++ QVG
Sbjct: 397 CERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVG 456
Query: 392 IVSWGI 397
++SWG+
Sbjct: 457 VISWGV 462
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 48.9 bits (115), Expect = 5e-06, Method: Composition-based stats.
Identities = 21/42 (50%), Positives = 29/42 (69%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHC 230
I+GG+ E+N PW VAI++ CGG L++ + VLTAAHC
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC 42
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/42 (54%), Positives = 30/42 (71%), Gaps = 1/42 (2%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQFCGGSLIDTQHVLTAAHC 230
IVGG N P+ V++ NSG FCGGSLI++Q V++AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHC 41
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 44.3 bits (103), Expect = 1e-04, Method: Composition-based stats.
Identities = 24/70 (34%), Positives = 41/70 (58%), Gaps = 11/70 (15%)
Query: 264 VKRLVRHKAFDMR-TLYNDVAILTLDKPVKYSDTIRAICLPRG-------RASYEGKIAT 315
++++ H ++ R L D+A++ L KPV +SD I +CLP +A Y+G+
Sbjct: 8 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGR--- 64
Query: 316 VIGWGSLRES 325
V GWG+L+E+
Sbjct: 65 VTGWGNLKET 74
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/68 (41%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 189 IVGGQNAEQNEWPWVVAIFNSGKQ--FCGGSLIDTQHVLTAAHCVAHMSSWD----VAKL 242
IV G +AE PW V +F Q CG SLI + VLTAAHC+ + WD L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLY-PPWDKNFTENDL 59
Query: 243 SVNLGDHN 250
V +G H+
Sbjct: 60 LVRIGKHS 67
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 198 NEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNE 256
+ PW V + NS GK FCGG +I VLT A C + L N+ +
Sbjct: 103 QDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKC---------SLLHRNITVKTYFNRTS 153
Query: 257 VKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
+ K+ + H +D ND+++L L+ P++ +C P
Sbjct: 154 QDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPE 201
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 198 NEWPWVVAIFNS-GKQFCGGSLIDTQHVLTAAHCVAHMSSWDVAKLSVNLGDHNIKQKNE 256
+ PW V + NS GK FCGG +I VLT A C + L N+ +
Sbjct: 62 QDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKC---------SLLHRNITVKTYFNRTS 112
Query: 257 VKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRAICLPR 304
+ K+ + H +D ND+++L L+ P++ +C P
Sbjct: 113 QDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPE 160
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 41.2 bits (95), Expect = 0.001, Method: Composition-based stats.
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 240 AKLSVNLGDHNIKQKNEVKHVERKVKRLVRHKAFDMRTLYNDVAILTLDKPVKYSDTIRA 299
+++ V LG+HNI + K ++ H F+ TL ND+ ++ L P + +
Sbjct: 1 SRIQVRLGEHNIDVLEGNEQFINAAK-IITHPNFNGNTLDNDIMLIKLSSPATLNSRVAT 59
Query: 300 ICLPRGRASYEGKIATVIGWGSLR 323
+ LPR A+ G + GWG+ +
Sbjct: 60 VSLPRSCAA-AGTECLISGWGNTK 82
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.136 0.437
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,683,124
Number of Sequences: 62578
Number of extensions: 593823
Number of successful extensions: 2399
Number of sequences better than 100.0: 360
Number of HSP's better than 100.0 without gapping: 355
Number of HSP's successfully gapped in prelim test: 5
Number of HSP's that attempted gapping in prelim test: 799
Number of HSP's gapped (non-prelim): 369
length of query: 425
length of database: 14,973,337
effective HSP length: 102
effective length of query: 323
effective length of database: 8,590,381
effective search space: 2774693063
effective search space used: 2774693063
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 53 (25.0 bits)